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This report presents an update of the prevalence
selected chronic conditions in the United States. Its purpos
to provide prevalence data by age, sex and age, race and
family income, and geographic region for major chron
condition systems. It further assesses the percent of sele
conditions that cause activity limitation, the percent for whi
a physician was consulted, and the percent that caused ho
talization. Conditions with the highest prevalence and tho
causing the most disability days are also analyzed. Trend
prevalence rates for the conditions with highest prevalence
examined as well.
Information for this report is based on data collecte
during the National Health Interview Survey (NHIS) for th
years 1990, 1991, and 1992. This is a continuing nationw
survey of households for which a probability sample of t
civilian noninstitutionalized population of the United States
interviewed by the U.S. Bureau of the Census regarding
health and other characteristics of each member of the ho
hold. The sample for the years 1990–92 was composed
142,638 households containing 368,075 persons. Each ho











Deformities or orthopedic impairments was the most
frequent chronic condition reported with almost 35 million
conditions. Other conditions high in prevalence were chronic
sinusitis, arthritis, and high blood pressure with annual aver
ages of 33.7, 31.8, and 27.6 million conditions, respectively
Mental retardation and multiple sclerosis caused the highe
percents of activity limitation among persons afflicted, 87.5 per
cent and 69.4 percent, respectively. Deformities and othe
orthopedic impairments, arthritis, and heart disease caused t
highest numbers of restricted activity days and bed disabilit
days per year, whereas, malignant neoplasms of the lun
bronchus, and other respiratory sites, caused the highe
number of restricted activity days per year, per condition
reported, 96.1 days.
In little more than a decade, the prevalence rate from
asthma has increased almost 50 percent and the rate fro
chronic bronchitis has increased 46 percent.
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by John Gary Collins, M.B.A., Division of Health
Interview Statistics
Highlights
Highlights of the data contained in this report for th
3-year period 1990–92 are summarized in the followin
statements:
+ From the time period 1979–81 to the time period 1990–9
the prevalence rate from asthma has increased alm
50 percent. The rates from chronic bronchitis and h
fever or allergic rhinitis without asthma have increase
46 percent and 25 percent, respectively.
+ The highest number of bed-disability days were caused
deformities or orthopedic impairments (161 million days
heart disease (158 million days), and arthritis (152 millio
days).
+ Mental retardation was the chronic condition most like
to cause limitation of activity, causing limitation of majo
or outside activities in 87.5 percent of persons affecte
Multiple sclerosis was the second highest causing limit
tion in 69.4 percent of those with the condition.
+ Deformities or orthopedic impairments was the chron
condition most frequently reported in the interviews, wit
an annual average prevalence of almost 35 million con
tions or 140.6 per every 1,000 persons in the civilia
noninstitutionalized population.
+ Chronic sinusitis, arthritis, and high blood pressure rank
second, third, and fourth in prevalence among the chro
conditions reported, with annual averages of 33.7, 31
and 27.6 million conditions, respectively.
+ Among persons under 18 years of age, the four mo
prevalent chronic conditions were hay fever, chronic sinu
tis, asthma, and chronic bronchitis, respectively.
+ Deformities or orthopedic impairments and chronic sinus
tis were by far the most prevalent chronic condition
among persons 18–44 years of age, with respective ra













+ Arthritis and high blood pressure were the condition
highest in prevalence among persons in the age grou
45–64 years and 65–74 years.
+ More than one-half the persons 75 years of age and ov
reported having arthritis and over 40 percent of thes
persons report having deafness and other hearing impa
ments.
+ Deformities or orthopedic impairments, chronic sinusitis
and deafness and other hearing impairments were the m
frequent conditions reported among males with respecti
rates of 136.7, 114.6, and 109.4 per 1,000 persons.
+ Among women, arthritis and chronic sinusitis were th
most frequently reported chronic conditions with rates o
158.1 and 155.5 per 1,000 persons, respectively.
+ Among black persons, high blood pressure was the mo
prevalent condition reported, with a rate of 135.3 pe
1,000 persons.
+ High blood pressure and heart disease were the mo
frequently reported circulatory conditions, whereas, chron
sinusitis and hay fever were the most prevalent respirato
conditions.
+ Deformities or orthopedic impairments and deafness an
other hearing impairments were by far the most prevale
impairments reported, with 35.0 and 23.3 million condi
tions, respectively.
+ The prevalence rate of cataracts among persons 75 ye
of age and over is almost 10 times the rate of the tot
population, 229.0 per 1,000 persons compared with 25.
+ The chronic conditions reported to cause the most restrict
activity days were deformities or orthopedic impairment
(600 million days), arthritis (445 million days), and hear
disease (400 million days).
+ Malignant neoplasms of the lung, bronchus, and oth
respiratory sites caused the highest number of restrict





























National estimates of the prevalence of selected chro
conditions in the civilian noninstitutionalized population of th
United States are presented in this report. These estimates
based on data collected by the National Center for Hea
Statistics (NCHS) by means of the National Health Intervie
Survey (NHIS) in 1990, 1991, and 1992. Data on the prev
lence of chronic conditions reported in household interview
are shown in terms of numbers and rates per 1,000 pers
cross tabulated by sex and age, race and age, family inco
and geographic region.
In addition, data are provided on the percent of chron
conditions causing limitation of activity, the percent for whic
a physician was consulted, and the percent that caused ho
talization. The numbers of restricted-activity days and be
disability days caused by selected chronic conditions and
associated days per condition are shown by an age dichoto
and by sex. Conditions with the highest prevalence, tho
causing the most restricted activity and bed disability, a
those causing the highest percent of activity limitation a

















+ Impairments and conditions of the nervous system an
sense organs
+ Conditions of the skin and subcutaneous tissue and of t
musculoskeletal system and connective tissue
+ Endocrine, nutritional, and metabolic diseases and imm
nity disorders; diseases of the blood and blood-formin
organs, and conditions of the genitourinary system
The most recent NCHS report that included NHIS data o
chronic disease prevalence wasCurrent Estimates from the
National Health Interview Survey, United States, 1994(1).
Other recent publications providing NHIS data on the preva

















































































Information in this report is based on data collect
during the National Health Interview Survey (NHIS), a co
tinuing nationwide survey of households. Each week a pr
ability sample of the civilian noninstitutionalized populatio
of the United States is interviewed by personnel of the U
Bureau of the Census. Information is obtained about the he
and other characteristics of each member of the househol
One of the strengths of NHIS is that it allows data to
combined over multiple years. This increases stability of
estimates because augmenting the sample size leads to sm
sampling errors. Combining data over time is possible beca
of the sampling design of NHIS and its use of standa
questions over several years. Combining data is particul
desirable when making estimates for relatively rare events
population subgroups—in this case, chronic conditions. The
fore, data for this report are based on information obtained
NCHS in the 1990, 1991, and 1992 surveys, and ann
averages for these three years are presented.
The NHIS sample for the 3 years combined was co
posed of 142,638 eligible households, containing 368,0
persons living at the time of interview. The total NHI
noninterview rate was about 4.4 percent; 2.8 percent was
to respondent refusal, and the remainder was primarily du
failure to locate an eligible respondent at home after repea
calls.
A description of the survey design, the methods used
estimation, and general qualifications of the data obtai
from the survey are presented inappendix I.
Because the estimates presented in this report are b
on a sample of the population, they are subject to samp
errors. Therefore, readers should pay particular attention to
section ofappendix Ientitled ‘‘Reliability of the estimates,’’
which presents formulas for calculating standard errors
instructions for their use. Sampling errors for most of t
estimates are relatively low. However, when an estima
number or the numerator or denominator of a rate or percen
small, the sampling error may be large. The relatively sm
size of the sample for the chronic condition lists (one-sixth
the total sample per year) limits the number of variables w
which the data can be effectively analyzed.
All information collected during the survey is from respo
sible family members residing in the household. When p
sible, all adult family members participate in the intervie

























who are not at home and are required for all children and f
family members who are physically or mentally incapable o
responding for themselves. Although a considerable effort
made to ensure accurate reporting, information from bo
proxy and self-respondents may be inaccurate because
respondent is unaware of relevant information, has forgott
it, does not wish to reveal it to an interviewer, or because t
respondent does not understand the intended meaning o
question. Errors may also be introduced by interviewe
coders, and others during the processing and analysis of
data.
Certain terms used in this report are defined inappendix II
and have specialized meanings for the purpose of the surve
is suggested that the reader become familiar with the
definitions.Appendix III contains the probe questions and th
recording forms used to obtain information on the prevalen
of selected chronic conditions and the resulting limitation
activity and disability days. The questionnaires used duri
the 1990, 1991, and 1992 surveys are presented in Series 1
Vital and Health Statistics(2–4). The portions of the question-
naire shown inappendix IIIfor 1992 are the same as those fo
1990 and 1991. Chronic conditions are coded using a slig
modification of theInternational Classification of Diseases
(ICD)(5), and impairments are coded by a classification show
in theNCHS Medical Coding Manual(6).
Methodological studies have shown that chronic cond
tions are generally underreported in interview surveys (7
Respondents in health interviews tend to report conditions
which they are aware and about which they are willing
report to the interviewer. Reporting is better for conditions th
have made a significant impact on affected individuals a
their families. Conditions that are severe or costly, or are bei
treated, tend to be better reported than conditions having l
impact. For instance, a condition that has caused limitation
activity, visits to the doctor, or days in bed is more likely to b
reported in the interview than one that has had little or n
impact on the person.
Methodological studies have also indicated that inclusio
of a checklist of descriptive condition titles as part of th
interview questionnaire increases the probability that a resp
dent will recognize the terms and report those of which th
respondent is aware. Of course, the diagnostic accuracy
condition reports depends on how well the respondent reme
bers information that the attending physician has passed on
the family or, in the absence of medical attendance, on t























































































s;During the period 1957–67, data were collected in NHI
on all chronic conditions. From 1968 through 1977, as part
a redesign of the data collection procedure, data on chro
conditions involving disability days, physician visits, hospita
izations, or limitation of activity were collected. In addition
prevalence information was obtained for only a single syste
of chronic conditions (for example, respiratory conditions) i
each survey year through the use of an extended checklis
chronic conditions in that system. A report describing th
design and the results of a study comparing the previo
method with the revised procedure is presented in Series 2
Vital and Health Statistics(8).
The current procedure for collecting information on chron
conditions was established in 1978. Currently, six categoric
lists of selected chronic conditions are included in the NHI
questionnaire. Each family in the NHIS is questioned on on
one of these six lists, selected on a predetermined ba
Therefore, each list is administered to only one-sixth of th
total NHIS sample each year.
These six categorical checklists of conditions are locat
in Section H of the questionnaire. For lists 3,4,6 and th
majority of list 1, items C through W, responses are based
the following question: ‘‘During the past 12 months did
anyone in the family (read names) have . . .?’’ For list 1, item
A and B, and all of list 2, responses are based on the quest
‘‘Does anyone in the family (read names) now have . . .?
Finally, for list 5, responses are based on the question ‘‘H
anyone in the family (read names) ever had . . .?’’
For each condition reported, additional information i
collected on the nature of the condition and whether th
condition caused the use of medical services (hospitalizat
and physician visits). Estimates for days of disability cause
by chronic conditions are based on the number of disabil
days reported for the 2 weeks before interview. Also
determination is made as to whether the reported conditi
causes limitation of activity.
The survey includes data only on persons living in th
household at the time of interview. Thus the experience
persons who died prior to the time of interview is exclude
from the data. Also excluded is the experience of persons w
were institutionalized or who were members of the Arme
Forces at the time of the household interview.
Estimating prevalence of chronic
conditions
‘‘Prevalence’’ often refers to the number of some item
existing at a given point in time; this definition of prevalenc
is usually referred to as ‘‘point prevalence.’’ Prevalence ca
also refer to the average number of some item existing duri
a specified interval of time and is usually called ‘‘period
prevalence.’’ The latter definition is used in the NHIS becau
the data are collected over intervals of time.
Chronic conditions are defined as conditions that eith
were first noticed 3 months or more before the date
interviews, or belong to a group of conditions considere




This report focuses on the prevalence of selected chro
conditions. The data presented represent the prevalence
conditions, not the prevalence of persons with a chron
condition. However, for most conditions, the condition preva
lence and the person prevalence are almost identical. T
purpose of this section is to clarify the instances in which larg
variations are present. Large variations between conditi
prevalence and person prevalence occur for two differe
reasons. The first is that a prevalence estimate of a condit
may include more than one of the specified checklist items
a checklist item and a specified ‘‘other condition’’ item tha
falls into the same ICD category as the checklist item. Th
second reason is that some prevalence categories shown a
combination of other categories and, as a result, a person m
have more than one of the conditions that are added to fo
the combined category. The following outlines the conditio
prevalence figures in this report that vary markedly from th
person prevalence for the condition:
+ Circulatory conditions—Two condition classes in the cir-
culatory condition tables are combinations of multipl
conditions that are not mutually exclusive. These two a
‘‘heart disease’’ and ‘‘heart rhythm disorders.’’ Thus the
prevalence estimates presented for these two conditio
are much higher than the person prevalence estima
would be. A third condition, ‘‘ischemic heart disease,’’ is
generated from multiple checklist items. The person prev
lence is estimated to be about 15 percent lower than t
condition prevalence shown in this report. Other circula
tory condition data shown in this report vary only margin
ally between person and condition prevalence.
+ Respiratory conditions—There are no significant differ-
ences between condition prevalence and person prevale
for the respiratory conditions shown in this report.
+ Digestive conditions—The only digestive condition cat-
egory for which condition prevalence and person prev
lence may vary substantially is ‘‘ulcer, gastric, duodena
and/or peptic,’’ which is a combined category of the thre
types of ulcers that are not mutually exclusive.
+ Impairments and conditions of nervous system and sen
organs—There are several combined categories among t
impairments for which condition prevalence and perso
prevalence may vary significantly. They are speech impa
ments, which includes two separate categories; absence
extremities or parts of extremities, which includes tw
categories; and deformities or orthopedic impairment
which includes four separate categories. All other cond
tion and person prevalence estimates in this section a
either identical or vary only slightly.
+ Conditions of skin and subcutaneous tissue and of mus
loskeletal system and connective tissue—The only condi-
tion in these groups for which there is a large difference
the condition and person prevalence estimates is arthri
The condition prevalence is more than 1 million cond
tions higher than the person prevalence estimate.
+ Endocrine, nutritional, and metabolic diseases and imm
nity disorders; diseases of blood and blood-forming organ
















































































n-differences between condition prevalence and person pre
lence for these categories shown in this report.
The concept of condition prevalence is generally used
NHIS because specific health indexes such as limitation
activity and disability days can be ascribed to specific cond
tions. In addition, prosthetic and pharmaceutical treatme
modes are more condition specific than person specific.
In instances when a condition prevalence estimate
distorted by multiple checklist items, such as in the case
coronary heart disease, person prevalence estimates have
and will continue to be given or the differences between th
two enumerated.
It should be pointed out that the restriction of the NHIS t
the civilian population not confined to institutions also affect
the estimated prevalence of chronic conditions. Omission
the institutionalized population reduces the prevalence es
mates, especially for the elderly, because the proportion
persons in institutions who have chronic conditions is hig
These estimates do not indicate the prevalence in the to
population.
Significance of results
In this report, terms such as ‘‘similar’’ and ‘‘the same’’
mean that no statistically significant difference exists betwe
the statistics being compared. Terms relating to difference (f
example, ‘‘greater’’ or ‘‘less’’) indicate that differences are
statistically significant. The t-test, with a critical value o
+1.96 (0.05 level of significance), was used to test all com
parisons that are discussed. Lack of comment regarding
difference between any two statistics does not mean that
difference was tested and found to be insignificant.
The significance tests in this report do not control fo
multiple comparisons. Thus some of the differences hig
lighted may not be significant when the effects of makin
multiple comparisons are considered. The reader should ass
the significance of any differences both in terms of th
statistical significance and the substantive significance of t
findings.
An asterisk is placed beside certain figures to indicate
30-percent or greater relative standard error. Figures mark
with an asterisk are given primarily to allow the reader t
combine them with related estimates and thereby possibly
produce a more reliable overall estimate for a broader catego
The Division of Health Interview Statistics, NCHS, should
be contacted for information about coding and editing proc
dures used to produce the final data file from which th
estimates shown in this report are derived.
Comparison to earlier NHIS data on
chronic conditions
Chronic condition data have been collected in NHIS sinc
1957. As described in the previous sections, the procedures
collecting chronic condition data have changed over the yea
In addition to changes in survey procedures, three ve
sions of the ICD have been used over this period. Because
























NHIS chronic condition data from 1979 and later years a
comparable for the purpose of trend analysis. There are e
exceptions within these years. For example, NHIS data
1979 showed prevalence of heart conditions that includ
rheumatic fever, whereas currently NHIS data show prev
lence of heart disease that does not include the same I
codes previously included. In addition, total deformities o
orthopedic impairments as shown in this report represen
total of the subclassifications, whereas some prior NH
publications did not treat this category as cumulative a
persons with impairments in multiple categories were on
counted once. Hence in these cases, the total shown was
than the sum of the subcategories.
Although a large amount of chronic condition data ha
been published over the years, only material published
about the last 25 years is referenced here. However, m
other publications are also cited within those publicatio
listed.
The following is a list of reports on data collected durin
the period when single systems were surveyed. A good dea
detailed and useful information is available in each of the
reports, but the reader should exercise caution in compar
estimates from the following reports with estimates fro
reports for 1979 and later years:
+ Series 10, No. 84: Prevalence of Selected Chronic Res
ratory Conditions, United States, 1970 (9)
+ Series 10, No. 92: Prevalence of Chronic Skin and Mu
culoskeletal Conditions, United States, 1969 (10)
+ Series 10, No. 94: Prevalence of Chronic Circulato
Conditions, United States, 1972 (11)
+ Series 10, No. 109: Prevalence of Chronic Conditions
the Genitourinary, Nervous, Endocrine, Metabolic, an
Blood and Blood-forming Systems and of Other Select
Chronic Conditions, United States, 1973 (12)
+ Series 10, No. 121: Characteristics of Persons with Hyp
tension, United States, 1974 (13)
+ Series 10, No. 123: Prevalence of Selected Chronic Dig
tive Conditions, United States, 1975 (14)
+ Series 10, No. 124: Prevalence of Chronic Skin an
Musculoskeletal Conditions, United States, 1976 (15)
+ Series 10, No. 134: Prevalence of Selected Impairmen
United States, 1977 (16)
In addition, data on the prevalence of chronic conditio
have been presented yearly since 1982 in theCurrent Esti-
matesreports. The most recent data are presented inCurrent
Estimates From the National Health Interview Survey, Unite
States, 1994(1). Information in theCurrent Estimatesreports
is not as detailed as the information is in this report; in th
Current Estimatesreports, estimates were subject to mo
variation because data for only 1 year were used, whereas
for 3 years were used for this report.
Finally, there have been three reports produced th
focused on the prevalence of all selected chronic conditio
since 1979:
+ Series 10, No. 155: Prevalence of Selected Chronic Co



































































































hic+ Advanced Data No. 155: Prevalence of Selected Chro
Conditions, United States, 1983–85 (18)
+ Series 10, No. 182: Prevalence of Selected Chronic C
ditions, United States, 1986–88 (19)
Other NCHS programs providing chronic
condition data
NCHS sponsors several programs that provide inform
tion on chronic conditions: NHIS, the survey from which da
in this report were obtained; the National Health and Nutriti
Examination Survey (NHANES); the vital statistics program
and the National Health Care Survey (NHCS), which h
several components that provide chronic condition-rela
data.
Because of major program differences in objectives, me
odology, and definitions, direct comparisons are precluded
the majority of instances. However, when these data sets
used to complement one another, it is possible to obtai
comprehensive overview of the prevalence and effects
chronic conditions in the United States.
The NHANES (20) design is a stratified, multistag
probability cluster sample of households throughout the Un
States. The process of selecting a sample of persons t
examined is a cascading one that involves the selection
primary sampling units (counties or small groups of contig
ous counties), census enumeration districts, segments (clu
of households), households, eligible persons, and, fina
sample persons.
NHANES is used to collect a broad range of morbidi
data and related health information. The essential differen
ing characteristic of NHANES is its supplementation
interview with specially standardized direct medical examin
tions, including tests and other procedures used in clin
practice. Because NHANES data includes results of exam
tions, estimates of prevalence of certain conditions fr
NHANES will include cases not previously identified and th
not reported by the participant. Estimates can also be mad
the distribution within the population of a broad variety
health-related measurements, including not only physical m
surements (such as height, weight, and various skinfolds)
also physiological measurements (such as diastolic bl
pressure and serum cholesterol level) and psychological m
surements. In addition, this survey provides an assessme
the nutritional status of the U.S. population ages 1–74 ye
that permits nutritional variables to be related to hea
measures.
NHANES is a recurring survey, and hence permits me
surement of changes in health and nutritional status over ti
Although information on the range of chronic condition
covered in NHIS is not obtainable through NHANES, exte
sive physiological and biological information on a number
‘‘target’’ conditions is available. Conditions for which exten
sive diagnostic and prevalence data have been colle
through NHANES include diabetes; kidney disease; liv
disease; allergic conditions; arthritis and disc degenerat
cardiovascular disease, including hypertension; skin con




















For a number of these conditions, diabetes and hypertensio
particular, the NHANES prevalence estimates are higher t
NHIS estimates because undiagnosed conditions are ident
during the NHANES examination. However, when only da
reported by respondents are compared, prevalence estim
are similar for both surveys (21). Thus it is advantageous
use data from both surveys when examining the extent
effects of the prevalence of selected chronic conditio
NHANES data can provide information on undiagnosed co
ditions. NHIS data can provide information on the prevalen
of serious chronic conditions (that is, those that cause lim
tions) as well as detailed medical and nonmedical informat
with which the condition prevalence information may b
related.
NHANES I was conducted from 1971 through 197
NHANES II from 1976 through 1980, and NHANES III wa
conducted from 1988 through 1994. In addition, the Hispa
Health and Nutrition Examination Survey (HHANES) wa
conducted from 1982 through 1984 to produce estimates of
health and nutritional status of Mexican-Americans, Cuba
Americans, and Puerto Ricans that are comparable with e
mates available for the general population.
One function of the vital statistics program of NCHS is
report the estimated number of deaths in the United States
cause of death. Data on deaths from chronic conditions are
included in NHIS because only civilian noninstitutionalize
persons who are alive at the time of interview are surveyed.
understand the entire spectrum of the problem of chro
conditions in this country, mortality data from the vita
statistics program must also be considered. The 10 lead
causes of death in the United States in 1993 are shown
table A along with the 10 most prevalent selected chron
conditions reported in NHIS for 1990–92. The list of leadin
causes of death includes conditions, such as pneumonia
influenza, that are considered acute and others, such
malignant neoplasms, that are not collected in their entirety
NHIS. Hence these lists are not altogether comparable but
nevertheless a useful complement to one another.
NHCS is comprised of five basic components, many
which provide chronic condition data.
1. Hospital and surgical care
The National Hospital Discharge Survey (NHDS) pr
vides statistics on the utilization of non-Federal short-s
hospitals based on data collected from a national sample
hospital records of discharged inpatients (22). It is a conti
ous survey that has been conducted by NCHS since 1965
Because NHDS focuses on hospital discharges, condi
data are available only for those conditions requiring hospi
ization during the survey year. These hospitalizations
discharge based and not person based; one person may
multiple discharges during the year. Estimates for this surv
are made by ‘‘first-listed diagnosis’’ as well as by ‘‘all-liste
diagnoses.’’ These data are not comparable with NHIS pre
lence data, but they can be used to estimate the numbe
hospitalizations resulting from selected chronic conditio
















































Table A. Statistics on selected chronic conditions with highest prevalence in the civilian noninstitutionalized population and conditions
causing the largest number of deaths, and respective ICD codes, in rank order: United States, 1990–92















Chronic conditions Cause of death
Deformities or orthopedic Diseases of the heart . . . . . . . . 390–398, 402,
impairments . . .X70,X71,X73,–X80,X84–X86,X89 1 34,964 140.6 404, 410–429 1 739.9 286.9
Chronic sinusitis . . . . . . . . . . . . . . . . . . . 473 2 33,736 135.6 Malignant neoplasms . . . . . . . . . . . . 140–205 2 530.9 205.8
Arthritis . . . . . . . . . . . . . . . . 711.0, 9, 712.8, 9,
714–716, 720.0, 721 3 31,788 127.8 Cerebrovascular diseases . . . . . . . . . 430–438 3 149.7 58.1
High blood pressure . . . . . . . . . . . . . . 401–405 4 27,600 111.0 Chronic obstructive pulmonary
disease . . . . . . . . . . . . . . . . . . . . 490–496 4 101.1 39.2
Hay fever or allergic rhinitis without asthma . . 477 5 24,060 96.7 Accidents and adverse effects. . . . . E800–E949 5 88.6 34.4
Deafness and other hearing
impairments . . . . . . . . . . . . . . . . . . X05–X09 6 23,266 93.5 Pneumonia and influenza. . . . . . . . . . 480–487 6 81.7 31.7
Heart disease . . . . . . . . . 413–417, 420.9, 421.0,
9, 422.9, 423, 424, 425.0–5, 9,
426, 427.0–6, 8, 9, 428, 429.0–5,
8, 9, 745, 746, 785.0–2 7 20,489 82.4 Diabetes mellitus . . . . . . . . . . . . . . . . . . 250 7 55.1 21.4
Human immunnodeficiency viral
Chronic bronchitis . . . . . . . . . . . . . . . 490, 491 8 12,884 51.8 infection. . . . . . . . . . . . . . . . . . . . 042–044 8 38.5 14.9
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . 493 9 11,482 46.2 Suicide . . . . . . . . . . . . . . . . . . . E950–E959 9 31.2 12.1
Other headache (excluding tension
headache) . . . . . . . . . . . . . . . . . . . . . 784.0 10 10,279 41.3 Homicide and legal intervention . . . . E960–E978 10 25.5 9.9
1Ninth Revision International Classification of Diseases Impairments are coded according to a special classification system for the National Health Interview Survey.
2Conditions per 1,000 persons in civilian noninstitutionalized population.
3Deaths per 100,000 resident population.
NOTE: Chronic condition data are for 1990–92; cause of death data are provisional for 1993.
Source: Mortality data are from the vital statistics program of the National Center for Health Statistics.profile of the persons hospitalized for the conditions. Th
NHDS data complement the NHIS chronic condition prev
lence estimates.
The National Survey of Ambulatory Surgery (NSAS
surveys hospital-based and freestanding ambulatory surg
care units and provides data on diagnoses, procedures,
patient characteristics. The survey was initiated in 1994
will provide data on chronic conditions that were heretofo
unavailable.
2. Ambulatory care
The National Ambulatory Medical Care Surve
(NAMCS)(23) is a continuing national probability sample
office-based physicians selected from the master files of
American Medical Association and the American Osteopat
Association. Selected physicians maintain a listing of
patient visits to their offices during a randomly assigned 7-d
period. The strength of these data is in the precision and d
of the medical information provided. Reliable data on info
mation such as diagnosis, reason for visit, diagnostic pro
dures, treatments, and medication therapy are reported by
physicians themselves. However, NAMCS includes only ph
sicians classified as non-Federal, office based, and prima
engaged in patient care activities. Hence the estimates of
numbers of physician visits for chronic condition diagnos
are not reflective of the total population. Because of the h
reliability of these data, it is nevertheless important to consi











conditions. Data from the NAMCS provide estimates
physician visits for specific conditions that can be cros
tabulated by a number of variables. This information is
useful complement to the NHIS prevalence estimates
chronic conditions presented in this report.
The National Hospital Ambulatory Medical Care Surve
(NHAMCS) (24) was initiated in 1992 to collect data o
patients visiting hospital emergency departments, outpat
departments, and clinics. The data are collected annually f
a sample of 70,000 visits from 440 hospitals. The informati
is gathered by abstracting medical records. This survey t
collects data on doctor visits that were not included
NAMCS. Although a large proportion of the visits are fo
acute conditions, data on such chronic conditions as h
disease and cerebrovascular disease are included that pro
an additional perspective to the understanding of chro
condition prevalence in the United States.
3. Long-term care
The National Nursing Home Survey (NNHS) is a contin
ing periodic survey of nursing homes that was first conduc
by NCHS from August 1973 through April 1974. The surve
was conducted again from May 1977 through December 1
and most recently from August 1985 through January 19
(25). All types of nursing homes in the coterminous Unite
States were included in the 1985–86 NNHS, regardless









































Medicaid programs, or their licensing. Data on nursing hom
facilities, residents, discharges, and chronic conditions
collected in the survey.
The institutionalized population is not included in NHIS
so chronic conditions reported in NNHS can be used
supplement the NHIS estimates. Information is available
all-listed diagnoses at time of survey, first-listed prima
diagnosis at time of survey, and prevalence rate of selec
diagnoses at time of survey, which eliminates multiple con
tions that fall under the same ICD subclassification (25).
In general, the total number of conditions for nursin
home residents is quite small when compared with the num
for the noninstitutionalized population. However, becau
most nursing home residents are 65 years of age or over (
most of the conditions reported by nursing home residents
for older persons and do have some impact on the estima
of condition prevalence for this age group.
In 1985–86, the 1.491 million nursing home residen
were reported to have 4.972 million conditions (all-liste
diagnoses), or 3.3 conditions per person, at the time of
survey (25).Table Bshows the conditions reported in NNHS
with the highest prevalence rates, along with their ICD cod
(25). Individual conditions are shown rather than system tot
because their rates, which are cumulative, are much hig




Table B. Number of chronic conditions with highest prevalence
among nursing home residents per 1,000 persons with
respective ICD codes, in rank order: United States, August
1985–January 1986





Ischemic heart disease . . . . . . . . . . . 410–414 1 241.5
Senile dementia or organic brain
syndrome. . . . . . . . . . . . . . . . . . . 290,310 2 233.7
Cerebrovascular disease . . . . . . . . . . 430–436 3 182.1
Arthritis or rheumatism . . . 710–713, 716, 729.0 4 179.1
Essential hyptertension . . . . . . . . . . . . . . 401 5 156.4
Other heart disease . . . . . . . 391–398,402,404,
415,420–427, 428.1–429.9 6 152.3
Diabetes mellitus . . . . . . . . . . . . . . . . . . 250 7 124.2
Psychoses other than senile
dementia . . . . . . . . . . . . . . . . . . . 291–299 8 110.6
Congestive heart failure. . . . . . . . . . . . . 428.0 9 106.8
Atherosclerosis . . . . . . . . . . . . . . . . . . . 440 10 74.7
Chronic obstructive pulmonary disease
allied conditions . . . . . . . . . . . . . . . 490–496 11 68.4
Alzheimer’s disease and other specified and
unspecified degeneration of the brain . . 331.0,
331.2 ,331.9 12 49.2
Malignant neoplasms . . . . . . . . . . . . 140–208 13 48.1
Other mental disorders . . . . . 302–309,311–316 14 47.9
Parkinson’s disease . . . . . . . . . . . . . . . . 332 15 47.4
Anemias . . . . . . . . . . . . . . . . . . . . 280–285 16 47.0
Urinary tract infection . . . . . . . . . . . . . . 599.0 17 38.9
Senility without psychoses . . . . . . . . . . . . 797 18 38.5
Mental retardation . . . . . . . . . . . . . . 317–319 19 33.9
Osteoporosis . . . . . . . . . . . . . . . . . . . 733.0 20 32.9












disease). This allows for a more equitable comparison w
prevalence estimates from NHIS if some combination data
desired.
The National Home and Hospice Care Survey (NHHC
provides data on people being served by this category
health care providers. The annual survey is based on appr
mately 1,500 sample agencies with personal interviews be
conducted with administrators and staff. Data collected inclu
referral, length of service, diagnoses, number of visits, patie
charges, health status, and type of service. The survey was
conducted between September and December 1992. Data f
this survey are complementary to the total scope of chro
conditions, since they provide in-depth information on perso
who are infirmed and suffer from debilitating and life threa
ening diseases.
4. The health provider inventory component
The health provider inventory component provides
comprehensive national listing of health care facilities, inclu
ing data on services, location, and staff of the facilities. Hen
it has information on facilities for persons with chroni
conditions, but no specific information on persons with cond
tions.
5. The patient follow-up component
The National Nursing Home Survey Follow-up (NNHSF
follows the surveying cohorts of sample patients from th
NNHS thus enabling an overview of outcomes from patien
with specific chronic conditions. This is a helpful tool fo
those assessing the utilization and financing of health care


























The tables in this report are organized primarily b
checklist. However, some modifications in the presentat
were made for instances in which more than one of the
lists included data from the same disease classification sys
as that in theNinth Revision of the International Classificatio
of Diseases(5).
Conditions with high prevalence
The selected chronic conditions with highest prevalen
during 1990–92 are presented intable Cfor all persons by sex,
race, and age group and intable D for all persons by family
income and geographic region. It should be noted that if a t
category such as deformities or orthopedic impairments
included in the top 10 listings, then a subcategory such






Deformities or orthopedic impairments . . . . . . . . . 1 1 3
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . 2 2 2
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 5 1
High blood pressure . . . . . . . . . . . . . . . . . . . . . 4 4 4
Hay fever or allergic rhinitis without asthma . . . . . . 5 6 5
Deafness and other hearing impairments . . . . . . . . 6 3 7
Heart disease . . . . . . . . . . . . . . . . . . . . . . . . . 7 7 6
Chronic bronchitis . . . . . . . . . . . . . . . . . . . . . . 8 9 8
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 8 (2)
Other headache (excludes tension headache) . . . . . 10 (2) 10
Blindness and other visual impairments . . . . . . . . . (2) 10 (2)
Migraine headache . . . . . . . . . . . . . . . . . . . . . (2) (2) 9
Dermatitis . . . . . . . . . . . . . . . . . . . . . . . . . . . (2) (2) (2)
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (2) (2) (2)
Chronic disease of tonsils and adenoids . . . . . . . . (2) (2) (2)
Speech impairments . . . . . . . . . . . . . . . . . . . . (2) (2) (2)
Hemorrhoids . . . . . . . . . . . . . . . . . . . . . . . . . (2) (2) (2)
Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . (2) (2) (2)
Cataracts . . . . . . . . . . . . . . . . . . . . . . . . . . . (2) (2) (2)
Tinnitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . (2) (2) (2)
1Includes races other than white and black.
2Indicated rank is not in top 10.







even though the prevalence rate is higher than that for so
other conditions that are included. It is not listed because it
already been included in the total category.
Deformities or orthopedic impairments ranked highest
prevalence for all persons, for males, for white persons,
persons 18–44 years of age, for persons with incomes un
$10,000 a year, for persons with incomes of $20,000–$34,
per year, and for persons living in the Northeast and W
regions. Chronic sinusitis ranked first among persons in fa
lies with incomes of $35,000 or more and persons from
Midwest and South regions. Arthritis was highest in prev
lence for women, persons 45–64, 65–74, and 75 years of
and over; and among persons in families in the $10,00
$19,999 income range. High blood pressure was the m
prevalent condition among black persons and hay fever w














1 3 6 1 3 5 5
2 2 2 2 4 6 7
3 4 (2) 8 1 1 1
4 1 (2) 6 2 2 3
6 5 1 3 7 10 (2)
5 8 10 7 5 3 2
7 6 9 (2) 6 4 4
8 9 4 9 9 (2) (2)
9 7 3 10 (2) (2) (2)
10 10 (2) 4 (2) (2) (2)
(2) (2) (2) (2) (2) (2) 8
(2) (2) (2) 5 (2) (2) (2)
(2) (2) 5 (2) (2) (2) (2)
(2) (2) 7 (2) (2) (2) (2)
(2) (2) 8 (2) (2) (2) (2)
(2) (2) 10 (2) (2) (2) (2)
(2) (2) (2) (2) 8 (2) (2)
(2) (2) (2) (2) 10 8 9
(2) (2) (2) (2) (2) 7 6
(2) (2) (2) (2) (2) 9 10












































































and over Northeast Midwest South West
Rank
Deformities or orthopedic impairments . . . . . . . . . 1 1 2 1 2 1 2 3 1
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . 2 4 3 2 1 4 1 1 6
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 2 1 3 4 2 3 2 3
High blood pressure . . . . . . . . . . . . . . . . . . . . . 4 3 4 4 5 3 4 4 5
Hay fever or allergic rhinitis without asthma . . . . . . 5 7 7 6 3 5 7 5 2
Deafness and other hearing impairments . . . . . . . . 6 5 5 5 6 6 5 6 4
Heart disease . . . . . . . . . . . . . . . . . . . . . . . . . 7 6 6 7 7 7 6 7 7
Chronic bronchitis . . . . . . . . . . . . . . . . . . . . . . 8 9 8 8 8 8 8 8 9
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 8 10 10 9 9 9 9 8
Other headache (excludes tension headache) . . . . . 10 10 9 9 (2) (2) 10 10 10
Dermatitis . . . . . . . . . . . . . . . . . . . . . . . . . . . (2) (2) (2) (2) 10 (2) (2) (2) (2)
Migraine headache . . . . . . . . . . . . . . . . . . . . . (2) (2) (2) (2) (2) 10 (2) (2) (2)
1Includes unknown family income.
2Indicated rank is not in top 10.
NOTE: This table shows rank by condition prevalence, not person prevalence. A person may have more than one condition in some group.most of the variables listed, the conditions in the top
rankings did not differ much, although their rank within th
top 10 did. The exception was for the age groups. Amo
persons under 18 years of age, dermatitis, acne, chro
disease of tonsils and adenoids, and speech impairment
rank in the top 10, whereas none of them ranked in the top
for all persons. Similarly, for persons 45–64 years of ag
hemorrhoids and diabetes ranked in the top 10; and
persons 65–74 years and 75 years and over cataracts, tinn
and diabetes ranked in the top 10. None of these conditi
ranked in the top 10 for all persons.
Percent distributions of the three selected chronic con
tions with the highest prevalence (deformities or orthope
impairments, chronic sinusitis, and arthritis) are presented
figure 1 by age and sex. Females accounted for a sligh
higher proportion of deformities or orthopedic impairmen
than did males, and almost three out of five chronic sinus
conditions and more than three out of five arthritis condition
The female to male ratio for arthritis is age related as mo
than two of three arthritis conditions among persons 65 ye
of age and over are among women. Among the age gro
shown, approximately one-half of both deformities or orth
pedic impairments and chronic sinusitis were reported amo
persons 18–44 years of age and about one-quarter of b
conditions among persons 45–64 years of age. For arthritis
distribution was quite different, with 37.3 percent of the cas
reported for persons 45–64 years, 24.9 percent for pers
65–74 years of age, and 20.8 percent for persons 75 year
age and over.
Figure 2 shows the 10 selected chronic conditions wi
the highest prevalence rate by the percent of conditio
causing limitation in major or outside activity. Limitation o
activity is defined inappendix II. The extent of disability that


















chronic sinusitis caused limitation of activity in only 1 of
every 200 conditions reported and chronic bronchitis, h
fever, and other headaches caused limitation of activity
about 1 of every 50 conditions; deformities or orthoped
impairments and heart disease resulted in activity limitatio
approximately 25 percent of the time.
The selected chronic conditions responsible for the larg
proportion of activity limitation, 30 percent or more, are
shown intable E. In this table, total categories and subcateg
ries are both included to provide data on the most disabli
conditions. Ranking is not done since some categories that
not mutually exclusive are included. Conditions causing th
highest percents of activity limitation were mental retardatio
(87.5 percent), multiple sclerosis (69.4 percent), malignant ne
plasm of stomach, intestines, colon, and rectum (62.1 perce
paralysis of extremities—complete or partial (60.7 percen
and malignant neoplasms of the lung, bronchus, and ot
respiratory sites (60.6 percent). Some subcategories of par
sis of extremities—complete or partial are higher than the to
category.
Table Fpresents the 10 selected chronic conditions wi
highest prevalence for 1990–92 by four time periods starti
with 1979–81. One of the conditions, other headache (exclu
ing tension headache), was not included on any of the
condition lists for 1979–81, and the way that data we
combined for deformities or orthopedic impairments and he
disease was modified somewhat in the later periods. D
collection methods for the other seven conditions were co
stant over the four time periods. Prevalence rates for chro
sinusitis, arthritis, and high blood pressure have remain
relatively stable for the four time periods and rates for hea
disease have been stable for the last three periods. Conver
prevalence rates from asthma have increased almost 50
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Figure 1. Percent distribution of selected chronic conditions with highest prevalence, by sex and age: United States, 1990–92or allergic rhinitis without asthma have increased 46 perce
and 25 percent, respectively. The rate for other headache
increased almost 80 percent in the three time periods
which data are available.
Selected circulatory conditions
Prevalence estimates for selected chronic circulatory co
ditions and corresponding rates per 1,000 persons by age
shown intable 1. Tables 2–5show this information for males,
females, white persons, and black persons, respectively.
percent of conditions causing limitation of activity, the perce
that caused one hospitalization or more, and the percent
caused one doctor visit or more are also included intables 1–
5. Tables 6and 7 contain prevalence estimates of chron
circulatory conditions and rates per 1,000 persons by fam
income and geographic region, respectively. Data presente
table 1 show that high blood pressure, estimated at 27
million conditions annually, or 111.0 per 1,000 persons, w
the most prevalent chronic circulatory condition. Other chron
circulatory conditions with high prevalence were heart di








million conditions; and varicose veins, 7.4 million condition
For young persons (under 18 years of age), heart disease
the most prevalent disease, whereas high blood pressure
highest in prevalence for persons 18–44 years, 45–64 ye
and 65–74 years of age. For persons 75 years of age and
high blood pressure and heart disease were about equal
high, 369.8 and 364.9 conditions per 1,000 persons, res
tively. Ischemic heart disease caused the highest percen
hospitalizations, 72.4 percent. Data fromtables 2and3 show
that high blood pressure, heart disease, and hemorrhoids
high in prevalence for both sexes and varicose veins was
high among women. The rate of ischemic heart disease
about 60 percent higher among males whereas the rate
varicose veins was about four times higher among wom
than for men. Women 65 years of age and over also had hig
rates for high blood pressure than did men.
The prevalence rate for chronic circulatory conditions a
shown for white persons and black persons intables 4and5.
The prevalence rates for chronic circulatory conditions amo
white persons were very similar to those for all persons. T
prevalence rate for high blood pressure was higher am


































































































1 2 3 4 5 6 7 8 9 10
Figure 2. Selected reported chronic conditions with highest prevalence, in rank order, by percent causing limitation in major or outside
activitiy: United States, 1990–92for heart disease, hemorrhoids, and varicose veins were hig
among white persons than black persons.
Table 6shows the estimated prevalence of chronic circ
latory conditions and rates per 1,000 persons by fam
income. For most circulatory conditions the rates were high
among those with family incomes of less than $10,000. Ra
among persons in families with incomes of $35,000 or mo
were lower than that of all income groups for heart disea
high blood pressure, and cerebrovascular disease. The
rates for persons in the under $10,000 family income categ
are likely age related since there is a disproportionate perc
of the elderly in this income group.
The prevalence of chronic circulatory conditions and ra
per 1,000 persons are shown by geographic region intable 7.
Among the regions, the prevalence rates for heart disease,
blood pressure, and hemorrhoids were all lower in the W
region.
Selected respiratory conditions
Tables 8–12contain the prevalence estimates for select
chronic respiratory conditions and rates per 1,000 persons











persons, respectively. The percent of the conditions caus
limitation of activity, the percent that caused one hospitaliz
tion or more, and the percent that caused one doctor visit
more are also included in these tables.Tables 13–14contain
estimates of chronic respiratory conditions and rates per 1,0
persons by family income and geographic region, respective
Chronic sinusitis was the most frequently reported res
ratory condition, with an annual average prevalence of alm
34 million conditions or 135.6 per 1,000 persons (table 8).
Other chronic respiratory conditions of high prevalence includ
hay fever (24.1 million conditions), chronic bronchitis (12.
million conditions), and asthma (11.5 million conditions
Among persons under 18 years of age, the four above conditi
were high in prevalence. In addition, chronic disease of tons
and adenoids was also high, with a prevalence rate of 24.9
1,000 persons under 18 years of age, which was more t
double the rate for this condition among persons of all ag
Chronic sinusitis had the highest prevalence rate amo
persons 18–44, 45–64, 65–74, and 75 years of age and o
The rate for emphysema was highest among older perso
from 0.8 per 1,000 persons 18–44 years of age to 39.9
1,000 persons 75 years of age and over. Malignant neopla


































Table E. Selected chronic conditions causing 30 percent or more
limitations in major or outside activity, by percent with limitation:
United States, 1990–92
Chronic condition Percent
Mental retardation . . . . . . . . . . . . . . . . . . . . . . 87.5
Multiple sclerosis . . . . . . . . . . . . . . . . . . . . . . . 69.4
Malignant neoplasms of stomach, intestines, colon,
and rectum . . . . . . . . . . . . . . . . . . . . . . . . . 62.1
Paralysis of extremities, complete or partial . . . . . . 60.7
Paralysis of extremities, complete . . . . . . . . . . . 54.5
Paralysis of extremities, partial . . . . . . . . . . . . . 65.5
Cerebral palsy . . . . . . . . . . . . . . . . . . . . . 74.0
Malignant neoplasms of the lung, bronchus, and
other respiratory sites . . . . . . . . . . . . . . . . . . . 60.6
Blindness, both eyes . . . . . . . . . . . . . . . . . . . . 60.3
Other deformities or orthopedic impairments . . . . . . 54.4
Paralysis of other sites, complete or partial . . . . . . 48.0
Other selected diseases of the heart
(excludes hypertension) . . . . . . . . . . . . . . . . . . 47.8
Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44.4
Emphysema . . . . . . . . . . . . . . . . . . . . . . . . . 44.1
Disorders of bone or cartilage . . . . . . . . . . . . . . . 37.9
Cerebrovascular disease . . . . . . . . . . . . . . . . . . 35.9
Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35.9
Absence of lower extremities or parts of
lower extremities . . . . . . . . . . . . . . . . . . . . . . 32.8
Absence of bone, joint, or muscle of extremity . . . . 32.0
Ischemic heart disease . . . . . . . . . . . . . . . . . . . 31.5
Deformities or othopedic impairments of
upper extremities . . . . . . . . . . . . . . . . . . . . . . 30.0
Orthopedic impairment of shoulder . . . . . . . . . . 36.4had the highest percents of activity limitation, 60.6 an
44.1 percent, respectively.
Data in tables 9and 10 show that for both males and
females, the prevalence rates for chronic sinusitis, hay fev
chronic bronchitis, and asthma were high, similar to th
pattern for all persons. However, the rates for two condition
chronic sinusitis and chronic bronchitis, were substantia
higher among females. The rates of emphysema among m
65–74 years and 75 years of age and over were more t
double the rates for females in those age groups.Table F. Prevalence rates per 1,000 persons for selected chronic conditions
for these conditions for the periods 1979–81, 1983–85, and 1986–88
Condition 1979–81
Deformities or orthopedic impairments1 . . . . . . . . . 92.6
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . 137.7
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122.8
High blood pressure . . . . . . . . . . . . . . . . . . . . . 112.6
Hay fever or allergic rhinitis without asthma . . . . . . 77.3
Deafness and other hearing impairments . . . . . . . . 80.0
Heart disease1 . . . . . . . . . . . . . . . . . . . . . . . . 68.9
Chronic bronchitis . . . . . . . . . . . . . . . . . . . . . . 35.4
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31.0
Other headache (excluding tension headache)2 . . . . - - -
1Deformities or orthopedic impairments and heart disease had different inclusions for the prevalence
2Other headache was not included on one of the six condition lists for 1979–81.




The prevalence rates of chronic respiratory conditions ar
shown for white persons intable 11and for black persons in
table 12. The rates for white persons were similar to those fo
all persons, whereas the prevalence rates among black pers
were much lower for chronic bronchitis and hay fever.
The estimated prevalence of chronic respiratory cond
tions and rates per 1,000 persons are shown by family incom
in table 13. Chronic bronchitis and asthma were highest in
prevalence among persons in families with incomes of les
than $10,000, whereas the prevalence rate for hay fever w
highest among persons in families with incomes of $35,000 o
more.
The prevalence of chronic respiratory conditions and rate
per 1,000 persons are shown by geographic region intable 14.
The rates for chronic sinusitis in the South and Midwes
regions were higher than rates in Northeast and West region
Selected digestive conditions
Prevalence estimates for selected chronic digestive cond
tions and the rates per 1,000 persons by age are shown for
persons, males, females, white persons, and black persons
tables 15–19. The percents of conditions causing limitation of
activity, the percents that caused one hospitalization or mor
and the percents that caused one doctor visit or more are a
included in tables 15–19. Tables 20–21contain prevalence
estimates for chronic digestive conditions and the rates p
1,000 persons by family income and geographic region
respectively.
Data presented intable 15show that the most prevalent
chronic digestive conditions were indigestion and other func
tional disorders of the stomach and digestive system (6.
million conditions), hernia of abdominal cavity (4.8 million
conditions), constipation (4.3 million conditions), and ulcers—
gastric, duodenal and/or peptic (4.2 million conditions). Per
sons 65–74 and 75 years of age and over reported substantia
higher prevalence rates for constipation and hernia of th
abdominal cavity than did their younger counterparts. Malig
nant neoplasms of stomach, intestines, colon, and rectum
although relatively small in prevalence, caused by far th
highest percent of activity limitations (62.1 percent).highest in prevalence in 1990–92 and the comparable rates
1983–85 1986–88 1990–92










































































































eo-Data from tables 16and 17 show that indigestion and
other functional disorders of the stomach and digestive sys
were the most prevalent conditions among males followed
hernia of the abdominal cavity. Digestive conditions of high
prevalence among females were indigestion and other fu
tional disorders of the stomach and digestive system
constipation. Constipation was particularly high in prevalen
among females 75 years of age and over, with almost 1 ou
10 suffering from this condition.
The prevalence of chronic digestive conditions and
rates per 1,000 persons by age are shown for white per
and black persons, respectively, intables 18and 19. The
prevalence rates by age for white persons closely para
those for all persons. Among black persons, a majority of
data by age are not reliable statistically so meaningful co
parisons cannot be made.
Table 20shows the estimated prevalence of chronic dig
tive conditions and rates per 1,000 persons by age and fa
income. Prevalence rates among persons in families w
incomes of less than $10,000 a year indicated that rates
ulcers and for constipation were more than triple the ra
reported by those in families with incomes of $35,000
more. Persons in the lower income families also repor
higher rates of indigestion and other functional disorders
the stomach and digestive system and hernia of the abdom
cavity, than did those living in families with incomes o
$35,000 or more. The prevalence of chronic digestive con
tions and the rates per 1,000 persons are shown by geogra
region in table 21. The rate for indigestion and other func
tional disorders of the stomach and digestive system w
lower in the Northeast than in the other three regions. Her
of the abdominal cavity was highest in prevalence amo
persons living in the South region.
Selected impairments and conditions of the
nervous system and sense organs
Tables 22–26contain the prevalence estimates for selec
impairments and chronic conditions of the nervous system
sense organs and rates per 1,000 persons by age, fo
persons, males, females, white persons, and black pers
respectively. The percent of conditions causing limitations
activity, the percent that caused one hospitalization or mo
and the percent that caused one or more doctor visits are
included in these tables.Tables 27–28contain prevalence
estimates of selected impairments and chronic conditions
the nervous system and sense organs and the correspo
rates per 1,000 persons by family income (table 27) and
geographic region (table 28).
Among the selected impairments reported, the most pre
lent for all persons were deformities or orthopedic impa
ments, 35.0 million conditions; deafness and other hear
impairments, 23.3 million conditions; and blindness and ot
visual impairments, 8.2 million conditions (table 22). Among
persons under 18 years of age, deformities or orthope
impairments were highest in prevalence (2.0 million con
tions) followed by deafness and other hearing impairme


























Deformities or orthopedic impairments were also highest
prevalence for persons 18–44 and 45–64 years of age, w
deafness and other hearing impairments second and blindn
and other visual impairments third in prevalence. Amon
persons 65–74 years and 75 years of age or more, deafn
and other hearing impairments was highest in prevalence a
deformities or orthopedic impairments second. Mental retard
tion caused the highest percent of activity limitation
87.5 percent.
Other headache (excluding tension headache) and migra
headache were the most prevalent conditions of the nervo
system and sense organs among all persons with 10.3 mill
and 10.0 million conditions, respectively. They were also th
conditions highest in prevalence among persons under
years and 18–44 years of age, and along with tinnitus f
persons 45–64 years of age. For persons 65–74 years and
years and over, cataracts was highest in prevalence. Multi
sclerosis caused the highest percent of activity limitatio
among conditions of the nervous system and sense orga
69.4 percent.
The prevalence pattern for selected impairments not
above for all persons was very similar for males (table 23) and
females (table 24). However, for most of the age groups, male
had higher prevalence rates than females had for deafness
other hearing impairments and blindness and other visu
impairments. In addition, the rate of speech impairmen
among males under 18 years of age was double that
females.
Among conditions of the nervous system and sen
organs, males reported tinnitus (3.7 million) and other hea
ache (3.2 million) most frequently. Females reported migrain
headache (7.3 million) and other headache (7.1 million) mo
frequently. The rate from color blindness among males w
almost 10 times that of females, 20.1 compared with 2.1 p
1,000 persons per year.
The prevalence patterns for selected impairments and
chronic conditions of the nervous system and sense organs
white persons were similar to those for all persons (table 25).
Black persons reported lower prevalence rates than wh
persons did for deafness and other hearing impairments a
deformities or orthopedic impairments. However, the prev
lence rate for speech impairments among black persons w
almost double that for white persons (table 26).
The estimated prevalence of selected impairments a
chronic conditions of the nervous system and sense organs
the rates per 1,000 persons are shown by family income
table 27. Prevalence rates for deformities or orthopedic impai
ments, deafness and other hearing impairments, blindness
other visual impairments, cataracts, and tinnitus were
higher among persons in families with incomes of unde
$10,000 than among persons in families with incomes
$35,000 or more. Because the lower income group has
higher proportion of persons 65 years of age and over, the
differences are, to a large degree, age related.
The prevalence of selected impairments and chronic co
ditions of the nervous system and sense organs and
corresponding rates per 1,000 persons are shown by g























































































notother hearing impairments and tinnitus were higher th
average in the Midwest region.
Selected conditions of skin and
subcutaneous tissue and musculoskeletal
system and connective tissue
Prevalence estimates for selected chronic conditions
the skin and subcutaneous tissue and musculoskeletal sy
and connective tissue and the rates per 1,000 persons by
are shown for all persons, males, females, white persons,
black persons intables 29–33. The percent of conditions
causing limitation of activity, the percent causing one or mo
hospitalizations, and the percent causing one doctor visi
more are also included.Tables 34–35contain prevalence esti
mates for chronic conditions of skin and subcutaneous tis
and musculoskeletal system and connective tissue and
rates per 1,000 persons by family income (table 34) and
geographic region (table 35).
Data presented intable 29show that the most prevalen
conditions of the skin and subcutaneous tissue were derma
(9.3 million conditions) and ingrown nails (6.1 million cond
tions). Dermatitis was highest in prevalence among pers
under 18 years of age, 18–44 years of age, and 45–64 yea
age. Persons under 18 years of age also reported a
prevalence rate from acne. Malignant neoplasms of the s
were higher in prevalence among persons 75 years of age
over than those in other age groups. The only condition in
group causing much activity limitation was chronic ulcer
the skin, 24.1 percent.
Among the selected chronic conditions of the muscu
skeletal system and connective tissue, arthritis was by far
most prevalent, 31.8 million conditions. Intervertebral di
disorders and bursitis were a distant second and third with
million and 4.7 million conditions, respectively. Arthritis wa
highest in prevalence for all age groups over 18 years of a
whereas intervertebral disc disorders caused the highest
cent of activity limitation, 45.2 percent.
Data fromtables 30and31 show that dermatitis was the
most prevalent chronic condition of the skin and subcutane
tissue among both males and females, although the rate
dermatitis was about 50 percent higher for females. Ingro
nails were also high for males, whereas ingrown nails, co
and calluses, and dry itching skin were prevalent amo
females.
Prevalence of dermatitis was highest of this disea
system for females under 18 years of age, 18–44 years,
45–64 years of age, whereas ingrown nails and corns
calluses were highest among females 65–74 years and
years of age and over. Malignant neoplasms of the skin w
the most prevalent condition among males 65–74 years an
years of age and over. In these age groups, the rates
malignant neoplasms of the skin among males were ab
double the rate for females.
Arthritis was the most prevalent chronic condition of th
musculoskeletal system and connective tissue for both m
and females. However, the rates for females were higher t


































The prevalence rate of bunions among females was about fi
times the rate reported among males.
The prevalence of chronic conditions of the skin an
subcutaneous tissue and musculoskeletal system and con
tive tissue and rates per 1,000 persons by age are shown
white persons intable 32and black persons intable 33. The
rates for white persons were similar to those for all persons
both condition groups. Among black persons, the prevalen
rate for conditions of the skin and subcutaneous tissue we
lower than the rates reported for white persons for almost
conditions. The exception was corns and calluses, which w
about a third higher among black persons. The prevalen
rates for most conditions of the musculoskeletal system a
connective tissue were lower among black persons than amo
white persons. Black persons reported only half the rate
intervertebral back disorders than white persons did.
Table 34shows the estimated prevalence of chronic co
ditions of the skin and subcutaneous tissue and of the mus
loskeletal system and connective tissue and rates per 1,0
persons by family income. For conditions of the skin an
subcutaneous tissue, persons in families with incomes of le
than $10,000 reported the highest rate for ingrown nails and
higher rate for corns and calluses than persons in all incom
groups. The less than $10,000 income group also had
highest prevalence rate for arthritis among chronic conditio
of the musculoskeletal system and connective tissue. The h
rate for arthritis is primarily age related as there is a high
percentage of older persons in this income group than in t
others.
The prevalence of chronic conditions of the skin an
subcutaneous tissue and of the musculoskeletal system
connective tissue and the rates per 1,000 persons are show
geographic region intable 35. Among persons in the North-
east, a lower prevalence rate for ingrown nails was report
among conditions of the skin and subcutaneous tissue, wher
persons in the West region reported the lowest prevalence r
from arthritis among conditions of the musculoskeletal syste
and connective tissue.
Selected endocrine, nutritional, and
metabolic diseases and immunity
disorders; diseases of the blood and
blood-forming organs; and genitourinary
conditions
Tables 36–40contain the prevalence estimates for selecte
endocrine, nutritional, and metabolic diseases and immun
disorders; diseases of the blood and blood-forming organs; a
genitourinary conditions and rates per 1,000 persons by a
for all persons, males, females, white persons, and bla
persons, respectively. The percent of conditions causing lim
tation of activity, the percent causing one hospitalization o
more, and the percent causing one doctor visit or more are a
included in these tables.Tables 41–42contain prevalence
estimates of these conditions and diseases and the corresp
ing rates per 1,000 persons by family income and geograp
region, respectively. Because these individual systems do







































































For all persons (table 36), the most prevalent conditions
were diabetes (7.0 million conditions), anemias (3.7 millio
conditions), and other diseases of the thyroid (3.3 milli
conditions). Among persons under 18 years of age, anem
was the most prevalent condition whereas persons 18–44 y
of age reported high prevalence rates for anemias, o
diseases of the female genital organs, and menstrual disord
Diabetes was by far the most prevalent chronic conditi
among persons 45–64 years, 65–74 years, and 75 years o
and over. Diabetes also caused the highest percent of act
limitation.
Among males (table 37), diabetes was also the mos
prevalent condition, followed by diseases of the prostate a
gout. For males under 18 years of age, anemias was repo
most frequently and diabetes was highest in prevalence in
other four age groups. Males 65–74 years and 75 years of
and over also reported high prevalence for diseases of
prostate. The conditions of highest prevalence among fem
(table 38) were diabetes, anemia, and other diseases of
thyroid. Anemia was highest for prevalence among fema
under 18 years of age and, along with other diseases of
female genital organs and menstrual disorders, highest
females 18–44 years of age. Diabetes was highest in pre
lence among females 45–64 years, 65–74 years, and 75 y
of age and over.
There was no apparent variation between the prevale
patterns reported for all persons and those reported for w
persons (table 39). However, among black persons (table 40),
the prevalence rates for diabetes, anemias, and gout w
higher than they were for white persons, and the rate for ot
diseases of the thyroid was lower.
The estimated prevalence of the three condition syste
and the rates per 1,000 persons are shown by family incom
table 41and geographic region intable 42. The prevalence
rate for diabetes among persons in families with incomes
less than $10,000 was more than triple that of persons
families with incomes of $35,000 or more, and anemia ra
were about 2½ times higher for persons in the less th
$10,000 income group than in the $35,000 or more inco
group (table 41). Among the geographic regions, the prev
lence rate of diabetes was lower in the West region than in
other three regions (table 42).
Restricted-activity days from selected
chronic conditions
The estimated number of restricted-activity days and
number of days per selected chronic condition are presen
by age (under 65 years of age and 65 years of age and o
































number of restricted-activity days for all persons exceeded th
cutoff for reliability were included.Table Gshows the top 10
rankings for the number of restricted-activity days and for th
number of days per condition by sex. Condition subcategorie
were not included in the ranking to avoid counting a condition
in more than one category.
Of all the selected chronic conditions, deformities or
orthopedic impairments were responsible for the highest num
ber of restricted activity days, 600.0 million per year. Ranking
second and third were arthritis and heart disease with 445
and 400.0 million days of restricted activity, respectively
Among males, deformities or orthopedic impairments cause
the highest number of restricted-activity days, followed by
heart disease and arthritis, whereas females had the sa
pattern as all persons for those three conditions. Deformitie
or orthopedic impairments caused the highest number
restricted-activity days among persons under 65 years of ag
whereas heart disease and arthritis caused the highest num
among persons 65 years of age and over.
The number of restricted-activity days per condition was
highest for malignant neoplasms of the lung, bronchus, an
other respiratory sites (96.1 days), followed by malignan
neoplasms of stomach, intestines, colon, and rectum (60
days).
Bed-disability days from selected
conditions
Table 44contains the estimated number of bed-disability
days (bed days) from selected chronic conditions and th
number of days per condition by age (under 65 years of ag
and 65 years of age and over) and sex. Only conditions fo
which the total number of bed-disability days exceeded th
variance cutoff for reliability were included.Table Gshows
the top 10 rankings by number of days and days per conditio
Of the selected chronic conditions, deformities or ortho
pedic impairments, heart disease, and arthritis were ea
responsible for more than twice as many bed-disability days a
any of the other conditions with 160.9, 157.9, and 152.
million days annually, respectively. Heart disease caused th
most bed-disability days among males, whereas arthritis caus
the most days among females, followed by deformities o
orthopedic impairments. Conditions causing the highest num
ber of bed-disability days per condition were paralysis of othe
site, complete or partial, and paralysis of extremities, comple
or partial, 33.3 and 20.5 days per condition per yea
respectively.
The population figures used in computing rates in thi
report are found intable 45.
Table G. Selected chronic conditions with the highest number of restricted-activity days and days per condition, by sex and rank order,













Deformities or orthopedic impairments . . . . . . . . . 1 1 1 (2) (2) (2) 1 (2)
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 3 2 (2) (2) (2) 3 (2)
Heart disease . . . . . . . . . . . . . . . . . . . . . . . . . 3 2 3 (2) (2) 8 2 10
Intervertebral disc disorder . . . . . . . . . . . . . . . . . 4 4 5 8 6 4 5 8
High blood pressure (hypertension) . . . . . . . . . . . 5 8 4 (2) (2) (2) 8 (2)
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 5 6 (2) (2) (2) 4 (2)
Cerebrovascular disease . . . . . . . . . . . . . . . . . . 7 7 8 7 5 3 7 4
Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 9 7 (2) (2) (2) 6 9
Emphysema . . . . . . . . . . . . . . . . . . . . . . . . . 9 6 (2) 4 3 2 10 3
Migraine headache . . . . . . . . . . . . . . . . . . . . . 10 (2) 10 (2) (2) (2) 9 (2)
Other headache (excluding tension headache) . . . . (2) 10 (2) (2) (2) (2) (2) (2)
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . (2) (2) 9 (2) (2) (2) (2) (2)
Malignant neoplasms of lung, bronchus, and
other respiratory sites . . . . . . . . . . . . . . . . . . . (2) (2) (2) 1 1 (1) (2) (2)
Malignant neoplasms of stomach, intestines, colon,
and rectum . . . . . . . . . . . . . . . . . . . . . . . . . (2) (2) (2) 2 2 (1) (2) (2)
Paralysis of other site, complete or partial . . . . . . . (2) (2) (2) 3 (1) (1) (2) 1
Paralysis of extremities, complete or partial . . . . . . (2) (2) (2) 5 7 1 (2) 2
Chronic ulcer of the skin . . . . . . . . . . . . . . . . . . (2) (2) (2) 6 (1) (1) (2) (2)
Disorders of bone or cartilage . . . . . . . . . . . . . . . (2) (2) (2) 9 (2) 5 (2) 5
Poor circulation . . . . . . . . . . . . . . . . . . . . . . . . (2) (2) (2) 10 (1) 6 (2) 6
Malignant neoplasms of prostate . . . . . . . . . . . . . (2) (2) . . . (2) 4 . . . (2) (2)
Other diseases of the lung . . . . . . . . . . . . . . . . . (2) (2) (2) (2) 8 (2) (2) 7
Liver disease, including cirrhosis . . . . . . . . . . . . . (2) (2) (2) (2) 9 (2) (2) (2)
Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . . . . (2) (2) (2) (2) 10 (2) (2) (2)
Other kidney trouble, not elsewhere classified . . . . . (2) (2) (2) (2) (2) 7 (2) (2)
Malignant neoplasms of breast . . . . . . . . . . . . . . (2) . . . (2) (2) . . . 9 (2) (2)
Gout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (2) (2) (2) (2) (2) 10 (2) (2)
. . . Category not applicable.
1Rate would have been in top 10 but estimates for days did not make 30-percent variance cutoff.
2Indicates rank is not in top 10.
NOTE: Only ranking of condition days and days per condition, not person days are shown. A person may have more than one condition day in some groupings such as deformities, orthopedic
impairments, or heart disease.
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Table 1. Average annual number of selected chronic circulatory conditions, rates per 1,000 persons by age, and percent of conditions
causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian population. The survey design, general qualifications, and information on the reliability of the estimates are given



























Rate per 1,000 persons Percent
Heart disease . . . . . . . . . . . . . . . . . 20,489 82.4 18.9 37.4 129.4 262.0 364.9 24.7 45.1 98.2
Ischemic heart disease . . . . . . . . . . 7,732 31.1 *0.1 4.1 60.3 131.8 168.9 31.5 72.4 99.5
Heart rhythm disorders . . . . . . . . . . 7,868 31.6 14.1 25.8 40.7 65.1 91.7 6.4 14.8 96.4
Tachycardia or rapid heart . . . . . . . 1,911 7.7 0.8 4.3 13.7 22.7 28.0 7.0 25.1 94.2
Heart murmurs . . . . . . . . . . . . . . 4,276 17.2 12.6 18.3 18.5 18.9 24.6 2.2 7.3 97.4
Other and unspecified heart
rhythm disorders . . . . . . . . . . . . 1,681 6.8 *0.7 3.1 8.5 23.5 39.1 16.3 22.4 96.3
Congenital heart disease . . . . . . . . . 741 3.0 2.6 2.4 2.9 5.6 6.5 17.9 49.3 99.1
Other selected diseases of heart
(excludes hypertension) . . . . . . . . . 4,148 16.7 2.1 5.2 25.4 59.5 97.8 47.8 50.9 99.2
Rheumatic fever, with or without heart
disease . . . . . . . . . . . . . . . . . . . . 2,029 8.2 *0.7 7.9 16.1 13.6 11.8 15.1 31.3 99.6
High blood pressure (hypertension) . . . . 27,600 111.0 1.6 52.1 229.7 364.3 369.8 10.6 7.8 99.1
Celebrovascular disease . . . . . . . . . . . 3,002 12.1 *0.5 1.4 16.7 57.9 80.8 35.9 70.3 99.6
Hardening of arteries . . . . . . . . . . . . . 2,074 8.3 *– *0.5 11.5 40.0 61.8 9.6 38.1 96.2
Aneurysm . . . . . . . . . . . . . . . . . . . . 226 0.9 *0.1 *0.1 1.8 3.4 5.4 *15.5 61.9 100.0
Phlebitis, thrombophlebitis . . . . . . . . . . 727 2.9 *– 1.7 4.6 9.4 13.0 17.2 47.6 98.1
Varicose veins of lower extremities . . . . 7,403 29.8 *0.3 24.8 52.8 73.3 77.2 2.2 8.9 60.1
Hemorrhoids . . . . . . . . . . . . . . . . . . 9,441 38.0 *0.5 39.8 70.2 65.8 56.7 *0.4 6.0 67.3
Poor circulation . . . . . . . . . . . . . . . . 980 3.9 *– 1.4 5.9 14.3 24.8 27.7 19.9 92.8
1Includes races other than white and black and unknown family income.
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 2. Average annual number of selected chronic circulatory conditions among males, rates per 1,000 persons by age, and percent of
conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the



























Rate per 1,000 persons Percent
Heart disease . . . . . . . . . . . . . . . . . 9,703 80.4 20.8 29.0 147.2 300.5 379.5 27.3 54.4 98.2
Ischemic heart disease . . . . . . . . . . 4,664 38.6 *0.1 5.7 86.0 178.4 212.3 32.5 76.6 99.4
Heart rhythm disorders . . . . . . . . . . 2,902 24.0 16.0 17.9 29.0 54.3 74.2 5.4 15.9 95.8
Tachycardia or rapid heart . . . . . . . 638 5.3 *0.9 3.1 10.7 17.5 13.2 *5.2 25.1 93.7
Heart murmurs . . . . . . . . . . . . . . 1,578 13.1 14.3 12.1 10.7 17.1 20.3 *2.2 6.8 96.4
Other and unspecified heart
rhythm disorders . . . . . . . . . . . . 685 5.7 *0.8 2.7 7.7 19.8 40.7 13.1 28.2 96.5
Congenital heart disease . . . . . . . . . 300 2.5 2.9 1.5 2.9 *4.6 *4.7 26.0 58.7 100.0
Other selected diseases of heart
(excludes hypertension) . . . . . . . . . 1,837 15.2 1.8 3.9 29.2 63.1 88.3 48.8 58.3 98.6
Rheumatic fever with or without heart
disease . . . . . . . . . . . . . . . . . . . . 575 4.8 *0.7 4.3 9.8 10.8 *4.5 15.7 37.9 100.0
High blood pressure (hypertension) . . . . 12,227 101.3 2.0 57.1 232.0 315.7 300.2 9.0 7.2 98.9
Cerebrovascular disease . . . . . . . . . . 1,450 12.0 *0.2 1.7 16.7 69.8 90.7 34.7 73.0 99.1
Hardening of arteries . . . . . . . . . . . . . 1,029 8.5 *– *0.9 13.4 45.1 68.6 9.1 49.0 96.6
Aneurysm . . . . . . . . . . . . . . . . . . . . 106 0.9 *– *– *1.7 *2.8 *10.1 *15.1 68.9 100.0
Phlebitis, thrombophlebitis . . . . . . . . . . 245 2.0 *– 1.3 3.1 7.2 *11.4 22.4 51.0 98.4
Varicose veins of lower extremities . . . . 1,466 12.1 *– 8.3 23.5 36.7 44.5 4.2 9.7 61.9
Hemorrhoids . . . . . . . . . . . . . . . . . . 4,110 34.0 *0.7 33.2 73.6 62.6 40.9 *0.0 7.8 67.6
Poor circulation . . . . . . . . . . . . . . . . 371 3.1 *– *0.8 4.0 13.3 29.1 33.4 25.6 93.8
1Includes races other than white and black and unknown family income.
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
0.0 Quantity more than zero but less than 0.05.
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Table 3. Average annual number of selected chronic circulatory conditions among females, rates per 1,000 persons by age, and percent
of conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the



























Rate per 1,000 persons Percent
Heart disease . . . . . . . . . . . . . . . . . 10,787 84.3 16.8 45.5 113.0 230.8 356.3 22.3 36.7 98.2
Ischemic heart disease . . . . . . . . . . 3,068 24.0 *– 2.5 36.7 94.2 143.0 30.0 65.9 99.6
Heart rhythm disorders . . . . . . . . . . 4,966 38.8 12.2 33.4 51.5 73.8 102.1 7.0 14.2 96.7
Tachycardia or rapid heart . . . . . . . 1,273 9.9 *0.7 5.5 16.5 26.8 36.8 7.9 25.1 94.5
Heart murmurs . . . . . . . . . . . . . . 2,697 21.1 10.8 24.3 25.6 20.5 27.1 2.3 7.6 98.0
Other and unspecified heart
rhythm disorders . . . . . . . . . . . . 995 7.8 *0.6 3.6 9.3 26.5 38.1 18.5 18.4 96.3
Congenital heart disease . . . . . . . . . 442 3.5 2.3 3.3 2.9 6.3 7.6 12.4 42.8 98.2
Other selected diseases of heart
(excludes hypertension) . . . . . . . . . 2,312 18.1 2.3 6.4 22.0 56.6 103.5 46.9 45.0 99.6
Rheumatic fever with or without heart
disease . . . . . . . . . . . . . . . . . . . . 1,454 11.4 *0.7 11.3 21.9 15.8 16.3 14.9 28.6 99.4
High blood pressure (hypertension) . . . . 15,373 120.1 *1.2 47.4 227.7 403.7 411.0 11.8 8.3 99.3
Cerebrovascular disease . . . . . . . . . . 1,552 12.1 *0.9 1.1 16.7 48.3 74.8 37.0 67.7 100.0
Hardening of arteries . . . . . . . . . . . . . 1,045 8.2 *– *0.2 9.6 35.8 57.7 10.1 27.4 95.9
Aneurysm . . . . . . . . . . . . . . . . . . . . 120 0.9 *0.1 *0.1 *1.9 *3.9 *2.7 *15.8 55.8 100.0
Phlebitis, thrombophlebitis . . . . . . . . . . 482 3.8 *– 2.1 6.0 11.2 14.0 14.5 46.1 98.1
Varicose veins of lower extremities . . . . 5,938 46.4 *0.7 40.6 79.8 102.9 96.6 1.7 8.7 59.6
Hemorrhoids . . . . . . . . . . . . . . . . . . 5,331 41.7 *0.4 46.1 67.0 68.3 66.2 *0.6 4.7 67.1
Poor circulation . . . . . . . . . . . . . . . . 609 4.8 *– 1.9 7.5 15.1 22.2 24.3 16.6 92.1
1Includes races other than white and black and unknown family income.
*– Figure does not meet standard of reliability or precision and quantity zero.
* Figure does not meet standard of reliability or precision.
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Table 4. Average annual number of selected chronic circulatory conditions among white persons, rates per 1,000 persons by age, and
percent of conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the























Rate per 1,000 persons Percent
Heart disease . . . . . . . . . . . . . . . . . 18,094 86.9 30.7 131.1 309.9 24.2 46.0 98.3
Ischemic heart disease . . . . . . . . . . 7,091 34.0 2.6 62.9 153.0 30.5 72.4 99.6
Heart rhythm disorders . . . . . . . . . . 6,786 32.6 21.4 41.0 77.6 6.5 14.9 96.5
Tachycardia or rapid heart . . . . . . . 1,706 8.2 3.3 13.6 25.4 6.7 25.6 94.3
Heart murmurs . . . . . . . . . . . . . . 3,560 17.1 15.9 18.5 21.1 2.1 6.6 97.6
Other and unspecified heart
rhythm disorders . . . . . . . . . . . . 1,520 7.3 2.2 8.8 31.1 16.4 22.4 96.3
Congenital heart disease . . . . . . . . . 666 3.2 2.7 3.3 5.6 18.5 49.1 98.9
Other selected diseases of heart
(excludes hypertension) . . . . . . . . . 3,551 17.1 4.1 23.9 73.7 46.3 52.0 99.0
Rheumatic fever with or without heart
disease . . . . . . . . . . . . . . . . . . . . 1,844 8.9 5.7 16.9 13.2 15.0 29.9 99.6
High blood pressure (hypertension) . . . . 22,810 109.5 30.1 215.7 359.6 8.9 7.0 99.1
Cerebrovascular disease . . . . . . . . . . 2,549 12.2 1.1 15.4 65.2 33.3 69.5 99.5
Hardening of arteries . . . . . . . . . . . . . 1,939 9.3 *0.2 12.3 51.6 9.7 39.0 96.3
Aneurysm . . . . . . . . . . . . . . . . . . . . 189 0.9 *0.0 1.9 4.0 *17.5 63.5 100.0
Phlebitis, thrombophlebitis . . . . . . . . . . 648 3.1 1.1 5.0 10.9 17.0 47.1 97.8
Varicose veins of lower extremities . . . . 6,764 32.5 17.1 55.7 77.0 2.0 9.3 60.3
Hemorrhoids . . . . . . . . . . . . . . . . . . 8,459 40.6 26.4 74.0 63.7 *0.4 6.0 67.2
Poor circulation . . . . . . . . . . . . . . . . 872 4.2 0.9 5.6 18.9 28.1 19.6 93.0
* Figure does not meet standard of reliability or precision.
0.0 Quantity more than zero but less than 0.05.
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Table 5. Average annual number of selected chronic circulatory conditions among black persons, rates per 1,000 persons by age, and
percent of conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the























Rate per 1,000 persons Percent
Heart disease . . . . . . . . . . . . . . . . . . 2,062 66.7 31.3 134.7 261.4 29.4 38.5 97.9
Ischemic heart disease. . . . . . . . . . . 514 16.6 *1.8 49.2 90.9 43.0 77.0 98.2
Heart rhythm disorders . . . . . . . . . . . 952 30.8 24.6 42.4 65.5 6.4 14.0 96.5
Tachycardia or rapid heart . . . . . . . 184 6.0 *2.3 15.6 21.5 *10.3 *20.7 92.4
Heart murmurs . . . . . . . . . . . . . . 627 20.3 19.8 20.1 25.4 *3.3 11.2 97.6
Other and unspecified heart rhythm
disorders . . . . . . . . . . . . . . . . . 141 4.6 2.5 *7.0 *18.7 *14.9 *17.7 97.2
Congenital heart disease . . . . . . . . . 60 1.9 *1.5 *0.8 *7.8 *16.7 *45.0 100.0
Other selected diseases of heart
(excludes hypertension) . . . . . . . . . 535 17.3 3.4 42.4 97.2 58.9 44.5 100.0
Rheumatic fever with or without heart
disease . . . . . . . . . . . . . . . . . . . . . 128 4.1 *2.3 *9.4 *11.3 *20.3 43.0 99.2
High blood pressure (hypertension) . . . . 4,181 135.3 52.4 365.9 455.3 19.8 12.6 99.4
Cerebrovascular disease . . . . . . . . . . . 405 13.1 *1.2 31.2 87.8 54.6 73.1 100.0
Hardening of arteries . . . . . . . . . . . . . 103 3.3 *0.3 *6.8 23.8 *5.8 *27.2 94.2
Aneurysm . . . . . . . . . . . . . . . . . . . . *32 *1.0 *0.3 *1.2 *7.0 *6.3 *46.9 *100.0
Phlebitis, thrombophlebitis . . . . . . . . . . 75 2.4 *1.3 *2.7 *12.9 *20.0 *54.7 100.0
Varicose veins of lower extremities . . . . . 533 17.2 9.1 36.5 54.6 *3.9 *3.8 58.9
Hemorrhoids. . . . . . . . . . . . . . . . . . . 776 25.1 16.7 49.6 55.4 *0.5 *4.6 68.7
Poor circulation . . . . . . . . . . . . . . . . . 104 3.4 *0.6 *9.0 *17.6 *25.0 *19.2 90.4
* Figure does not meet standard of reliability or precision.
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Table 6. Average annual number of selected chronic circulatory conditions and rates per 1,000 persons, by family income: United States,
1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the























Number in thousands Rate per 1,000 persons
Heart disease . . . . . . . . . . . . . . . . . . 20,489 3,194 4,208 4,099 5,107 82.4 131.8 108.7 78.1 57.0
Ischemic heart disease. . . . . . . . . . . 7,732 1,081 1,701 1,478 1,737 31.1 44.6 43.9 28.2 19.4
Heart rhythm disorders . . . . . . . . . . . 7,868 1,154 1,434 1,668 2,424 31.6 47.6 37.0 31.8 27.0
Tachycardia or rapid heart . . . . . . . 1,911 367 366 334 534 7.7 15.1 9.5 6.4 6.0
Heart murmurs . . . . . . . . . . . . . . 4,276 452 709 993 1,527 17.2 18.7 18.3 18.9 17.0
Other and unspecified heart rhythm
disorders . . . . . . . . . . . . . . . . . 1,681 335 359 342 363 6.8 13.8 9.3 6.5 4.0
Congenital heart disease . . . . . . . . . 741 86 127 169 273 3.0 3.5 3.3 3.2 3.0
Other selected diseases of heart
(excludes hypertension) . . . . . . . . . 4,148 872 947 785 673 16.7 36.0 24.5 15.0 7.5
Rheumatic fever with or without heart
disease . . . . . . . . . . . . . . . . . . . . . 2,029 232 348 341 814 8.2 9.6 9.0 6.5 9.1
High blood pressure (hypertension) . . . . 27,600 3,927 5,442 5,577 7,306 111.0 162.1 140.6 106.2 81.5
Celebrovascular disease . . . . . . . . . . . 3,002 601 666 558 476 12.1 24.8 17.2 10.6 5.3
Hardening of arteries . . . . . . . . . . . . . 2,074 395 492 403 390 8.3 16.3 12.7 7.7 4.4
Aneurysm . . . . . . . . . . . . . . . . . . . . 226 *33 *45 *42 64 0.9 *1.4 *1.2 *0.8 *0.7
Phlebitis, thrombophlebitis . . . . . . . . . . 727 162 147 159 158 2.9 6.7 3.8 3.0 1.8
Varicose veins of lower extremities . . . . . 7,403 912 1,255 1,683 2,291 29.8 37.6 32.4 32.1 25.6
Hemorrhoids. . . . . . . . . . . . . . . . . . . 9,441 1,122 1,422 2,041 3,555 38.0 46.3 36.7 38.9 39.7
Poor circulation . . . . . . . . . . . . . . . . . 980 254 225 153 166 3.9 10.5 5.8 2.9 1.9
1Includes unknown family income.
* Figure does not meet standard of reliability or precision.
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Table 7. Average annual number of selected chronic circulatory conditions and rates per 1,000 persons, by geographic region:
United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the




regions Northeast Midwest South West All regions Northeast Midwest South West
Number in thousands Rate per 1,000 persons
Heart disease . . . . . . . . . . . . . . . . . . 20,489 4,116 5,296 7,438 3,639 82.4 82.2 87.8 88.3 67.2
Ischemic heart disease. . . . . . . . . . . 7,732 1,645 1,908 2,992 1,187 31.1 32.9 31.6 35.5 21.9
Heart rhythm disorders . . . . . . . . . . . 7,868 1,618 2,105 2,564 1,581 31.6 32.3 34.9 30.4 29.2
Tachycardia or rapid heart . . . . . . . 1,911 364 539 666 343 7.7 7.3 8.9 7.9 6.3
Heart murmurs . . . . . . . . . . . . . . 4,276 921 1,078 1,358 919 17.2 18.4 17.9 16.1 17.0
Other and unspecified heart rhythm
disorders . . . . . . . . . . . . . . . . . 1,681 333 488 540 320 6.8 6.7 8.1 6.4 5.9
Congenital heart disease . . . . . . . . . 741 135 247 209 150 3.0 2.7 4.1 2.5 2.8
Other selected diseases of heart
(excludes hypertension) . . . . . . . . . 4,148 718 1,036 1,673 721 16.7 14.3 17.2 19.9 13.3
Rheumatic fever with or without heart
disease . . . . . . . . . . . . . . . . . . . . . 2,029 415 569 651 394 8.2 8.3 9.4 7.7 7.3
High blood pressure (hypertension) . . . . 27,600 5,296 7,272 10,223 4,809 111.0 105.8 120.5 121.4 88.8
Celebrovascular disease . . . . . . . . . . . 3,002 466 798 1,225 513 12.1 9.3 13.2 14.5 9.5
Hardening of arteries . . . . . . . . . . . . . 2,074 372 554 802 345 8.3 7.4 9.2 9.5 6.4
Aneurysm . . . . . . . . . . . . . . . . . . . . 226 *43 61 95 *27 0.9 *0.9 1.0 1.1 *0.5
Phlebitis, thrombophlebitis . . . . . . . . . . 727 156 163 267 142 2.9 3.1 2.7 3.2 2.6
Varicose veins of lower extremities . . . . . 7,403 1,316 2,051 2,360 1,676 29.8 26.3 34.0 28.0 31.0
Hemorrhoids. . . . . . . . . . . . . . . . . . . 9,441 1,629 2,557 3,414 1,841 38.0 32.5 42.4 40.5 34.0
Poor circulation . . . . . . . . . . . . . . . . . 980 137 298 408 138 3.9 2.7 4.9 4.8 2.5
* Figure does not meet standard of reliability or precision.
Table 8. Average annual number of selected chronic respiratory conditions, rates per 1,000 persons by age, and percent of conditions
causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the



























Rate per 1,000 persons Percent
Chronic bronchitis. . . . . . . . . . . . . . . . . . 12,884 51.8 53.4 45.1 56.6 70.4 54.8 2.0 9.8 94.9
Emphysema . . . . . . . . . . . . . . . . . . . . . 1,861 7.5 *– 0.8 13.5 35.8 39.9 44.1 27.4 97.8
Asthma . . . . . . . . . . . . . . . . . . . . . . . . 11,482 46.2 61.2 41.2 41.5 38.2 37.3 21.8 21.9 96.8
Hay fever or allergic rhinitis without asthma . . 24,060 96.7 64.3 121.1 101.4 79.8 66.7 1.4 1.7 71.2
Nasal polyps . . . . . . . . . . . . . . . . . . . . . 805 3.2 1.4 3.0 5.3 5.2 4.5 *0.4 16.5 88.9
Chronic sinusitis . . . . . . . . . . . . . . . . . . . 33,736 135.6 62.0 157.1 180.3 156.2 140.8 0.5 2.5 70.9
Deviated nasal septum. . . . . . . . . . . . . . . 1,646 6.6 0.9 8.4 9.5 8.7 7.0 *0.2 11.7 95.2
Chronic disease of tonsils and adenoids . . . . 2,836 11.4 24.9 9.7 2.9 2.2 *0.6 *0.4 12.1 94.2
Chronic laryngitis . . . . . . . . . . . . . . . . . . 1,508 6.1 2.2 7.1 7.2 10.3 6.5 *– *3.4 68.2
Pleurisy . . . . . . . . . . . . . . . . . . . . . . . . 690 2.8 *0.2 2.9 4.7 5.2 *4.4 *1.6 10.7 86.7
Pneumoconiosis and asbestosis . . . . . . . . . 324 1.3 *0.1 0.8 2.2 4.9 *3.7 26.2 *12.3 84.0
Malignant neoplasms of lung, bronchus, and
other respiratory sites. . . . . . . . . . . . . . . 218 0.9 *– *0.1 1.9 4.0 *3.6 60.6 71.6 100.0
Other diseases of the lung . . . . . . . . . . . . 1,141 4.6 3.7 2.8 5.9 8.8 13.5 16.2 31.2 99.6
1Includes races other than white and black and unknown family income.
*– Figure does not meet standard of reliability or precision and quantity zero.
* Figure does not meet standard of reliability or precision.
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Table 9. Average annual number of selected chronic respiratory conditions among males, rates per 1,000 persons by age, and percent of
conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the



























Rate per 1,000 persons Percent
Chronic bronchitis. . . . . . . . . . . . . . . . . . 5,124 42.4 57.7 30.4 39.0 65.0 43.6 2.3 9.4 94.5
Emphysema . . . . . . . . . . . . . . . . . . . . . 1,165 9.6 *– *0.8 17.7 55.9 59.5 44.8 27.9 98.5
Asthma . . . . . . . . . . . . . . . . . . . . . . . . 5,331 44.1 72.3 34.2 31.6 30.6 36.7 21.4 22.1 96.1
Hay fever or allergic rhinitis without asthma . . 11,150 92.3 63.6 116.8 92.5 69.3 65.9 1.3 2.0 67.7
Nasal polyps . . . . . . . . . . . . . . . . . . . . . 427 3.5 *1.5 3.8 5.8 *3.8 *4.5 *– 19.4 92.5
Chronic sinusitis . . . . . . . . . . . . . . . . . . . 13,833 114.6 60.7 129.7 154.5 125.3 120.3 0.5 2.5 67.5
Deviated nasal septum. . . . . . . . . . . . . . . 931 7.7 *1.3 8.8 13.2 12.2 *7.4 *0.4 11.7 94.5
Chronic disease of tonsils and adenoids . . . . 1,086 9.0 20.5 6.7 *1.5 *2.1 *– *0.4 13.5 92.9
Chronic laryngitis . . . . . . . . . . . . . . . . . . 333 2.8 1.7 2.7 3.9 *4.5 *2.5 *– *5.7 63.7
Pleurisy . . . . . . . . . . . . . . . . . . . . . . . . 212 1.8 *0.3 1.3 3.9 *3.1 *4.9 *1.9 *16.5 78.8
Pneumoconiosis and asbestosis . . . . . . . . . 306 2.5 *– 1.6 4.4 9.8 *9.8 26.5 *12.4 83.0
Malignant neoplasms of lung, bronchus,
and other respiratory sites . . . . . . . . . . . . 144 1.2 *– *0.2 2.5 *6.2 *6.3 62.5 83.3 100.0
Other diseases of the lung . . . . . . . . . . . . 571 4.7 4.0 2.8 6.5 8.8 16.5 16.8 32.6 99.3
1Includes races other than white and black and unknown family income.
*– Figure does not meet standard of reliability or precision and quantity zero.
* Figure does not meet standard of reliability or precision.
Table 10. Average annual number of selected chronic respiratory conditions among females, rates per 1,000 persons by age, and
percent of conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the



























Rate per 1,000 persons Percent
Chronic bronchitis. . . . . . . . . . . . . . . . . . 7,760 60.6 48.8 59.3 72.7 74.8 61.4 1.7 10.1 95.2
Emphysema . . . . . . . . . . . . . . . . . . . . . 696 5.4 *– *0.9 9.7 19.6 28.3 42.8 26.6 96.6
Asthma . . . . . . . . . . . . . . . . . . . . . . . . 6,151 48.1 49.7 48.0 50.6 44.3 37.7 22.2 21.7 97.4
Hay fever or allergic rhinitis without asthma . . 12,910 100.9 65.1 125.3 109.6 88.3 67.1 1.4 1.4 74.3
Nasal polyps . . . . . . . . . . . . . . . . . . . . . 378 3.0 *1.3 2.2 4.9 6.3 *4.7 *0.8 *13.2 84.9
Chronic sinusitis . . . . . . . . . . . . . . . . . . . 19,902 155.5 63.3 183.6 204.1 181.3 153.0 0.5 2.4 73.3
Deviated nasal septum. . . . . . . . . . . . . . . 714 5.6 *0.6 8.1 6.1 5.9 *6.8 *– 11.8 96.2
Chronic disease of tonsils and adenoids . . . . 1,750 13.7 29.5 12.5 4.2 *2.3 *0.9 *0.5 11.2 95.0
Chronic laryngitis . . . . . . . . . . . . . . . . . . 1,174 9.2 2.7 11.5 10.3 14.9 8.9 *– *2.8 69.4
Pleurisy . . . . . . . . . . . . . . . . . . . . . . . . 478 3.7 *0.1 4.4 5.5 7.0 *4.1 *1.5 *8.2 90.2
Pneumoconiosis and asbestosis . . . . . . . . . *18 *0.1 *0.1 *– *0.2 *0.9 *– *22.2 *11.1 *100.0
Malignant neoplasms of lung, bronchus, and
other respiratory sites. . . . . . . . . . . . . . . 74 0.6 *– *0.1 *1.3 *2.3 *2.0 *56.8 *48.6 100.0
Other diseases of the lung . . . . . . . . . . . . 570 4.5 3.3 2.8 5.4 8.8 11.7 15.6 29.8 100.0
1Includes races other than white and black and unknown family income.
*– Figure does not meet standard of reliability or precision and quantity zero.
* Figure does not meet standard of reliability or precision.
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Table 11. Average annual number of selected chronic respiratory conditions among white persons, rates per 1,000 persons by age, and
percent of conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the























Rate per 1,000 persons Percent
Chronic bronchitis. . . . . . . . . . . . . . . . . . 11,464 55.0 51.8 58.1 67.3 1.8 9.3 94.8
Emphysema . . . . . . . . . . . . . . . . . . . . . 1,746 8.4 0.6 14.5 39.5 44.4 27.5 97.7
Asthma . . . . . . . . . . . . . . . . . . . . . . . . 9,511 45.7 48.4 42.2 36.9 20.2 20.7 97.1
Hay fever or allergic rhinitis without asthma . . 21,132 101.5 106.2 102.4 75.6 1.3 1.6 70.8
Nasal polyps . . . . . . . . . . . . . . . . . . . . . 678 3.3 2.5 5.2 4.5 *0.4 18.9 89.8
Chronic sinusitis . . . . . . . . . . . . . . . . . . . 29,116 139.8 124.6 183.8 152.2 0.4 2.5 71.1
Deviated nasal septum. . . . . . . . . . . . . . . 1,576 7.6 6.3 10.9 9.0 *0.3 11.9 95.5
Chronic disease of tonsils and adenoids . . . . 2,488 11.9 16.6 3.0 *1.5 *0.5 11.0 94.5
Chronic laryngitis . . . . . . . . . . . . . . . . . . 1,394 6.7 5.9 7.8 9.1 *– *3.2 69.0
Pleurisy . . . . . . . . . . . . . . . . . . . . . . . . 636 3.1 2.1 5.0 5.1 *1.7 10.2 86.6
Pneumoconiosis and asbestosis . . . . . . . . . 297 1.4 0.6 2.4 4.3 26.6 *11.4 84.2
Malignant neoplasms of lung, bronchus, and
other respiratory sites. . . . . . . . . . . . . . . 205 1.0 *0.1 2.1 4.0 61.5 70.2 100.0
Other diseases of the lung . . . . . . . . . . . . 1,045 5.0 3.6 6.1 10.8 15.4 29.2 100.0
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
Table 12. Average annual number of selected chronic respiratory conditions among black persons, rates per 1,000 persons by age, and
percent of conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the























Rate per 1,000 persons Percent
Chronic bronchitis. . . . . . . . . . . . . . . . . . 1,176 38.0 34.6 53.5 39.8 *4.3 15.9 95.7
Emphysema . . . . . . . . . . . . . . . . . . . . . 93 3.0 *0.2 *7.4 *20.7 *44.1 *28.0 100.0
Asthma . . . . . . . . . . . . . . . . . . . . . . . . 1,648 53.3 56.3 42.6 46.0 30.3 29.0 96.1
Hay fever or allergic rhinitis without asthma . . 2,108 68.2 64.8 88.5 60.5 *1.9 *1.8 78.6
Nasal polyps . . . . . . . . . . . . . . . . . . . . . 96 3.1 *1.9 *7.0 *7.0 *– *– 89.6
Chronic sinusitis . . . . . . . . . . . . . . . . . . . 3,975 128.6 116.3 183.8 136.2 *1.0 2.3 69.5
Deviated nasal septum. . . . . . . . . . . . . . . *42 *1.4 *1.7 *0.6 *– *– *11.9 *100.0
Chronic disease of tonsils and adenoids . . . . 309 10.0 12.2 *3.3 *2.3 *– 18.8 94.2
Chronic laryngitis . . . . . . . . . . . . . . . . . . 101 3.3 2.7 *4.7 *5.9 *– *5.9 61.4
Pleurisy . . . . . . . . . . . . . . . . . . . . . . . . *46 *1.5 *1.0 *3.3 *2.7 *– *8.7 *84.8
Pneumoconiosis and asbestosis . . . . . . . . . *18 *0.6 *– *0.6 *5.9 *33.3 *33.3 *100.0
Malignant neoplasms of lung, bronchus, and
other respiratory sites. . . . . . . . . . . . . . . *9 *0.3 *– *0.8 *2.0 *33.3 *100.0 *100.0
Other diseases of the lung . . . . . . . . . . . . 76 2.5 *1.2 *5.5 *9.0 *25.0 *47.4 94.7
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 13. Average annual number of selected chronic respiratory conditions and rates per 1,000 persons, by family income:
United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the























Number in thousands Rate per 1,000 persons
Chronic bronchitis. . . . . . . . . . . . . . . . . . 12,884 1,554 2,094 2,685 4,611 51.8 64.1 54.1 51.2 51.4
Emphysema . . . . . . . . . . . . . . . . . . . . . 1,861 319 525 261 326 7.5 13.2 13.6 5.0 3.6
Asthma . . . . . . . . . . . . . . . . . . . . . . . . 11,482 1,601 1,888 2,147 4,085 46.2 66.1 48.8 40.9 45.6
Hay fever or allergic rhinitis without asthma . . 24,060 1,752 3,158 4,804 11,241 96.7 72.3 81.6 91.5 125.4
Nasal polyps . . . . . . . . . . . . . . . . . . . . . 805 94 138 190 243 3.2 3.9 3.6 3.6 2.7
Chronic sinusitis . . . . . . . . . . . . . . . . . . . 33,736 3,609 5,545 7,558 11,613 135.6 148.9 143.2 144.0 129.6
Deviated nasal septum. . . . . . . . . . . . . . . 1,646 109 175 335 864 6.6 4.5 4.5 6.4 9.6
Chronic disease of tonsils and adenoids . . . . 2,836 431 478 556 1,014 11.4 17.8 12.3 10.6 11.3
Chronic laryngitis . . . . . . . . . . . . . . . . . . 1,508 138 255 307 560 6.1 5.7 6.6 5.8 6.2
Pleurisy . . . . . . . . . . . . . . . . . . . . . . . . 690 111 159 140 169 2.8 4.6 4.1 2.7 1.9
Pneumoconiosis and asbestosis . . . . . . . . . 324 *22 100 86 62 1.3 *0.9 2.6 1.6 0.7
Malignant neoplasms of lung, bronchus, and
other respiratory sites. . . . . . . . . . . . . . . 218 *16 70 *39 56 0.9 *0.7 1.8 *0.7 0.6
Other diseases of the lung . . . . . . . . . . . . 1,141 179 205 277 292 4.6 7.4 5.3 5.3 3.3
1Includes unknown family income.
* Figure does not meet standard of reliability or precision.
Table 14. Average annual number of selected chronic respiratory conditions and rates per 1,000 persons, by geographic region:
United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the




regions Northeast Midwest South West
All
regions Northeast Midwest South West
Number in thousands Rate per 1,000 persons
Chronic bronchitis. . . . . . . . . . . . . . . . . . 12,884 2,475 3,444 4,331 2,635 51.8 49.4 57.1 51.4 48.7
Emphysema . . . . . . . . . . . . . . . . . . . . . 1,861 343 431 761 326 7.5 6.9 7.1 9.0 6.0
Asthma . . . . . . . . . . . . . . . . . . . . . . . . 11,482 2,272 2,772 3,721 2,717 46.2 45.4 45.9 44.2 50.2
Hay fever or allergic rhinitis without asthma . . 24,060 4,234 4,948 8,556 6,323 96.7 84.6 82.0 101.6 116.8
Nasal polyps . . . . . . . . . . . . . . . . . . . . . 805 132 165 266 241 3.2 2.6 2.7 3.2 4.5
Chronic sinusitis . . . . . . . . . . . . . . . . . . . 33,736 4,710 9,487 14,754 4,784 135.6 94.1 157.2 175.2 88.4
Deviated nasal septum. . . . . . . . . . . . . . . 1,646 428 419 425 374 6.6 8.5 6.9 5.0 6.9
Chronic disease of tonsils and adenoids . . . . 2,836 377 871 1,010 579 11.4 7.5 14.4 12.0 10.7
Chronic laryngitis . . . . . . . . . . . . . . . . . . 1,508 208 403 564 333 6.1 4.2 6.7 6.7 6.2
Pleurisy . . . . . . . . . . . . . . . . . . . . . . . . 690 77 235 283 96 2.8 1.5 3.9 3.4 1.8
Pneumoconiosis and asbestosis . . . . . . . . . 324 77 60 130 57 1.3 1.5 1.0 1.5 1.1
Malignant neoplasms of lung, bronchus, and
other respiratory sites. . . . . . . . . . . . . . . 218 *35 *52 83 *47 0.9 *0.7 *0.9 1.0 *0.9
Other diseases of the lung . . . . . . . . . . . . 1,141 214 307 383 236 4.6 4.3 5.1 4.5 4.4
* Figure does not meet standard of reliability or precision.
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Table 15. Average annual number of selected chronic digestive conditions, rates per 1,000 persons by age, and percent of conditions
causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the



























Rate per 1,000 persons Percent
Gallbladder stones . . . . . . . . . . . . . . . . . 1,068 4.3 *0.2 3.4 7.8 12.2 8.8 11.0 54.9 99.1
Liver diseases including cirrhosis . . . . . . . . 766 3.1 0.9 2.7 5.7 4.7 5.2 17.0 26.9 97.4
Ulcer, gastric, duodenal and/or peptic. . . . . . 4,201 16.9 1.0 18.1 27.1 31.3 30.9 7.8 26.5 97.3
Gastric ulcer. . . . . . . . . . . . . . . . . . . . 3,121 12.5 0.9 14.1 20.2 19.9 20.9 7.7 25.1 96.8
Duodenal ulcer . . . . . . . . . . . . . . . . . . 613 2.5 *0.1 2.0 4.0 7.3 6.2 10.4 29.5 100.0
Peptic ulcer . . . . . . . . . . . . . . . . . . . . 468 1.9 *0.1 2.0 2.9 4.1 *3.8 *5.3 32.1 97.2
Hernia of abdominal cavity . . . . . . . . . . . . 4,768 19.2 3.4 10.1 35.5 55.0 66.3 9.8 21.5 96.8
Disease of the esophagus. . . . . . . . . . . . . 834 3.4 *0.6 2.7 6.1 5.7 9.7 *5.4 27.7 97.6
Gastritis and duodenitis . . . . . . . . . . . . . . 3,003 12.1 2.4 12.0 19.3 23.1 20.8 *1.0 12.8 88.4
Indigestion and other functional disorders of
the stomach and digestive system . . . . . . . 6,437 25.9 2.9 28.3 38.3 48.2 47.6 1.1 5.8 64.1
Enteritis and colitis . . . . . . . . . . . . . . . . . 2,333 9.4 2.7 9.4 12.8 17.4 20.1 6.9 20.6 85.6
Spastic colon. . . . . . . . . . . . . . . . . . . . . 1,686 6.8 *0.4 7.5 11.3 11.5 10.2 *2.7 13.3 94.7
Diverticula of intestines . . . . . . . . . . . . . . 1,999 8.0 *0.0 1.8 12.3 42.2 37.9 4.3 27.9 97.7
Constipation . . . . . . . . . . . . . . . . . . . . . 4,302 17.3 6.5 13.1 18.1 36.4 80.7 *0.7 3.8 69.4
Other stomach and intestinal disorders. . . . . 2,060 8.3 2.6 7.2 11.9 17.6 20.5 8.9 16.1 85.4
Malignant neoplasms of stomach, intestines,
colon, and rectum . . . . . . . . . . . . . . . . . 322 1.3 *– *0.2 2.2 6.5 6.2 62.1 67.7 100.0
1Includes races other than white and black and unknown family income.
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
0.0 Quantity more than zero but less than 0.05.
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Table 16. Average annual number of selected chronic digestive conditions among males, rates per 1,000 persons by age, and percent of
conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the



























Rate per 1,000 persons Percent
Gallbladder stones . . . . . . . . . . . . . . . . . 308 2.6 *0.2 1.4 4.9 9.0 *9.2 *11.0 49.4 98.1
Liver diseases including cirrhosis . . . . . . . . 406 3.4 *0.9 3.3 6.1 *4.4 *6.9 23.2 22.2 96.1
Ulcer, gastric, duodenal and/or peptic. . . . . . 1,967 16.3 *1.1 16.9 26.6 34.2 37.6 9.0 29.0 97.1
Gastric ulcer. . . . . . . . . . . . . . . . . . . . 1,474 12.2 *0.9 13.0 20.8 21.4 27.9 9.5 28.3 97.0
Duodenal ulcer . . . . . . . . . . . . . . . . . . 281 2.3 *0.1 1.9 3.8 8.3 *5.1 *7.5 34.9 100.0
Peptic ulcer . . . . . . . . . . . . . . . . . . . . 212 1.8 *0.1 2.0 *2.1 *4.5 *4.7 *7.1 25.9 93.9
Hernia of abdominal cavity . . . . . . . . . . . . 2,347 19.4 4.8 11.4 38.5 52.0 66.6 9.8 26.6 96.5
Disease of the esophagus. . . . . . . . . . . . . 399 3.3 *0.7 2.6 6.7 *5.1 *11.2 *4.5 23.8 99.2
Gastritis and duodenitis . . . . . . . . . . . . . . 1,154 9.6 2.1 10.5 14.1 14.9 20.8 *0.6 13.4 84.8
Indigestion and other functional disorders of
the stomach and digestive system . . . . . . . 3,086 25.6 2.1 29.7 38.5 43.2 55.7 *1.0 4.7 59.6
Enteritis and colitis . . . . . . . . . . . . . . . . . 817 6.8 2.6 6.9 9.3 14.3 *9.6 7.2 20.1 82.6
Spastic colon. . . . . . . . . . . . . . . . . . . . . 295 2.4 *0.2 2.9 3.1 *5.3 *4.7 *0.3 *9.2 90.2
Diverticula of intestines . . . . . . . . . . . . . . 591 4.9 *0.1 1.5 6.8 35.2 15.4 *4.4 30.1 97.8
Constipation . . . . . . . . . . . . . . . . . . . . . 1,099 9.1 6.5 4.5 8.8 24.0 55.7 *1.9 *3.3 71.6
Other stomach and intestinal disorders. . . . . 815 6.7 3.1 5.9 9.5 15.5 13.2 10.4 14.0 81.5
Malignant neoplasms of stomach, intestines,
colon, and rectum . . . . . . . . . . . . . . . . . 146 1.2 *– *0.2 *2.2 7.0 *7.2 65.1 63.7 100.0
1Includes races other than white and black and unknown family income.
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 17. Average annual number of selected chronic digestive conditions among females, rates per 1,000 persons by age, and percent
of conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the



























Rate per 1,000 persons Percent
Gallbladder stones . . . . . . . . . . . . . . . . . 760 5.9 *0.2 5.2 10.5 14.8 8.6 10.9 57.1 99.5
Liver diseases including cirrhosis . . . . . . . . 360 2.8 *1.0 2.1 5.4 *4.9 *4.1 *10.0 32.2 98.9
Ulcer, gastric, duodenal and/or peptic. . . . . . 2,235 17.5 *1.0 19.2 27.5 28.9 26.8 6.8 24.3 97.4
Gastric ulcer. . . . . . . . . . . . . . . . . . . . 1,647 12.9 *0.8 15.3 19.6 18.7 16.9 6.0 22.2 96.6
Duodenal ulcer . . . . . . . . . . . . . . . . . . 332 2.6 *0.1 2.0 4.3 6.4 *6.8 *12.7 25.0 100.0
Peptic ulcer . . . . . . . . . . . . . . . . . . . . 256 2.0 *– 1.9 3.6 *3.8 *3.3 *3.9 37.1 100.0
Hernia of abdominal cavity . . . . . . . . . . . . 2,421 18.9 2.0 8.8 32.7 57.4 66.0 9.8 16.6 97.1
Disease of the esophagus. . . . . . . . . . . . . 435 3.4 *0.6 2.8 5.6 6.2 8.8 *6.4 31.5 96.1
Gastritis and duodenitis . . . . . . . . . . . . . . 1,849 14.4 2.6 13.3 24.1 29.6 20.7 *1.3 12.4 90.6
Indigestion and other functional disorders of
the stomach and digestive system . . . . . . . 3,351 26.2 3.7 26.8 38.2 52.2 42.9 *1.2 6.8 68.3
Enteritis and colitis . . . . . . . . . . . . . . . . . 1,517 11.9 2.9 11.7 16.1 19.9 26.4 6.7 20.9 87.1
Spastic colon. . . . . . . . . . . . . . . . . . . . . 1,391 10.9 *0.6 11.8 18.9 16.6 13.6 *3.2 14.2 95.8
Diverticula of intestines . . . . . . . . . . . . . . 1,407 11.0 *– 2.0 17.4 47.8 51.3 4.2 26.9 97.8
Constipation . . . . . . . . . . . . . . . . . . . . . 3,203 25.0 6.5 21.4 26.6 46.4 95.4 *0.2 4.0 68.7
Other stomach and intestinal disorders. . . . . 1,245 9.7 2.1 8.3 14.2 19.3 24.7 8.0 17.4 88.0
Malignant neoplasms of stomach, intestines,
colon, and rectum . . . . . . . . . . . . . . . . . 175 1.4 *– *0.3 2.3 6.1 *5.6 60.0 71.4 100.0
1Includes races other than white and black and unknown family income.
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 18. Average annual number of selected chronic digestive conditions among white persons, rates per 1,000 persons by age, and
percent of conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the























Rate per 1,000 persons Percent
Gallbladder stones . . . . . . . . . . . . . . . . . 929 4.5 2.2 7.7 11.0 9.7 53.8 98.9
Liver diseases including cirrhosis . . . . . . . . 682 3.3 2.0 6.2 5.2 17.4 26.5 97.7
Ulcer, gastric, duodenal and/or peptic. . . . . . 3,580 17.2 12.1 25.7 30.4 7.2 26.8 97.6
Gastric ulcer. . . . . . . . . . . . . . . . . . . . 2,600 12.5 9.3 18.9 19.2 7.1 25.0 97.2
Duodenal ulcer . . . . . . . . . . . . . . . . . . 575 2.8 1.4 4.2 7.4 *9.4 31.1 100.0
Peptic ulcer . . . . . . . . . . . . . . . . . . . . 405 1.9 1.4 2.6 3.8 *4.9 32.3 96.8
Hernia of abdominal cavity . . . . . . . . . . . . 4,422 21.2 8.0 38.8 63.3 9.0 20.8 96.7
Disease of the esophagus. . . . . . . . . . . . . 795 3.8 2.2 6.7 7.9 *5.7 26.8 97.5
Gastritis and duodenitis . . . . . . . . . . . . . . 2,604 12.5 8.5 19.9 22.1 *0.8 13.7 88.0
Indigestion and other functional disorders of
the stomach and digestive system . . . . . . . 5,726 27.5 20.1 38.8 48.4 1.0 5.6 64.8
Enteritis and colitis . . . . . . . . . . . . . . . . . 2,195 10.5 7.7 14.2 19.4 6.8 20.3 87.2
Spastic colon. . . . . . . . . . . . . . . . . . . . . 1,622 7.8 5.6 12.2 12.2 *2.7 13.2 94.9
Diverticula of intestines . . . . . . . . . . . . . . 1,928 9.3 1.3 13.4 44.1 4.2 27.5 97.8
Constipation . . . . . . . . . . . . . . . . . . . . . 3,556 17.1 10.3 16.7 52.5 *0.6 4.0 70.8
Other stomach and intestinal disorders. . . . . 1,814 8.7 5.8 12.4 18.3 8.9 16.3 85.0
Malignant neoplasms of stomach, intestines,
colon, and rectum . . . . . . . . . . . . . . . . . 287 1.4 *0.1 2.1 6.7 60.6 66.6 100.0
* Figure does not meet standard of reliability or precision.
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Table 19. Average annual number of selected chronic digestive conditions among black persons, rates per 1,000 persons by age, and
percent of conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the























Rate per 1,000 persons Percent
Gallbladder stones . . . . . . . . . . . . . . . . . 93 3.0 *1.8 *5.9 *9.0 *23.7 69.9 100.0
Liver diseases including cirrhosis . . . . . . . . 61 2.0 *1.9 *2.9 *0.8 *18.0 *41.0 100.0
Ulcer, gastric, duodenal and/or peptic. . . . . . 495 16.0 8.8 37.1 42.5 12.3 25.5 99.2
Gastric ulcer. . . . . . . . . . . . . . . . . . . . 415 13.4 7.8 30.5 33.2 *12.0 25.3 99.3
Duodenal ulcer . . . . . . . . . . . . . . . . . . *21 *0.7 *0.5 *0.6 *2.3 *28.6 *9.5 *100.0
Peptic ulcer . . . . . . . . . . . . . . . . . . . . 59 1.9 *0.5 *5.9 *7.0 *8.5 *32.2 100.0
Hernia of abdominal cavity . . . . . . . . . . . . 310 10.0 6.6 17.0 28.1 19.7 31.3 97.1
Disease of the esophagus. . . . . . . . . . . . . *34 *1.1 *0.7 *2.9 *2.0 *– *52.9 *100.0
Gastritis and duodenitis . . . . . . . . . . . . . . 350 11.3 8.5 18.0 24.2 *2.9 *8.0 91.1
Indigestion and other functional disorders of
the stomach and digestive system . . . . . . . 571 18.5 11.4 39.1 43.7 *2.3 *8.1 62.9
Enteritis and colitis . . . . . . . . . . . . . . . . . 91 2.9 2.5 *3.1 *7.0 *12.1 *35.2 68.1
Spastic colon. . . . . . . . . . . . . . . . . . . . . *45 *1.5 *0.9 *4.5 *0.8 *4.4 *15.6 *95.6
Diverticula of intestines . . . . . . . . . . . . . . 71 2.3 *0.3 *7.0 *10.9 *5.6 *36.6 97.2
Constipation . . . . . . . . . . . . . . . . . . . . . 646 20.9 13.9 28.9 70.2 *0.9 *2.5 62.7
Other stomach and intestinal disorders. . . . . 223 7.2 4.1 11.5 27.7 *9.9 *16.1 87.4
Malignant neoplasms of stomach, intestines,
colon, and rectum . . . . . . . . . . . . . . . . . *35 *1.1 *0.2 *3.9 *4.3 *74.3 *77.1 *100.0
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
Table 20. Average annual number of selected chronic digestive conditions and rates per 1,000 persons, by family income: United States,
1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the























Number in thousands Rate per 1,000 persons
Gallbladder stones . . . . . . . . . . . . . . . . . 1,068 114 271 185 326 4.3 4.7 7.0 3.5 3.6
Liver diseases including cirrhosis . . . . . . . . 766 192 127 142 153 3.1 7.9 3.3 2.7 1.7
Ulcer, gastric, duodenal and/or peptic. . . . . . 4,201 757 898 928 911 16.9 31.2 23.2 17.7 10.2
Gastric ulcer. . . . . . . . . . . . . . . . . . . . 3,121 573 676 699 617 12.5 23.6 17.5 13.3 6.9
Duodenal ulcer . . . . . . . . . . . . . . . . . . 613 90 116 137 191 2.5 3.7 3.0 2.6 2.1
Peptic ulcer . . . . . . . . . . . . . . . . . . . . 468 93 107 92 103 1.9 3.8 2.8 1.8 1.1
Hernia of abdominal cavity . . . . . . . . . . . . 4,768 660 872 1,066 1,344 19.2 27.2 22.5 20.3 15.0
Disease of the esophagus. . . . . . . . . . . . . 834 96 115 203 321 3.4 4.0 3.0 3.9 3.6
Gastritis and duodenitis . . . . . . . . . . . . . . 3,003 462 481 612 996 12.1 19.1 12.4 11.7 11.1
Indigestion and other functional disorders of
the stomach and digestive system . . . . . . . 6,437 864 1,214 1,427 2,094 25.9 35.7 31.4 27.2 23.4
Enteritis and colitis . . . . . . . . . . . . . . . . . 2,333 316 374 467 836 9.4 13.0 9.7 8.9 9.3
Spastic colon. . . . . . . . . . . . . . . . . . . . . 1,686 207 259 335 651 6.8 8.5 6.7 6.4 7.3
Diverticula of intestines . . . . . . . . . . . . . . 1,999 284 429 408 479 8.0 11.7 11.1 7.8 5.3
Constipation . . . . . . . . . . . . . . . . . . . . . 4,302 846 897 899 962 17.3 34.9 23.2 17.1 10.7
Other stomach and intestinal disorders. . . . . 2,060 348 376 440 557 8.3 14.4 9.7 8.4 6.2
Malignant neoplasms of stomach, intestines,
colon, and rectum . . . . . . . . . . . . . . . . . 322 63 76 59 65 1.3 *2.6 2.0 *1.1 0.7
1Includes unknown family income.
* Figure does not meet standard of reliability or precision.
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Table 21. Average annual number of selected chronic digestive conditions and rates per 1,000 persons, by geographic region:
United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the




regions Northeast Midwest South West
All
regions Northeast Midwest South West
Number in thousands Rate per 1,000 persons
Gallbladder stones . . . . . . . . . . . . . . . . . 1,068 228 249 365 226 4.3 4.6 4.1 4.3 4.2
Liver diseases including cirrhosis . . . . . . . . 766 133 161 276 196 3.1 2.7 2.7 3.3 3.6
Ulcer, gastric, duodenal and/or peptic. . . . . . 4,201 625 1,024 1,706 847 16.9 12.5 17.0 20.3 15.6
Gastric ulcer. . . . . . . . . . . . . . . . . . . . 3,121 449 767 1,301 604 12.5 9.0 12.7 15.4 11.2
Duodenal ulcer . . . . . . . . . . . . . . . . . . 613 104 167 197 145 2.5 2.1 2.8 2.3 2.7
Peptic ulcer . . . . . . . . . . . . . . . . . . . . 468 72 90 208 98 1.9 1.4 1.5 2.5 1.8
Hernia of abdominal cavity . . . . . . . . . . . . 4,768 848 1,088 2,071 762 19.2 16.9 18.0 24.6 14.1
Disease of the esophagus. . . . . . . . . . . . . 834 147 229 359 98 3.4 2.9 3.8 4.3 1.8
Gastritis and duodenitis . . . . . . . . . . . . . . 3,003 579 802 1,009 613 12.1 11.6 13.3 12.0 11.3
Indigestion and other functional disorders of
the stomach and digestive system . . . . . . . 6,437 863 1,663 2,583 1,328 25.9 17.2 27.6 30.7 24.5
Enteritis and colitis . . . . . . . . . . . . . . . . . 2,333 530 569 723 511 9.4 10.6 9.4 8.6 9.4
Spastic colon. . . . . . . . . . . . . . . . . . . . . 1,686 329 420 592 344 6.8 6.6 7.0 7.0 6.4
Diverticula of intestines . . . . . . . . . . . . . . 1,999 349 433 877 339 8.0 7.0 7.2 10.4 6.3
Constipation . . . . . . . . . . . . . . . . . . . . . 4,302 691 984 1,706 921 17.3 13.8 16.3 20.3 17.0
Other stomach and intestinal disorders. . . . . 2,060 403 519 717 421 8.3 8.0 8.6 8.5 7.8
Malignant neoplasms of stomach, intestines,
colon, and rectum . . . . . . . . . . . . . . . . . 322 79 73 106 64 1.3 1.6 1.2 1.3 1.2
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Table 22. Average annual number of selected impairments and of chronic conditions of the nervous system and sense organs, rates
per 1,000 persons by age, and percent of conditions causing activity limitation, hospitalization, and physician visits: United States,
1990–92—Con.
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Impairment and chronic condition


























Impairment Rate per 1,000 persons Percent
Blindness and other visual impairments . . . . . 8,169 32.8 8.2 29.2 45.0 59.8 110.6 15.8 14.9 82.7
Blind, both eyes. . . . . . . . . . . . . . . . . . . 551 2.2 *0.5 1.5 2.3 3.3 16.1 60.3 22.3 98.2
Other visual impairments . . . . . . . . . . . . . 7,618 30.6 7.7 27.7 42.8 56.5 94.4 12.6 14.3 81.6
Deafness and other hearing impairments. . . . . 23,266 93.5 17.3 50.7 148.6 262.6 410.3 5.5 6.1 74.8
Deaf, both ears . . . . . . . . . . . . . . . . . . . 1,465 5.9 *0.9 1.8 7.4 17.7 45.0 14.5 8.2 90.9
Other hearing impairments . . . . . . . . . . . . 21,801 87.6 16.4 48.9 141.3 244.9 365.3 4.9 6.0 73.7
Speech impairments . . . . . . . . . . . . . . . . . 2,725 11.0 17.3 7.9 7.9 10.4 15.9 20.4 5.4 69.4
Impairment of sensation . . . . . . . . . . . . . . . 1,142 4.6 *0.1 2.7 7.7 12.2 21.3 5.8 9.6 64.4
Mental retardation . . . . . . . . . . . . . . . . . . . 1,562 6.3 11.5 6.0 3.0 *0.6 *1.5 87.5 8.4 85.9
Absence of extremities or parts of
extremities (excluding absence of tips
of fingers or toes only) . . . . . . . . . . . . . . . 1,479 5.9 1.0 4.2 9.9 17.0 16.3 19.7 59.2 100.0
Absence of upper extremities or parts
of upper extremities . . . . . . . . . . . . . . . 946 3.8 *0.7 3.0 6.0 9.7 9.8 12.4 52.3 100.0
Absence of lower extremities or parts
of lower extremities . . . . . . . . . . . . . . . . 533 2.1 *0.3 1.2 3.8 7.3 6.5 32.8 71.5 100.0
Absence of lung . . . . . . . . . . . . . . . . . . . . 236 0.9 *– *0.3 2.1 3.9 *2.6 *22.5 80.9 100.0
Absence of kidney. . . . . . . . . . . . . . . . . . . 556 2.2 *0.7 1.3 3.6 6.6 6.9 11.5 75.9 99.1
Absence of breast . . . . . . . . . . . . . . . . . . . 1,153 4.6 *– 0.7 8.2 18.8 28.5 *4.7 91.8 100.0
Absence of bone, joint, or muscle of
extremity . . . . . . . . . . . . . . . . . . . . . . . . 876 3.5 *0.2 2.0 4.4 11.4 19.8 32.0 66.1 99.1
Absence of tips of fingers or toes . . . . . . . . . 366 1.5 *0.2 1.4 2.3 4.1 *1.8 *5.7 29.5 100.0
Paralysis of extremities, complete or partial . . . 1,464 5.9 2.7 3.1 8.0 16.0 24.3 60.7 42.5 99.5
Paralysis of extremities, complete. . . . . . . . 626 2.5 *0.6 1.2 4.6 6.5 10.8 54.5 53.8 100.0
Paralysis of extremities, partial. . . . . . . . . . 838 3.4 2.2 1.9 3.4 9.5 13.4 65.5 34.0 99.2
Cerebral palsy . . . . . . . . . . . . . . . . . . 258 1.0 2.0 1.0 *0.4 *– *0.3 74.4 43.8 100.0
Paralysis of other site, complete or partial . . . . 371 1.5 *0.6 0.8 2.5 *2.6 6.6 48.0 37.5 98.7
Deformities or orthopedic impairments, total . . . 34,964 140.6 30.7 161.7 195.4 203.5 242.2 25.2 18.6 90.4
Deformities or orthopedic impairments
of back . . . . . . . . . . . . . . . . . . . . . . . 18,144 72.9 10.3 90.8 103.7 92.6 106.5 22.4 15.6 92.2
Curvature or other deformity of back
or spine . . . . . . . . . . . . . . . . . . . . . 5,078 20.4 7.9 25.1 21.8 23.3 37.8 12.2 8.9 93.4
Deformities or orthopedic impairments
of upper extremities . . . . . . . . . . . . . . . 3,846 15.5 2.1 16.2 23.5 29.3 29.0 30.0 26.1 94.2
Orthopedic impairment, shoulder . . . . . . . 2,919 11.7 1.2 13.1 18.6 18.8 19.2 36.4 24.6 94.6
Deformities or orthopedic impairments
of lower extremities . . . . . . . . . . . . . . . . 12,518 50.3 18.0 52.8 66.1 79.2 98.6 26.8 20.8 86.4
Flat feet . . . . . . . . . . . . . . . . . . . . . . 3,698 14.9 10.0 15.7 18.6 17.9 15.0 *1.2 2.6 69.5
Other deformities or orthopedic impairment . . 456 1.8 *0.4 1.8 2.1 *2.4 8.1 54.4 13.4 96.3
Cleft palate . . . . . . . . . . . . . . . . . . . . . . . 217 0.9 1.0 0.8 1.2 *0.7 *0.3 *3.2 63.1 95.4
Condition of nervous system
and sense organs
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . 2,433 9.8 *0.4 2.1 12.2 43.3 67.7 13.4 10.5 99.8
Cataracts . . . . . . . . . . . . . . . . . . . . . . . . 6,416 25.8 1.1 2.7 22.7 122.1 229.0 6.1 9.9 98.4
Color blindness . . . . . . . . . . . . . . . . . . . . 2,697 10.8 4.0 12.7 15.0 13.7 11.8 *0.2 *– 58.0
Diseases of retina . . . . . . . . . . . . . . . . . . . 1,293 5.2 *0.4 2.0 4.8 18.7 40.9 28.9 20.7 99.8
Tinnitus . . . . . . . . . . . . . . . . . . . . . . . . . 7,144 28.7 1.8 16.8 54.6 91.6 82.5 0.8 1.5 69.2
Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . 1,243 5.0 4.4 5.6 5.0 3.9 4.6 44.4 47.8 98.9
Migraine headache . . . . . . . . . . . . . . . . . . 9,992 40.2 13.2 57.2 51.6 22.9 19.1 3.4 7.7 81.8
Other headache (excluding tension
headache) . . . . . . . . . . . . . . . . . . . . . . . 10,279 41.3 12.7 57.6 50.3 34.7 29.1 1.8 2.8 63.6
Multiple sclerosis . . . . . . . . . . . . . . . . . . . 180 0.7 *– 0.9 1.4 *0.9 *0.2 69.4 43.9 100.0
1Includes races other than white and black and unknown family income.
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 23. Average annual number of selected impairments and of chronic conditions of the nervous system and sense organs among
males, rates per 1,000 persons by age, and percent of conditions causing activity limitation, hospitalization, and physician visits:
United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Impairment and chronic condition


























Impairment Rate per 1,000 persons Percent
Blindness and other visual impairments . . . . . 5,099 42.2 11.6 41.0 59.8 80.9 125.4 12.8 15.0 77.8
Blind, both eyes. . . . . . . . . . . . . . . . . . . 286 2.4 *0.5 2.0 2.6 *4.4 16.1 57.7 23.1 97.2
Other visual impairments . . . . . . . . . . . . . 4,813 39.9 11.1 39.1 57.2 76.5 109.3 10.1 14.5 76.7
Deafness and other hearing impairments. . . . . 13,205 109.4 20.5 62.5 197.8 334.4 456.4 4.8 5.3 75.0
Deaf, both ears . . . . . . . . . . . . . . . . . . . 843 7.0 *0.7 2.3 11.6 24.1 52.7 10.4 7.8 90.7
Other hearing impairments . . . . . . . . . . . . 12,362 102.4 19.8 60.2 186.2 310.3 403.7 4.4 5.2 73.9
Speech impairments . . . . . . . . . . . . . . . . . 1,722 14.3 24.0 10.3 9.4 12.2 15.4 22.4 6.0 67.4
Impairment of sensation . . . . . . . . . . . . . . . 624 5.2 *0.1 3.3 8.9 15.2 27.7 *8.3 13.8 64.6
Mental retardation . . . . . . . . . . . . . . . . . . . 902 7.5 14.2 6.8 2.4 *0.7 *2.5 91.4 7.5 85.1
Absence of extremities or parts of
extremities (excluding absence of tips
of fingers or toes only) . . . . . . . . . . . . . . . 1,137 9.4 *1.0 7.0 16.0 31.2 26.6 19.3 60.7 100.0
Absence of upper extremities or parts
of upper extremities . . . . . . . . . . . . . . . 786 6.5 *1.0 5.0 11.2 19.6 17.7 12.0 53.8 100.0
Absence of lower extremities or parts
of lower extremities . . . . . . . . . . . . . . . . 351 2.9 *0.1 2.0 4.8 11.6 *8.9 35.6 76.1 100.0
Absence of lung . . . . . . . . . . . . . . . . . . . . 130 1.1 *– *0.4 *2.3 *5.5 *2.7 *31.5 83.8 100.0
Absence of kidney. . . . . . . . . . . . . . . . . . . 215 1.8 *0.6 *0.9 2.7 7.0 *6.0 *12.6 76.7 100.0
Absence of breast . . . . . . . . . . . . . . . . . . . *20 *0.2 *– *– *0.3 *0.5 *2.2 *– *75.0 *100.0
Absence of bone, joint, or muscle of
extremity . . . . . . . . . . . . . . . . . . . . . . . . 375 3.1 *0.4 2.4 5.1 8.6 12.3 32.5 62.1 100.0
Absence of tips of fingers or toes . . . . . . . . . 319 2.6 *0.4 2.2 4.7 7.7 *4.9 *6.6 29.5 100.0
Paralysis of extremities, complete or partial . . . 785 6.5 3.1 3.8 10.5 18.2 21.9 64.2 44.3 99.6
Paralysis of extremities, complete. . . . . . . . 364 3.0 *0.6 1.7 6.2 8.4 *11.4 59.3 56.9 100.0
Paralysis of extremities, partial. . . . . . . . . . 421 3.5 2.5 2.1 4.4 9.9 *10.5 68.4 33.5 99.3
Cerebral palsy . . . . . . . . . . . . . . . . . . 158 1.3 2.4 1.1 *0.8 *– *– 74.7 39.9 100.0
Paralysis of other site, complete or partial . . . . 198 1.6 *0.7 *0.8 3.3 *2.2 *9.2 55.1 34.3 100.0
Deformities or orthopedic impairments, total . . . 16,504 136.7 27.9 166.3 199.3 191.6 190.2 26.0 21.4 90.4
Deformities or orthopedic impairments
of back . . . . . . . . . . . . . . . . . . . . . . . 7,825 64.8 8.0 82.8 98.6 86.1 70.6 23.8 17.7 91.7
Curvature or other deformity of back
or spine . . . . . . . . . . . . . . . . . . . . . 1,547 12.8 5.6 16.2 15.1 14.5 12.7 12.8 9.4 92.4
Deformities or orthopedic impairments
of upper extremities . . . . . . . . . . . . . . . 2,124 17.6 *1.2 20.5 27.4 32.3 30.0 29.7 31.7 94.4
Orthopedic impairment, shoulder . . . . . . . 1,578 13.1 *0.6 15.5 21.4 22.7 18.6 36.8 30.6 94.2
Deformities or orthopedic impairments
of lower extremities . . . . . . . . . . . . . . . . 6,298 52.2 18.0 60.7 71.1 70.8 78.7 26.6 22.9 87.5
Flat feet . . . . . . . . . . . . . . . . . . . . . . 1,841 15.2 11.0 16.1 19.1 17.6 12.7 *1.0 *2.7 72.1
Other deformities or orthopedic impairment . . 257 2.1 *0.7 2.2 *2.2 *2.3 *10.7 46.3 *14.0 93.4
Cleft palate . . . . . . . . . . . . . . . . . . . . . . . 142 1.2 *1.3 1.1 *1.5 *0.4 *0.9 *4.9 62.7 95.1
Condition of nervous system
and sense organs
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . 1,103 9.1 *0.5 2.6 12.5 44.9 66.6 14.6 12.4 100.0
Cataracts . . . . . . . . . . . . . . . . . . . . . . . . 2,148 17.8 *1.0 2.2 17.4 99.8 175.7 5.4 11.6 97.3
Color blindness . . . . . . . . . . . . . . . . . . . . 2,425 20.1 7.4 22.7 28.9 27.3 26.4 *0.2 *– 58.6
Diseases of retina . . . . . . . . . . . . . . . . . . . 521 4.3 *0.4 2.0 4.9 17.6 33.8 34.7 25.7 100.0
Tinnitus . . . . . . . . . . . . . . . . . . . . . . . . . 3,687 30.5 2.1 17.2 64.3 105.3 90.1 *0.5 1.7 71.4
Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . 608 5.0 4.7 5.4 4.7 *4.5 *6.3 50.2 47.5 98.8
Migraine headache . . . . . . . . . . . . . . . . . . 2,643 21.9 12.5 30.9 22.9 9.9 *4.7 3.1 7.0 75.9
Other headache (excluding tension
headache) . . . . . . . . . . . . . . . . . . . . . . . 3,179 26.3 10.3 34.7 32.9 24.7 18.6 2.0 3.1 57.1
Multiple sclerosis . . . . . . . . . . . . . . . . . . . 68 0.6 *– *0.7 *1.0 *1.0 *– *55.9 *23.5 100.0
1Includes races other than white and black and unknown family income.
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 24. Average annual number of selected impairments and of chronic conditions of the nervous system and sense organs among
females, rates per 1,000 persons by age, and percent of conditions causing activity limitation, hospitalization, and physician visits:
United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Impairment and chronic condition


























Impairment Rate per 1,000 persons Percent
Blindness and other visual impairments . . . . . 3,070 24.0 4.6 17.7 31.4 42.6 101.8 20.7 14.7 90.9
Blind, both eyes. . . . . . . . . . . . . . . . . . . 265 2.1 *0.5 1.1 *1.9 *2.3 16.2 63.0 21.9 99.2
Other visual impairments . . . . . . . . . . . . . 2,805 21.9 4.1 16.7 29.5 40.3 85.6 16.8 14.1 90.1
Deafness and other hearing impairments. . . . . 10,061 78.6 14.1 39.4 103.3 204.6 382.9 6.4 7.2 74.5
Deaf, both ears . . . . . . . . . . . . . . . . . . . 622 4.9 *1.2 1.3 3.4 12.6 40.3 19.9 *8.5 91.3
Other hearing impairments . . . . . . . . . . . . 9,439 73.7 12.9 38.0 99.9 192.0 342.5 5.5 7.1 73.4
Speech impairments . . . . . . . . . . . . . . . . . 1,003 7.8 10.2 5.7 6.5 9.0 16.3 16.7 *4.4 72.8
Impairment of sensation . . . . . . . . . . . . . . . 518 4.0 *0.2 2.2 6.5 9.9 17.5 *2.7 *4.6 64.3
Mental retardation . . . . . . . . . . . . . . . . . . . 661 5.2 8.7 5.3 3.4 *0.5 *0.9 81.8 9.5 86.7
Absence of extremities or parts of
extremities (excluding absence of tips
of fingers or toes only) . . . . . . . . . . . . . . . 341 2.7 *1.0 1.4 4.2 5.5 10.1 21.1 54.5 100.0
Absence of upper extremities or parts
of upper extremities . . . . . . . . . . . . . . . 160 1.3 *0.5 1.1 *1.3 *1.8 *5.0 *14.4 45.0 100.0
Absence of lower extremities or parts
of lower extremities . . . . . . . . . . . . . . . . 181 1.4 *0.5 *0.3 2.9 *3.9 *5.0 *27.1 63.0 100.0
Absence of lung . . . . . . . . . . . . . . . . . . . . 106 *0.8 *– *0.2 *2.0 *2.7 *2.5 *11.3 78.3 100.0
Absence of kidney. . . . . . . . . . . . . . . . . . . 341 2.7 *0.9 1.6 4.4 6.2 7.4 *10.9 75.4 98.5
Absence of breast . . . . . . . . . . . . . . . . . . . 1,134 8.9 *– 1.4 15.6 33.6 44.1 *4.8 92.1 100.0
Absence of bone, joint, or muscle of
extremity . . . . . . . . . . . . . . . . . . . . . . . . 500 3.9 *– 1.6 3.8 13.7 24.2 31.4 69.2 98.6
Absence of tips of fingers or toes . . . . . . . . . *46 *0.4 *– *0.6 *0.1 *1.2 *– *– *30.4 *100.0
Paralysis of extremities, complete or partial . . . 679 5.3 2.4 2.4 5.6 14.0 25.6 56.8 40.4 99.4
Paralysis of extremities, complete. . . . . . . . 262 2.0 *0.6 *0.7 3.1 *5.0 10.5 47.7 49.6 100.0
Paralysis of extremities, partial. . . . . . . . . . 417 3.3 1.8 1.7 2.6 9.1 15.1 62.6 34.5 99.0
Cerebral palsy . . . . . . . . . . . . . . . . . . 100 0.8 *1.7 *0.8 *– *– *0.5 74.0 *51.0 100.0
Paralysis of extremities, complete or partial . . . 173 1.4 *0.5 *0.9 *1.8 *2.9 *5.2 39.3 41.0 97.1
Deformities or orthopedic impairments, total . . . 18,461 144.2 33.7 157.2 191.9 213.1 273.1 24.6 16.1 90.3
Deformities or orthopedic impairments
of back . . . . . . . . . . . . . . . . . . . . . . . 10,319 80.6 12.6 98.5 108.4 97.8 127.8 21.4 14.1 92.6
Curvature or other deformity of back
or spine . . . . . . . . . . . . . . . . . . . . . 3,530 27.6 10.2 33.7 27.9 30.6 52.6 11.9 8.6 93.9
Deformities or orthopedic impairments
of upper extremities . . . . . . . . . . . . . . . 1,723 13.5 3.0 12.1 19.9 26.8 28.4 30.4 19.3 93.8
Orthopedic impairment, shoulder . . . . . . . 1,341 10.5 1.8 10.9 16.0 15.6 19.4 36.0 17.4 95.1
Deformities or orthopedic impairments
of lower extremities . . . . . . . . . . . . . . . . 6,220 48.6 18.0 45.2 61.5 86.1 110.3 27.0 18.6 85.3
Flat feet . . . . . . . . . . . . . . . . . . . . . . 1,857 14.5 8.9 15.2 18.2 18.1 16.3 *1.5 *2.5 66.9
Other deformities or orthopedic impairment . . 199 1.6 *– 1.4 *2.0 *2.4 *6.5 64.8 *12.6 100.0
Cleft palate . . . . . . . . . . . . . . . . . . . . . . . 76 0.6 *0.7 *0.5 *0.8 *0.8 *– *– *63.2 94.7
Condition of nervous system
and sense organs
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . 1,329 10.4 *0.3 1.7 11.9 41.9 68.2 12.5 9.0 99.7
Cataracts . . . . . . . . . . . . . . . . . . . . . . . . 4,268 33.3 *1.1 3.2 27.6 140.2 260.9 6.4 9.0 98.9
Color blindness . . . . . . . . . . . . . . . . . . . . 272 2.1 *0.4 2.9 *2.1 *2.7 *3.1 *– *– 53.3
Diseases of retina . . . . . . . . . . . . . . . . . . . 773 6.0 *0.4 2.0 4.7 19.6 45.2 25.0 17.3 99.5
Tinnitus . . . . . . . . . . . . . . . . . . . . . . . . . 3,457 27.0 *1.5 16.4 45.6 80.6 78.1 *1.1 *1.4 66.8
Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . 636 5.0 4.1 5.8 5.4 *3.5 *3.6 39.0 48.0 98.7
Migraine headache . . . . . . . . . . . . . . . . . . 7,349 57.4 14.0 82.5 78.1 33.4 27.6 3.5 7.9 83.9
Other headache (excluding tension
headache) . . . . . . . . . . . . . . . . . . . . . . . 7,100 55.5 15.2 79.7 66.4 42.7 35.2 1.7 2.7 66.5
Multiple sclerosis . . . . . . . . . . . . . . . . . . . 112 0.9 *– 1.1 *1.8 *0.8 *0.3 77.7 56.3 100.0
1Includes races other than white and black and unknown family income.
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 25. Average annual number of selected impairments and of chronic conditions of the nervous system and sense organs among
white persons, rates per 1,000 persons by age, and percent of conditions causing activity limitation, hospitalization, and physician
visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Impairment and chronic condition






















Impairment Rate per 1,000 persons Percent
Blindness and other visual impairments . . . . . 7,111 34.1 22.1 44.7 80.1 15.1 15.0 82.3
Blind, both eyes. . . . . . . . . . . . . . . . . . . 480 2.3 1.3 1.9 8.3 60.0 21.5 97.9
Other visual impairments . . . . . . . . . . . . . 6,631 31.8 20.9 42.8 71.9 11.9 14.5 81.2
Deafness and other hearing impairments. . . . . 21,135 101.5 40.8 156.6 331.6 5.4 6.2 75.3
Deaf, both ears . . . . . . . . . . . . . . . . . . . 1,387 6.7 1.6 8.2 30.4 14.5 7.9 91.1
Other hearing impairments . . . . . . . . . . . . 19,748 94.8 39.2 148.4 301.2 4.8 6.1 74.2
Speech impairments . . . . . . . . . . . . . . . . . 2,064 9.9 10.6 6.5 11.5 20.9 5.6 73.0
Impairment of sensation . . . . . . . . . . . . . . . 1,005 4.8 1.8 7.4 16.4 *4.6 10.0 64.0
Mental retardation . . . . . . . . . . . . . . . . . . . 1,221 5.9 7.7 2.8 *1.0 86.7 7.1 85.3
Absence of extremities or parts of
extremities (excluding absence of tips
of fingers or toes only) . . . . . . . . . . . . . . . 1,320 6.3 3.2 10.4 16.2 19.9 59.5 100.0
Absence of upper extremities or parts of
upper extremities . . . . . . . . . . . . . . . . . 837 4.0 2.3 6.3 9.4 12.5 52.2 100.0
Absence of lower extremities or parts
of lower extremities . . . . . . . . . . . . . . . . 483 2.3 0.9 4.1 6.8 32.7 72.3 100.0
Absence of lung . . . . . . . . . . . . . . . . . . . . 203 1.0 *0.2 2.1 3.1 *20.7 79.8 100.0
Absence of kidney. . . . . . . . . . . . . . . . . . . 497 2.4 1.2 3.5 7.0 *10.5 75.5 99.0
Absence of breast . . . . . . . . . . . . . . . . . . . 1,064 5.1 0.5 8.7 23.6 *4.7 91.9 100.0
Absence of bone, joint, or muscle of
extremity . . . . . . . . . . . . . . . . . . . . . . . . 822 3.9 1.4 5.0 15.7 31.9 66.7 99.0
Absence of tips of fingers or toes . . . . . . . . . 348 1.7 1.1 2.3 3.4 *4.9 30.2 100.0
Paralysis of extremities, complete or partial . . . 1,213 5.8 2.9 7.6 18.0 60.6 43.4 99.4
Paralysis of extremities, complete. . . . . . . . 504 2.4 *0.9 4.5 7.2 53.6 56.2 100.0
Paralysis of extremities, partial. . . . . . . . . . 709 3.4 2.0 3.1 10.9 65.6 34.4 99.2
Cerebral palsy . . . . . . . . . . . . . . . . . . 219 1.1 1.4 *0.4 *0.1 70.8 46.1 100.0
Paralysis other site, complete or partial. . . . . . 321 1.5 0.7 2.5 4.4 47.4 38.9 99.1
Deformities or orthopedic impairments, total . . . 30,612 147.0 118.3 196.3 220.9 24.5 18.7 90.8
Deformities or orthopedic impairments
of back . . . . . . . . . . . . . . . . . . . . . . . 16,218 77.9 65.1 106.1 101.1 21.5 15.4 92.2
Curvature or other deformity of back
or spine . . . . . . . . . . . . . . . . . . . . . 4,696 22.5 20.7 23.4 30.8 11.3 8.9 93.5
Deformities or orthopedic impairments
of upper extremities . . . . . . . . . . . . . . . 3,367 16.2 11.3 24.0 29.5 29.8 25.5 93.9
Orthopedic impairment, shoulder . . . . . . . 2,526 12.1 8.9 18.6 19.0 36.5 23.3 94.5
Deformities or orthopedic impairments
of lower extremities . . . . . . . . . . . . . . . . 10,703 51.4 40.8 64.4 86.6 26.6 21.7 87.5
Flat feet . . . . . . . . . . . . . . . . . . . . . . 3,080 14.8 13.4 17.9 17.1 *1.4 2.7 71.7
Other deformities or orthopedic impairment . . 325 1.6 1.1 1.8 3.7 48.6 *14.2 97.8
Cleft palate . . . . . . . . . . . . . . . . . . . . . . . 200 1.0 0.9 1.3 *0.6 *1.5 65.5 95.0
Condition of nervous system
and sense organs
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . 2,054 9.9 1.6 11.4 49.9 12.3 9.3 99.8
Cataracts . . . . . . . . . . . . . . . . . . . . . . . . 5,762 27.7 2.2 22.6 166.6 5.8 10.3 98.4
Color blindness . . . . . . . . . . . . . . . . . . . . 2,506 12.0 10.6 15.9 13.8 *0.2 *– 58.5
Diseases of retina . . . . . . . . . . . . . . . . . . . 1,237 5.9 1.5 5.2 30.0 28.7 21.3 99.7
Tinnitus . . . . . . . . . . . . . . . . . . . . . . . . . 6,369 30.6 11.3 56.4 91.1 *0.8 1.4 70.1
Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . 996 4.8 5.0 4.7 3.9 41.5 47.6 98.8
Migraine headache . . . . . . . . . . . . . . . . . . 8,743 42.0 42.2 54.2 22.3 3.4 8.0 82.2
Other headache (excluding tension
headache) . . . . . . . . . . . . . . . . . . . . . . . 8,806 42.3 41.8 51.1 31.4 1.7 2.5 63.0
Multiple sclerosis . . . . . . . . . . . . . . . . . . . 154 0.7 0.6 *1.3 *0.7 70.1 46.1 100.0
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 26. Average annual number of selected impairments and of chronic conditions of the nervous system and sense organs among
black persons, rates per 1,000 persons by age, and percent of conditions causing activity limitation, hospitalization, and physician
visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Impairment and chronic condition






















Impairment Rate per 1,000 persons Percent
Blindness and other visual impairments . . . . . . . . 892 28.9 18.2 52.3 81.5 20.6 14.8 86.1
Blind, both eyes . . . . . . . . . . . . . . . . . . . . . 69 2.2 *0.5 *5.9 *10.9 *63.8 *29.0 100.0
Other visual impairments . . . . . . . . . . . . . . . . 823 26.6 17.7 46.3 70.6 16.9 13.6 85.1
Deafness and other hearing impairments . . . . . . . 1,638 53.0 24.5 97.6 229.8 6.5 3.6 67.3
Deaf, both ears . . . . . . . . . . . . . . . . . . . . . . 64 2.1 *1.1 *0.4 *14.4 *17.2 *15.6 84.4
Other hearing impairments . . . . . . . . . . . . . . . 1,574 50.9 23.4 97.2 215.0 6.1 *3.1 66.6
Speech impairments . . . . . . . . . . . . . . . . . . . . 589 19.1 17.9 21.3 25.8 17.1 *3.4 56.4
Impairment of sensation . . . . . . . . . . . . . . . . . . 117 3.8 *1.6 *9.8 *12.5 *17.1 *8.5 72.6
Mental retardation. . . . . . . . . . . . . . . . . . . . . . 308 10.0 12.0 *5.1 *0.8 89.3 *13.3 86.7
Absence of extremities or parts of
extremities (excluding absence of tips
of fingers or toes only) . . . . . . . . . . . . . . . . . . 126 4.1 *1.4 *6.1 23.8 *18.3 56.3 100.0
Absence of upper extremities or parts
of upper extremities . . . . . . . . . . . . . . . . . . 87 2.8 *1.4 *4.1 *13.7 *9.2 *55.2 100.0
Absence of lower extremities or parts of
lower extremities . . . . . . . . . . . . . . . . . . . . *39 *1.3 *0.1 *2.3 *10.1 *38.5 *59.0 *100.0
Absence of lung . . . . . . . . . . . . . . . . . . . . . . . *26 *0.8 *– *2.7 *5.1 *38.5 *80.8 *100.0
Absence of kidney . . . . . . . . . . . . . . . . . . . . . *48 *1.6 *0.7 *5.3 *2.3 *18.8 *72.9 *100.0
Absence of breast . . . . . . . . . . . . . . . . . . . . . 78 2.5 *0.5 *6.1 *14.4 *– 100.0 100.0
Absence of bone, joint, or muscle of
extremity . . . . . . . . . . . . . . . . . . . . . . . . . . *46 *1.5 *0.9 *1.4 *7.0 *39.1 *67.4 *100.0
Absence of tips of fingers or toes . . . . . . . . . . . . *14 *0.5 *– *2.3 *1.2 *28.6 *21.4 *100.0
Paralysis of extremities, complete or partial . . . . . . 213 6.9 3.2 *9.8 34.7 60.1 35.7 100.0
Paralysis of extremities, complete . . . . . . . . . . 105 3.4 *1.3 *3.9 21.5 57.1 *43.8 100.0
Paralysis of extremities, partial . . . . . . . . . . . . 108 3.5 *2.0 *5.7 *13.3 63.0 *27.8 100.0
Cerebral palsy . . . . . . . . . . . . . . . . . . . . . *33 *1.1 *1.4 *– *– *97.0 *27.3 *100.0
Paralysis other site, complete or partial . . . . . . . . *50 *1.6 *1.1 *3.5 *2.7 *52.0 *28.0 *96.0
Deformities or orthopedic impairments, total. . . . . . 3,455 111.8 85.6 197.6 188.1 29.4 18.4 87.7
Deformities or orthopedic impairments
of back . . . . . . . . . . . . . . . . . . . . . . . . . . 1,433 46.4 35.8 90.0 60.1 30.7 18.3 93.1
Curvature or other deformity of back
or spine . . . . . . . . . . . . . . . . . . . . . . . . 278 9.0 8.7 *10.9 *7.4 21.6 *7.9 93.2
Deformities or orthopedic impairments
of upper extremities . . . . . . . . . . . . . . . . . . 377 12.2 9.0 21.1 24.6 32.4 33.4 98.9
Orthopedic impairment, shoulder . . . . . . . . . . 325 10.5 7.7 19.9 *18.7 35.1 36.0 98.5
Deformities or orthopedic impairments
of lower extremities. . . . . . . . . . . . . . . . . . . 1,552 50.2 38.4 84.4 94.0 25.9 15.3 79.9
Flat feet . . . . . . . . . . . . . . . . . . . . . . . . . 546 17.7 16.1 26.6 *14.4 *0.5 *2.4 57.1
Other deformities or orthopedic impairments . . . . 93 3.0 2.4 *2.3 *9.8 *57.0 *9.7 89.2
Cleft palate . . . . . . . . . . . . . . . . . . . . . . . . . . *17 *0.6 *0.7 *– *– *23.5 *35.3 *100.0
Condition of nervous system
and sense organs
Glaucoma. . . . . . . . . . . . . . . . . . . . . . . . . . . 341 11.0 *0.7 20.5 87.4 21.7 18.5 100.0
Cataracts . . . . . . . . . . . . . . . . . . . . . . . . . . . 574 18.6 *1.9 28.3 152.2 *9.2 *6.3 98.4
Color blindness . . . . . . . . . . . . . . . . . . . . . . . 156 5.0 3.9 *10.5 *5.5 *– *– 50.6
Diseases of retina. . . . . . . . . . . . . . . . . . . . . . *45 *1.5 *1.0 *2.5 *3.9 *35.6 *11.1 *100.0
Tinnitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . 618 20.0 10.3 41.2 68.3 *1.0 *2.9 59.1
Epilepsy. . . . . . . . . . . . . . . . . . . . . . . . . . . . 221 7.2 6.6 *8.8 *9.0 56.6 52.5 99.1
Migraine headache . . . . . . . . . . . . . . . . . . . . . 924 29.9 30.6 36.5 *10.5 *4.0 *5.8 82.4
Other headache (excluding tension headache) . . . . 1,151 37.2 34.1 48.2 44.5 *1.9 *4.3 68.1
Multiple sclerosis . . . . . . . . . . . . . . . . . . . . . . *21 *0.7 *0.5 *2.0 *– *61.9 *38.1 *100.0
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 27. Average annual number of selected impairments and of chronic conditions of the nervous system and sense organs and rates
per 1,000 persons, by family income: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualfications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Impairment and chronic condition






















Impairment Number in thousands Rate per 1,000 persons
Blindness and other visual impairments . . . . . . . . 8,169 1,345 1,413 1,707 2,486 32.8 55.5 36.5 32.5 27.7
Blind, both eyes . . . . . . . . . . . . . . . . . . . . . 551 81 97 95 137 2.2 3.3 2.5 1.8 1.5
Other visual impairments . . . . . . . . . . . . . . . . 7,618 1,264 1,316 1,612 2,349 30.6 52.2 34.0 30.7 26.2
Deafness and other hearing impairments . . . . . . . 23,266 3,281 4,512 4,872 6,393 93.5 135.4 116.6 92.8 71.3
Deaf, both ears . . . . . . . . . . . . . . . . . . . . . . 1,465 221 332 296 359 5.9 9.1 8.6 5.6 4.0
Other hearing impairments . . . . . . . . . . . . . . . 21,801 3,061 4,180 4,576 6,034 87.6 126.3 108.0 87.2 67.3
Speech impairments . . . . . . . . . . . . . . . . . . . . 2,725 550 514 423 783 11.0 22.7 13.3 8.1 8.7
Impairment of sensation . . . . . . . . . . . . . . . . . . 1,142 129 288 263 254 4.6 5.3 7.4 5.0 2.8
Mental retardation. . . . . . . . . . . . . . . . . . . . . . 1,562 316 310 243 330 6.3 13.0 8.0 4.6 3.7
Absence of extremities or parts of
extremities (excluding absence of tips
of fingers or toes only) . . . . . . . . . . . . . . . . . . 1,479 218 288 353 365 5.9 9.0 7.4 6.7 4.1
Absence of upper extremities or parts
of upper extremities . . . . . . . . . . . . . . . . . . 946 153 158 251 230 3.8 6.3 4.1 4.8 2.6
Absence of lower extremities or parts
of lower extremities. . . . . . . . . . . . . . . . . . . 533 65 130 101 134 2.1 2.7 3.4 1.9 1.5
Absence of lung . . . . . . . . . . . . . . . . . . . . . . . 236 *51 *37 *49 *42 0.9 *2.1 *1.0 *0.9 *0.5
Absence of kidney . . . . . . . . . . . . . . . . . . . . . 556 74 76 119 176 2.2 3.1 2.0 2.3 2.0
Absence of breast . . . . . . . . . . . . . . . . . . . . . 1,153 159 233 259 281 4.6 6.6 6.0 4.9 3.1
Absence of bone, joint, or muscle of
extremity . . . . . . . . . . . . . . . . . . . . . . . . . . 876 123 219 179 221 3.5 5.1 5.7 3.4 2.5
Absence of tips of fingers or toes . . . . . . . . . . . . 366 *52 73 70 108 1.5 *2.1 1.9 1.3 1.2
Paralysis of extremities, complete or partial . . . . . . 1,464 307 306 326 316 5.9 12.7 7.9 6.2 3.5
Paralysis of extremities, complete . . . . . . . . . . 626 113 129 142 149 2.5 4.7 3.3 2.7 1.7
Paralysis of extremities, partial . . . . . . . . . . . . 838 194 178 183 166 3.4 8.0 4.6 3.5 1.9
Cerebral palsy . . . . . . . . . . . . . . . . . . . . . 258 *38 *50 57 71 1.0 *1.6 *1.3 1.1 0.8
Paralysis of other site, complete or partial . . . . . . . 371 87 80 *45 79 1.5 3.6 2.1 *0.9 0.9
Deformities or orthopedic impairment, total . . . . . . 34,964 4,872 5,936 7,687 11,413 140.6 201.1 153.3 146.4 127.3
Deformities or orthopedic impairments
of back . . . . . . . . . . . . . . . . . . . . . . . . . . 18,144 2,295 2,915 4,110 6,235 72.9 94.7 75.3 78.3 69.6
Curvature or other deformity of back
or spine . . . . . . . . . . . . . . . . . . . . . . . . 5,078 664 836 1,101 1,855 20.4 27.4 21.6 21.0 20.7
Deformities or orthopedic impairments
of upper extremities . . . . . . . . . . . . . . . . . . 3,846 643 723 803 1,112 15.5 26.5 18.7 15.3 12.4
Orthopedic impairment, shoulder . . . . . . . . . . 2,919 483 540 581 864 11.7 19.9 13.9 11.1 9.6
Deformities or orthopedic impairments
of lower extremities. . . . . . . . . . . . . . . . . . . 12,518 1,814 2,205 2,682 3,969 50.3 74.9 57.0 51.1 44.3
Flat feet . . . . . . . . . . . . . . . . . . . . . . . . . 3,698 403 582 876 1,380 14.9 16.6 15.0 16.7 15.4
Other deformities or orthopedic impairments . . . . 456 119 94 92 98 1.8 4.9 2.4 1.8 1.1
Cleft palate . . . . . . . . . . . . . . . . . . . . . . . . . . 217 *16 *24 54 93 0.9 *0.7 *0.6 1.0 1.0
Condition of nervous system
and sense organs
Glaucoma. . . . . . . . . . . . . . . . . . . . . . . . . . . 2,433 410 481 473 548 9.8 16.9 12.4 9.0 6.1
Cataracts . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,416 1,345 1,417 1,195 1,006 25.8 55.5 36.6 22.8 11.2
Color blindness . . . . . . . . . . . . . . . . . . . . . . . 2,697 227 312 636 1,193 10.8 9.4 8.1 12.1 13.3
Diseases of retina. . . . . . . . . . . . . . . . . . . . . . 1,293 132 284 350 334 5.2 5.4 7.3 6.7 3.7
Tinnitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,144 1,183 1,473 1,410 2,025 28.7 48.8 38.1 26.9 22.6
Epilepsy. . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,243 300 200 225 243 5.0 12.4 5.2 4.3 2.7
Migraine headache . . . . . . . . . . . . . . . . . . . . . 9,992 1,219 1,592 2,110 3,720 40.2 50.3 41.1 40.2 41.5
Other headache (excluding tension headache) . . . . 10,279 1,425 1,989 2,275 3,140 41.3 58.8 51.4 43.3 35.0
Multiple sclerosis . . . . . . . . . . . . . . . . . . . . . . 180 *21 *20 *41 56 0.7 *0.9 *0.5 *0.8 0.6
1Includes unknown family income.
* Figure does not meet standard of reliability or precision.
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Table 28. Average annual number of selected impairments and of chronic conditions of the nervous system and sense organs and rates
per 1,000 persons, by geographic region: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Impairment and chronic condition
of the nervous system and sense organs
Geographic region
All
regions Northeast Midwest South West
All
regions Northeast Midwest South West
Impairment Number in thousands Rate per 1,000 persons
Blindness and other visual impairments . . . . . . 8,169 1,466 2,239 2,718 1,745 32.8 29.3 37.1 32.3 32.2
Blind, both eyes . . . . . . . . . . . . . . . . . . . 551 98 181 189 82 2.2 2.0 3.0 2.2 1.5
Other visual impairments . . . . . . . . . . . . . 7,618 1,368 2,058 2,529 1,663 30.6 27.3 34.1 30.0 30.7
Deafness and other hearing impairments . . . . . 23,266 4,126 6,438 7,791 4,911 93.5 82.4 106.7 92.5 90.7
Deaf, both ears . . . . . . . . . . . . . . . . . . . 1,465 263 382 466 354 5.9 5.3 6.3 5.5 6.5
Other hearing impairments . . . . . . . . . . . . 21,801 3,863 6,056 7,325 4,557 87.6 77.2 100.4 87.0 84.2
Speech impairments . . . . . . . . . . . . . . . . . . 2,725 489 649 1,118 469 11.0 9.8 10.8 13.3 8.7
Impairment of sensation . . . . . . . . . . . . . . . 1,142 178 359 354 251 4.6 3.6 6.0 4.2 4.6
Mental retardation . . . . . . . . . . . . . . . . . . . 1,562 315 445 509 293 6.3 6.3 7.4 6.0 5.4
Absence of extremities or parts of
extremities (excluding absence of tips
of fingers or toes only). . . . . . . . . . . . . . . . 1,479 255 472 559 193 5.9 5.1 7.8 6.6 3.6
Absence of upper extremities or parts
of upper extremities . . . . . . . . . . . . . . . . 946 141 322 359 124 3.8 2.8 5.3 4.3 2.3
Absence of lower extremities or parts
of lower extremities . . . . . . . . . . . . . . . . 533 113 150 200 69 2.1 2.3 2.5 2.4 1.3
Absence of lung . . . . . . . . . . . . . . . . . . . . 236 *40 96 60 *40 0.9 *0.8 1.6 0.7 *0.7
Absence of kidney . . . . . . . . . . . . . . . . . . . 556 95 169 191 102 2.2 1.9 2.8 2.3 1.9
Absence of breast . . . . . . . . . . . . . . . . . . . 1,153 270 276 368 239 4.6 5.4 4.6 4.4 4.4
Absence of bone, joint, or muscle of
extremity . . . . . . . . . . . . . . . . . . . . . . . . 876 171 260 258 187 3.5 3.4 4.3 3.1 3.5
Absence of tips of fingers or toes . . . . . . . . . . 366 58 91 107 109 1.5 1.2 1.5 1.3 2.0
Paralysis of extremities, complete or partial . . . 1,464 287 415 489 273 5.9 5.7 6.9 5.8 5.0
Paralysis of extremities, complete . . . . . . . . 626 122 191 200 113 2.5 2.4 3.2 2.4 2.1
Paralysis of extremities, partial . . . . . . . . . . 838 165 224 290 159 3.4 3.3 3.7 3.4 2.9
Cerebral palsy. . . . . . . . . . . . . . . . . . . 258 59 80 71 *48 1.0 1.2 1.3 0.8 *0.9
Paralysis of other site, complete or partial . . . . 371 *37 109 155 70 1.5 *0.7 1.8 1.8 1.3
Deformity or orthopedic impairments, total . . . . 34,964 6,296 9,170 10,592 8,907 140.6 125.8 152.0 125.8 164.5
Deformities or orthopedic impairments of
back . . . . . . . . . . . . . . . . . . . . . . . . . 18,144 3,236 4,759 5,313 4,836 72.9 64.6 78.9 63.1 89.3
Curvature or other deformity of back
or spine . . . . . . . . . . . . . . . . . . . . . . 5,078 977 1,373 1,436 1,293 20.4 19.5 22.8 17.1 23.9
Deformities or orthopedic impairments
of upper extremities . . . . . . . . . . . . . . . . 3,846 697 923 1,134 1,093 15.5 13.9 15.3 13.5 20.2
Orthopedic impairment, shoulder . . . . . . . 2,919 454 743 921 800 11.7 9.1 12.3 10.9 14.8
Deformities or orthopedic impairments
of lower extremities . . . . . . . . . . . . . . . . 12,518 2,243 3,410 3,987 2,878 50.3 44.8 56.5 47.3 53.2
Flat feet. . . . . . . . . . . . . . . . . . . . . . . 3,698 778 1,058 1,123 739 14.9 15.5 17.5 13.3 13.7
Other deformity or orthopedic impairment . . . 456 120 78 158 100 1.8 2.4 1.3 1.9 1.8
Cleft palate . . . . . . . . . . . . . . . . . . . . . . . 217 *50 57 70 *41 0.9 *1.0 0.9 0.8 *0.8
Condition of nervous system and
sense organs
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . 2,433 522 556 914 441 9.8 10.4 9.2 10.9 8.1
Cataracts. . . . . . . . . . . . . . . . . . . . . . . . . 6,416 1,257 1,692 2,314 1,153 25.8 25.1 28.0 27.5 21.3
Color blindness . . . . . . . . . . . . . . . . . . . . . 2,697 501 764 815 617 10.8 10.0 12.7 9.7 11.4
Diseases of retina . . . . . . . . . . . . . . . . . . . 1,293 224 440 353 277 5.2 4.5 7.3 4.2 5.1
Tinnitus . . . . . . . . . . . . . . . . . . . . . . . . . . 7,144 1,193 2,003 2,331 1,616 28.7 23.8 33.2 27.7 29.8
Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . 1,243 259 295 474 216 5.0 5.2 4.9 5.6 4.0
Migraine headache. . . . . . . . . . . . . . . . . . . 9,992 2,018 2,426 3,223 2,324 40.2 40.3 40.2 38.3 42.9
Other headache (excluding tension
headache) . . . . . . . . . . . . . . . . . . . . . . . 10,279 1,609 2,737 3,497 2,436 41.3 32.1 45.4 41.5 45.0
Multiple sclerosis . . . . . . . . . . . . . . . . . . . . 180 *39 *48 *46 *46 0.7 *0.8 *0.8 *0.5 *0.8
* Figure does not meet standard of reliability or precision.
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Table 29. Average annual number of selected chronic conditions of the skin and subcutaneous tissue and of the musculoskeletal system
and connective tissue, rates per 1,000 persons by age, and percent of conditions causing activity limitation, hospitalization, and
physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic condition of skin and



























Condition of skin and subcutaneous tissue Rate per 1,000 persons Percent
Sebaceous skin cyst. . . . . . . . . . . . . . . . . . . . 1,249 5.0 1.6 6.2 6.4 7.4 4.6 *0.2 6.0 93.3
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,904 19.7 25.7 28.4 4.3 *1.2 *0.3 *– *0.4 67.6
Psoriasis . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,378 9.6 2.6 9.3 16.2 14.4 16.1 *2.1 2.9 88.4
Dermatitis . . . . . . . . . . . . . . . . . . . . . . . . . . 9,273 37.3 34.5 39.5 38.5 36.7 29.2 1.5 1.6 85.2
Dry (itching) skin, not elsewhere classified . . . . . . 5,123 20.6 10.0 21.1 23.9 31.3 44.8 *0.1 *0.5 54.0
Chronic ulcer of skin. . . . . . . . . . . . . . . . . . . . 332 1.3 *0.1 0.9 1.8 4.4 5.9 24.1 20.8 93.4
Ingrown nails . . . . . . . . . . . . . . . . . . . . . . . . 6,078 24.4 8.2 24.5 30.6 45.1 56.5 *0.3 1.0 54.1
Corns and calluses . . . . . . . . . . . . . . . . . . . . 4,731 19.0 1.0 16.3 33.1 40.4 52.9 *0.5 1.5 46.7
Benign neoplasms of the skin . . . . . . . . . . . . . . 862 3.5 1.1 3.0 5.4 7.4 7.3 *2.1 *3.4 97.2
Malignant neoplasms of the skin . . . . . . . . . . . . 2,269 9.1 *0.1 2.0 16.9 34.4 51.8 3.9 3.4 97.1
Condition of musculoskeletal system
and connective tissue
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31,788 127.8 2.3 49.8 250.2 433.0 550.0 21.2 7.4 82.6
Rheumatism, unspecified . . . . . . . . . . . . . . . . . 454 1.8 *0.1 1.2 3.0 5.6 6.8 17.0 *8.6 78.9
Sciatica (including lumbago) . . . . . . . . . . . . . . . 2,058 8.3 *– 6.5 17.5 19.6 15.3 6.5 6.9 88.1
Intervertebral disc disorders . . . . . . . . . . . . . . . 4,976 20.0 *0.3 19.3 43.1 33.6 21.5 45.2 38.4 98.7
Bone spur or tendinitis, not otherwise specified . . . 2,633 10.6 0.9 9.2 21.1 23.1 15.6 9.6 9.6 92.1
Disorders of bone or cartilage . . . . . . . . . . . . . . 1,568 6.3 1.5 3.7 9.3 19.7 23.5 37.9 18.0 97.2
Bunions . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,907 11.7 0.9 7.9 22.3 28.0 37.2 *0.9 5.0 58.0
Bursitis, not elsewhere classified . . . . . . . . . . . . 4,674 18.8 *0.8 14.1 40.6 42.3 36.7 *5.3 3.9 88.8
Neuritis or neuralgia, unspecified . . . . . . . . . . . . 518 2.1 *0.0 0.9 4.2 6.8 7.9 *4.6 *8.7 77.8
1Includes races other than white and black and unknown family income.
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
0.0 Quantity more than zero but less than 0.05.
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Table 30. Average annual number of selected chronic conditions of the skin and subcutaneous tissue and of the musculoskeletal system
and connective tissue among males, rates per 1,000 persons by age, and percent of conditions causing activity limitation,
hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic condition of skin and



























Condition of skin and subcutaneous tissue Rate per 1,000 persons Percent
Sebaceous skin cyst. . . . . . . . . . . . . . . . . . . . 649 5.4 *1.6 6.5 6.2 10.3 *7.8 *– *5.9 93.5
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,218 18.4 28.8 22.3 3.4 *2.0 *– *– *0.4 67.2
Psoriasis . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,220 10.1 2.3 8.9 19.2 19.0 20.3 *3.3 *4.1 88.7
Dermatitis . . . . . . . . . . . . . . . . . . . . . . . . . . 3,521 29.2 31.1 28.1 29.3 29.6 25.7 *1.1 2.4 83.0
Dry (itching) skin, not elsewhere classified . . . . . . 2,063 17.1 8.3 17.2 20.4 28.5 43.6 *– *0.7 58.3
Chronic ulcer of skin. . . . . . . . . . . . . . . . . . . . 163 1.3 *0.2 *1.0 *1.7 *4.0 *7.6 *14.1 *20.2 95.7
Ingrown nails . . . . . . . . . . . . . . . . . . . . . . . . 2,795 23.1 9.3 26.4 28.5 34.5 40.9 *0.1 *0.8 51.9
Corns and calluses . . . . . . . . . . . . . . . . . . . . 1,577 13.1 *0.8 13.6 23.5 18.3 36.0 *0.5 *1.6 37.2
Benign neoplasms of the skin . . . . . . . . . . . . . . 402 3.3 *0.7 3.0 4.9 11.5 *4.7 *3.7 *4.0 97.8
Malignant neoplasms of the skin . . . . . . . . . . . . 1,315 10.9 *0.1 1.6 22.2 45.8 77.8 4.6 *4.1 98.1
Condition of musculoskeletal system
and connective tissue
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,547 95.6 1.7 41.0 199.2 358.0 425.8 18.0 8.2 78.3
Rheumatism, unspecified . . . . . . . . . . . . . . . . . 199 1.6 *– *0.8 3.3 *4.4 *11.0 *7.5 *5.0 78.4
Sciatica (including lumbago) . . . . . . . . . . . . . . . 718 5.9 *– 5.3 13.0 14.1 *7.8 *2.9 *4.9 85.5
Intervertebral disc disorders . . . . . . . . . . . . . . . 2,750 22.8 *0.1 22.9 50.0 39.7 22.1 45.5 40.2 98.1
Bone spur or tendinitis, not otherwise specified . . . 1,094 9.1 *1.2 8.4 17.4 21.2 *11.0 6.9 10.6 93.5
Disorders of bone or cartilage . . . . . . . . . . . . . . 441 3.7 2.0 3.1 4.8 8.6 *6.7 37.9 23.8 94.6
Bunions . . . . . . . . . . . . . . . . . . . . . . . . . . . 434 3.6 *0.4 2.5 8.4 *6.2 *11.2 *– *4.6 45.2
Bursitis, not elsewhere classified . . . . . . . . . . . . 1,901 15.7 *0.3 13.2 33.1 40.8 27.0 3.5 *1.8 84.3
Neuritis or neuralgia, unspecified . . . . . . . . . . . . 166 1.4 *0.1 *0.5 3.0 6.6 *2.9 *4.2 *11.4 75.9
1Includes races other than white and black and unknown family income.
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 31. Average annual number of selected chronic conditions of the skin and subcutaneous tissue and of the musculoskeletal system
and connective tissue among females, rates per 1,000 persons by age, and percent of conditions causing activity limitation,
hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic condition of skin and



























Condition of skin and subcutaneous tissue Rate per 1,000 persons Percent
Sebaceous skin cyst. . . . . . . . . . . . . . . . . . . . 600 4.7 *1.7 5.9 6.6 *5.0 *2.5 *0.5 *6.2 92.8
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,687 21.0 22.4 34.2 5.1 *0.7 *0.5 *– *0.4 67.9
Psoriasis . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,157 9.0 3.0 9.6 13.5 10.8 13.6 *0.8 *1.6 88.1
Dermatitis . . . . . . . . . . . . . . . . . . . . . . . . . . 5,752 44.9 38.1 50.5 47.0 42.5 31.2 1.7 1.1 86.5
Dry (itching) skin, not elsewhere classified . . . . . . 3,060 23.9 11.7 24.8 27.2 33.6 45.6 *0.2 *0.5 51.1
Chronic ulcer of skin. . . . . . . . . . . . . . . . . . . . 168 1.3 *– *0.7 *1.9 *4.6 *4.9 33.9 *21.4 91.7
Ingrown nails . . . . . . . . . . . . . . . . . . . . . . . . 3,283 25.6 6.9 22.7 32.6 53.7 65.6 *0.5 *1.2 56.0
Corns and calluses . . . . . . . . . . . . . . . . . . . . 3,154 24.6 *1.2 18.9 41.9 58.3 63.0 *0.4 *1.5 51.5
Benign neoplasms of the skin . . . . . . . . . . . . . . 460 3.6 *1.5 3.0 5.8 *4.2 8.9 *0.7 *3.0 96.7
Malignant neoplasms of the skin . . . . . . . . . . . . 954 7.5 *0.1 2.3 12.1 25.1 36.4 *3.0 *2.4 95.6
Condition of musculoskeletal
system and connective tissue
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20,241 158.1 2.9 58.3 297.2 493.6 623.9 23.1 6.9 85.1
Rheumatism, unspecified . . . . . . . . . . . . . . . . . 254 2.0 *0.1 1.6 2.7 6.5 *4.4 24.8 *11.4 79.5
Sciatica (including lumbago) . . . . . . . . . . . . . . . 1,341 10.5 *– 7.7 21.6 24.1 19.7 8.4 8.0 89.5
Intervertebral disc disorders . . . . . . . . . . . . . . . 2,226 17.4 *0.5 15.9 36.8 28.6 21.1 44.8 36.2 99.2
Bone spur or tendinitis, not otherwise specified . . . 1,539 12.0 *0.6 9.9 24.4 24.5 18.3 11.4 9.0 91.2
Disorders of bone or cartilage . . . . . . . . . . . . . . 1,127 8.8 *1.0 4.2 13.4 28.6 33.5 37.9 15.8 98.2
Bunions . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,474 19.3 *1.4 13.1 35.1 45.7 52.5 *1.0 5.1 60.2
Bursitis, not elsewhere classified . . . . . . . . . . . . 2,773 21.7 *1.2 15.0 47.5 43.5 42.4 6.5 5.3 91.8
Neuritis or neuralgia, unspecified . . . . . . . . . . . . 352 2.8 *– 1.3 5.2 7.0 10.9 *4.8 *7.4 78.7
1Includes races other than white and black and unknown family income.
* Figure does not meet standard of reliability or precision.
*–Figure does not meet standard of reliability or precision and quantity zero.
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Table 32. Average annual number of selected chronic conditions of the skin and subcutaneous tissue and of the musculoskeletal system
and connective tissue among white persons, rates per 1,000 persons by age, and percent of conditions causing activity limitation,
hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic condition of skin and























Condition of skin and subcutaneous tissue Rate per 1,000 persons Percent
Sebaceous skin cyst. . . . . . . . . . . . . . . . . . . . 1,116 5.4 4.6 6.9 6.8 *– *3.9 92.5
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,181 20.1 28.3 4.6 *1.0 *– *0.3 68.7
Psoriasis . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,219 10.7 7.5 17.6 16.3 *2.2 3.1 88.0
Dermatitis . . . . . . . . . . . . . . . . . . . . . . . . . . 8,026 38.5 39.0 39.2 35.3 1.5 1.4 84.9
Dry (itching) skin, not elsewhere classified . . . . . . 4,397 21.1 17.0 23.6 38.4 *0.1 *0.6 53.2
Chronic ulcer of skin. . . . . . . . . . . . . . . . . . . . 284 1.4 0.6 1.5 5.3 22.9 18.7 94.0
Ingrown nails . . . . . . . . . . . . . . . . . . . . . . . . 5,324 25.6 19.6 30.5 48.6 *0.3 *0.9 55.1
Corns and calluses . . . . . . . . . . . . . . . . . . . . 3,907 18.8 9.9 31.7 45.0 *0.6 *1.2 48.3
Benign neoplasms of the skin . . . . . . . . . . . . . . 860 4.1 2.7 6.2 8.2 *2.1 *3.4 97.2
Malignant neoplasms of the skin . . . . . . . . . . . . 2,230 10.7 1.4 19.4 45.6 3.8 3.5 97.0
Condition of musculoskeletal
system and connective tissue
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28,113 135.0 33.5 251.7 482.7 20.2 7.4 82.2
Rheumatism, unspecified . . . . . . . . . . . . . . . . . 406 1.9 0.8 3.2 6.1 15.8 *9.1 80.8
Sciatica (including lumbago) . . . . . . . . . . . . . . . 1,989 9.6 4.6 19.6 19.8 6.0 6.5 88.2
Intervertebral disc disorders . . . . . . . . . . . . . . . 4,521 21.7 13.3 45.2 29.8 44.4 37.5 98.6
Bone spur or tendinitis, not otherwise specified . . . 2,452 11.8 6.4 23.9 21.4 9.4 10.0 92.1
Disorders of bone or cartilage . . . . . . . . . . . . . . 1,481 7.1 3.2 10.1 22.8 38.6 17.9 98.0
Bunions . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,501 12.0 5.4 21.4 32.0 *1.0 5.4 59.9
Bursitis, not elsewhere classified . . . . . . . . . . . . 4,141 19.9 9.6 41.0 41.1 5.1 3.4 88.5
Neuritis or neuralgia, unspecified . . . . . . . . . . . . 455 2.2 0.6 4.1 7.2 *4.6 *9.0 76.7
*– Figure does not meet standard of reliability or precision and quantity zero.
* Figure does not meet standard of reliability or precision.
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Table 33. Average annual number of selected chronic conditions of the skin and subcutaneous tissue and of the musculoskeletal system
and connective tissue among black persons, rates per 1,000 persons by age, and percent of conditions causing activity limitation,
hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic condition of skin and























Condition of skin and subcutaneous tissue Rate per 1,000 persons Percent
Sebaceous skin cyst . . . . . . . . . . . . . . . . . . 100 3.2 3.1 *4.3 *2.3 *3.0 *16.0 100.0
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . 453 14.7 19.0 *1.4 *– *– *1.8 56.3
Psoriasis. . . . . . . . . . . . . . . . . . . . . . . . . . 111 3.6 2.7 *8.8 *1.6 *– *– 91.9
Dermatitis . . . . . . . . . . . . . . . . . . . . . . . . . 853 27.6 28.2 32.2 *13.3 *1.6 *2.9 89.1
Dry (itching) skin, not elsewhere classified . . . . . 529 17.1 14.8 27.1 *19.5 *– *– 55.8
Chronic ulcer of skin . . . . . . . . . . . . . . . . . . *44 *1.4 *0.5 *4.9 *3.1 *34.1 *36.4 *100.0
Ingrown nails . . . . . . . . . . . . . . . . . . . . . . . 574 18.6 10.9 33.6 60.5 *– *2.8 46.7
Corns and calluses . . . . . . . . . . . . . . . . . . . 743 24.0 15.0 51.0 55.8 *– *3.2 37.8
Benign neoplasms of the skin . . . . . . . . . . . . . *2 *0.1 *– *– *0.8 *– *– *100.0
Malignant neoplasms of the skin . . . . . . . . . . . *18 *0.6 *0.1 *1.8 *2.3 *27.8 *– *100.0
Condition of musculoskeletal system
and connective tissue
Arthritis. . . . . . . . . . . . . . . . . . . . . . . . . . . 3,090 100.0 23.7 267.5 479.1 30.7 7.5 86.1
Rheumatism, unspecified. . . . . . . . . . . . . . . . *34 *1.1 *0.3 *2.3 *5.9 *38.2 *5.9 *76.5
Sciatica (including lumbago) . . . . . . . . . . . . . . *42 *1.4 *1.1 *2.5 *2.0 *16.7 *21.4 *85.7
Intervertebral disc disorders . . . . . . . . . . . . . . 324 10.5 5.0 32.2 *19.5 54.0 55.9 98.5
Bone spur or tendinitis, not otherwise specified . . 129 4.2 3.5 *3.7 *10.9 *17.1 *6.2 98.4
Disorders of bone or cartilage. . . . . . . . . . . . . 71 2.3 *1.3 *4.1 *8.6 *32.4 *19.7 87.3
Bunions . . . . . . . . . . . . . . . . . . . . . . . . . . 308 10.0 4.6 26.8 26.9 *– *3.6 45.1
Bursitis, not elsewhere classified . . . . . . . . . . . 436 14.1 6.4 39.1 36.7 *7.8 *8.3 92.2
Neuritis or neuralgia, unspecified . . . . . . . . . . . *40 *1.3 *0.1 *3.3 *8.2 *– *– *75.0
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 34. Average annual number of selected chronic conditions of the skin and subcutaneous tissue and of the musculoskeletal system
and connective tissue and rates per 1,000 persons, by family income: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic condition of skin and
























Condition of skin and subcutaneous tissue Number in thousands Rate per 1,000 persons
Sebaceous skin cyst. . . . . . . . . . . . . . . . . . . . 1,249 187 197 244 504 5.0 7.7 5.1 4.6 5.6
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,904 629 657 1,068 2,084 19.7 26.0 17.0 20.3 23.3
Psoriasis . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,378 288 405 488 878 9.6 11.9 10.5 9.3 9.8
Dermatitis . . . . . . . . . . . . . . . . . . . . . . . . . . 9,273 823 1,366 2,001 3,982 37.3 34.0 35.3 38.1 44.4
Dry (itching) skin, not elsewhere classified . . . . . . 5,123 620 987 1,136 1,680 20.6 25.6 25.5 21.6 18.7
Chronic ulcer of skin. . . . . . . . . . . . . . . . . . . . 332 58 55 65 65 1.3 2.4 1.4 1.2 0.7
Ingrown nails . . . . . . . . . . . . . . . . . . . . . . . . 6,078 921 1,111 1,312 1,785 24.4 38.0 28.7 25.0 19.9
Corns and calluses . . . . . . . . . . . . . . . . . . . . 4,731 619 848 1,036 1,484 19.0 25.5 21.9 19.7 16.6
Benign neoplasms of the skin . . . . . . . . . . . . . . 862 105 111 186 345 3.5 4.3 2.9 3.5 3.8
Malignant neoplasms of the skin . . . . . . . . . . . . 2,269 213 499 361 717 9.1 8.8 12.9 6.9 8.0
Condition of musculoskeletal system
and connective tissue
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31,788 4,824 6,810 6,189 7,492 127.8 199.1 175.9 117.9 83.6
Rheumatism, unspecified . . . . . . . . . . . . . . . . . 454 72 118 *49 116 1.8 3.0 3.0 *0.9 1.3
Sciatica (including lumbago) . . . . . . . . . . . . . . . 2,058 197 281 395 865 8.3 8.1 7.3 7.5 9.7
Intervertebral disc disorders . . . . . . . . . . . . . . . 4,976 522 932 1,050 1,672 20.0 21.5 24.1 20.0 18.7
Bone spur or tendinitis, not elsewhere classified . . 2,633 284 418 553 999 10.6 11.7 10.8 10.5 11.1
Disorders of bone or cartilage . . . . . . . . . . . . . . 1,568 195 347 374 352 6.3 8.0 9.0 7.1 3.9
Bunions . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,907 354 550 643 927 11.7 14.6 14.2 12.2 10.3
Bursitis, not elsewhere classified . . . . . . . . . . . . 4,674 483 943 1,017 1,582 18.8 19.9 24.4 19.4 17.6
Neuritis or neuralgia, unspecified . . . . . . . . . . . . 518 85 100 79 131 2.1 3.5 2.6 1.5 1.5
1Includes unknown family income.
* Figure does not meet standard of reliability or precision.
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Table 35. Average annual number of selected chronic conditions of the skin and subcutaneous tissue and of the musculoskeletal system
and connective tissue and rates per 1,000 persons, by geographic region: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic condition of skin and





regions Northeast Midwest South West
All
regions Northeast Midwest South West
Condition of skin and subcutaneous tissue Number in thousands Rate per 1,000 persons
Sebaceous skin cyst. . . . . . . . . . . . . . . . . . . . 1,249 205 329 447 268 5.0 4.1 5.5 5.3 5.0
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,904 747 1,475 1,547 1,136 19.7 14.9 24.4 18.4 21.0
Psoriasis . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,378 437 693 698 550 9.6 8.7 11.5 8.3 10.2
Dermatitis . . . . . . . . . . . . . . . . . . . . . . . . . . 9,273 1,825 2,498 2,743 2,208 37.3 36.5 41.4 32.6 40.8
Dry (itching) skin, not elsewhere classified . . . . . . 5,123 820 1,590 1,598 1,116 20.6 16.4 26.4 19.0 20.6
Chronic ulcer of skin. . . . . . . . . . . . . . . . . . . . 332 86 110 99 *37 1.3 1.7 1.8 1.2 *0.7
Ingrown nails . . . . . . . . . . . . . . . . . . . . . . . . 6,078 937 1,510 2,345 1,286 24.4 18.7 25.0 27.8 23.8
Corns and calluses . . . . . . . . . . . . . . . . . . . . 4,731 959 1,186 1,603 983 19.0 19.2 19.7 19.0 18.2
Benign neoplasms of the skin . . . . . . . . . . . . . . 862 142 216 302 201 3.5 2.8 3.6 3.6 3.7
Malignant neoplasms of the skin . . . . . . . . . . . . 2,269 320 388 1,000 561 9.1 6.4 6.4 11.9 10.4
Condition of musculoskeletal system
and connective tissue
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31,788 6,260 8,583 11,267 5,677 127.8 125.0 142.3 133.8 104.9
Rheumatism, unspecified . . . . . . . . . . . . . . . . . 454 *48 101 205 100 1.8 *1.0 1.7 2.4 1.8
Sciatica (including lumbago) . . . . . . . . . . . . . . . 2,058 625 543 416 474 8.3 12.5 9.0 4.9 8.8
Intervertebral disc disorders . . . . . . . . . . . . . . . 4,976 1,034 1,214 1,655 1,073 20.0 20.7 20.1 19.7 19.8
Bone spur or tendinitis, not elsewhere classified . . 2,633 489 721 872 550 10.6 9.8 12.0 10.4 10.2
Disorders of bone or cartilage . . . . . . . . . . . . . . 1,568 287 419 571 290 6.3 5.7 6.9 6.8 5.4
Bunions . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,907 487 815 1,000 606 11.7 9.7 13.5 11.9 11.2
Bursitis, not elsewhere classified . . . . . . . . . . . . 4,674 889 1,201 1,644 939 18.8 17.8 19.9 19.5 17.3
Neuritis or neuralgia, unspecified . . . . . . . . . . . . 518 95 144 181 99 2.1 1.9 2.4 2.1 1.8
* Figure does not meet standard of reliability or precision.
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Table 36. Average annual number of selected chronic endocrine, nutritional, and metabolic diseases and immunity disorders; diseases
of the blood and blood-forming organs; and genitourinary conditions; rates per 1,000 persons by age; and percent of conditions causing
activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic endocrine, nutritional,
and metabolic diseases and immunity
disorders; diseases of the blood


























Endocrine, nutritional, and metabolic
diseases and immunity disorders Rate per 1,000 persons Percent
Gout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,167 8.7 *– 3.8 18.0 31.1 29.2 9.6 5.8 93.8
Goiter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 478 1.9 *0.3 1.6 3.4 5.6 *1.6 *5.6 15.5 100.0
Other diseases of the thyroid . . . . . . . . . . . . . . 3,303 13.3 1.0 9.3 26.6 34.9 30.3 6.5 13.0 99.3
Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,962 28.0 1.0 11.7 54.7 106.7 92.8 34.7 26.5 100.0
Diseases of the blood and
blood-forming organs
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,739 15.0 9.2 17.7 12.9 19.2 25.9 4.2 9.3 97.9
Genitourinary conditions
Kidney stones. . . . . . . . . . . . . . . . . . . . . . . . 1,009 4.1 *0.1 4.1 7.7 8.5 4.5 *3.4 50.0 98.8
Kidney infections . . . . . . . . . . . . . . . . . . . . . . 1,325 5.3 1.5 6.1 6.6 8.5 9.7 *3.5 24.0 96.2
Other kidney trouble, not elsewhere classified . . . . 862 3.5 1.8 2.5 3.8 8.5 11.4 27.5 35.8 95.0
Bladder infections . . . . . . . . . . . . . . . . . . . . . 1,616 6.5 1.7 7.8 7.4 8.9 14.2 *2.5 11.1 97.3
Other disorders of bladder . . . . . . . . . . . . . . . . 1,822 7.3 2.3 5.0 8.6 17.3 34.9 4.9 20.1 90.0
Diseases of prostate. . . . . . . . . . . . . . . . . . . . 1,513 6.1 *– 1.9 11.0 27.2 24.2 5.2 28.3 97.2
Inflammatory disease of female genital organs. . . . 184 0.7 *0.3 1.3 *0.4 *0.2 *– *2.2 *21.7 100.0
Noninflammatory disease of female
genital organs . . . . . . . . . . . . . . . . . . . . . . . 1,219 4.9 0.8 9.1 3.4 *1.6 *1.3 *3.0 37.7 99.7
Menstrual disorders . . . . . . . . . . . . . . . . . . . . 1,984 8.0 3.3 14.3 5.4 *0.2 *0.3 *0.9 10.5 89.5
Other diseases of female genital organs . . . . . . . 2,382 9.6 2.5 15.4 9.8 4.2 4.5 7.7 21.0 92.0
Female trouble, not otherwise specified . . . . . . . . 144 0.6 *– 0.8 *1.1 *0.3 *– *4.9 *29.9 93.1
Malignant neoplasm of breast . . . . . . . . . . . . . . 802 3.2 *– 0.7 5.4 14.3 17.3 23.7 85.3 100.0
Malignant neoplasm of female genital organs . . . . 221 0.9 *– 1.1 *1.0 *2.0 *1.4 *16.3 57.5 100.0
Malignant neoplasm of prostate . . . . . . . . . . . . . 344 1.4 *– *0.1 1.3 8.8 9.4 22.1 70.6 100.0
Benign neoplasm of breast. . . . . . . . . . . . . . . . 73 0.3 *– *0.4 *0.3 *0.5 *0.8 *2.7 *30.1 100.0
Benign neoplasm of female genital organs . . . . . . 746 3.0 *– 4.1 5.4 *2.3 *1.1 *5.0 49.6 100.0
1Includes races other than white and black and unknown family income.
*– Figure does not meet standard of reliability or precision and quantity zero.
* Figure does not meet standard of reliability or precision.
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Table 37. Average annual number of selected chronic endocrine, nutritional, and metabolic diseases and immunity disorders; diseases
of the blood and blood-forming organs; and genitourinary conditions among males, rates per 1,000 persons by age; and percent of
conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic endocrine, nutritional, and
metabolic diseases and immunity disorders;
diseases of the blood and blood-forming

























Endocrine, nutritional, and metabolic
diseases and immunity disorders Rate per 1,000 persons Percent
Gout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,456 12.1 *– 6.2 25.4 47.7 37.8 8.7 5.8 94.4
Goiter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 0.5 *0.2 *0.5 *0.5 *2.1 *0.9 *10.8 *26.2 100.0
Other diseases of the thyroid . . . . . . . . . . . . . . 490 4.1 *0.2 3.0 8.0 11.5 *11.8 *4.3 14.1 99.2
Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,041 25.2 *0.8 10.0 53.1 106.5 93.0 33.4 26.0 100.0
Diseases of the blood and
blood-forming organs
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . 607 5.0 7.6 2.1 2.6 11.5 19.9 *5.4 13.3 97.5
Genitourinary conditions
Kidney stones. . . . . . . . . . . . . . . . . . . . . . . . 636 5.3 *– 5.0 11.7 10.6 *4.9 *1.9 53.1 99.4
Kidney infections . . . . . . . . . . . . . . . . . . . . . . 172 1.4 *0.8 1.2 *2.0 *2.4 *4.0 *– *18.6 90.7
Other kidney trouble, not elsewhere classified . . . . 341 2.8 *0.8 1.9 4.4 7.1 13.0 28.2 35.8 90.6
Bladder infections . . . . . . . . . . . . . . . . . . . . . 161 1.3 *0.4 *0.9 *2.1 *2.2 *7.6 *10.6 *29.8 98.1
Other disorders of bladder . . . . . . . . . . . . . . . . 320 2.6 *1.0 *1.0 3.3 *5.7 25.9 *7.5 25.0 90.6
Diseases of prostate. . . . . . . . . . . . . . . . . . . . 1,513 12.5 *– 4.0 22.9 60.8 64.8 5.2 28.3 97.2
Inflammatory disease of female genital organs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Noninflammatory disease of female
genital organs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Menstrual disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other diseases of female genital organs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Female trouble, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Malignant neoplasm of breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Malignant neoplasm of female genital organs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Malignant neoplasm of prostate . . . . . . . . . . . . . 344 2.8 *– *0.2 2.7 19.7 25.3 22.1 70.6 100.0
Benign neoplasm of breast. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benign neoplasm of female genital organs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1Includes races other than white and black and unknown family income.
*– Figure does not meet standard of reliability or precision and quantity zero.
. . . Category not applicable.
* Figure does not meet standard of reliability or precision.
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Table 38. Average annual number of selected chronic endocrine, nutritional, and metabolic diseases and immunity disorders; diseases
of the blood and blood-forming organs; and genitourinary conditions among females, rates per 1,000 persons by age; and percent of
conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic endocrine, nutritional, and
metabolic diseases and immunity disorders;


























Endocrine, nutritional, and metabolic
diseases and immunity disorders Rate per 1,000 persons Percent
Gout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 711 5.6 *– 1.4 11.1 17.7 24.1 11.4 *5.9 92.4
Goiter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 413 3.2 *0.5 2.8 6.1 8.5 *2.0 *4.8 13.8 100.0
Other diseases of the thyroid . . . . . . . . . . . . . . 2,813 22.0 1.8 15.3 43.7 53.8 41.3 6.9 12.8 99.4
Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,922 30.6 *1.2 13.4 56.2 106.9 92.8 35.7 27.0 100.0
Diseases of the blood and
blood-forming organs
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,132 24.5 10.8 32.6 22.4 25.5 29.6 3.9 8.6 98.0
Genitourinary conditions
Kidney stones. . . . . . . . . . . . . . . . . . . . . . . . 373 2.9 *0.1 3.2 3.9 6.8 *4.4 *5.9 44.8 97.6
Kidney infections . . . . . . . . . . . . . . . . . . . . . . 1,153 9.0 2.3 10.7 10.8 13.5 13.0 *4.1 24.8 97.1
Other kidney trouble, not elsewhere classified . . . . 520 4.1 3.0 3.2 3.2 9.6 10.5 27.1 36.2 98.1
Bladder infections . . . . . . . . . . . . . . . . . . . . . 1,455 11.4 3.1 14.4 12.3 14.1 18.2 *1.7 9.1 97.2
Other disorders of bladder . . . . . . . . . . . . . . . . 1,502 11.7 3.6 8.9 13.5 26.6 40.3 4.3 19.1 89.8
Diseases of prostate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Inflammatory disease of female genital organs. . . . 184 1.4 *0.7 2.6 *0.8 *0.4 *– *2.2 *21.7 100.0
Noninflammatory disease of female
genital organs . . . . . . . . . . . . . . . . . . . . . . . 1,219 9.5 1.7 17.9 6.4 *2.9 *2.1 *3.0 37.7 99.7
Menstrual disorders . . . . . . . . . . . . . . . . . . . . 1,984 15.5 6.8 28.0 10.3 *0.4 *0.5 *0.9 10.5 89.5
Other diseases of female genital organs . . . . . . . 2,382 18.6 5.1 30.2 18.9 7.6 7.2 7.7 21.0 92.0
Female trouble, not otherwise specified . . . . . . . . 144 1.1 *– 1.6 *2.1 *0.5 *– *4.9 *29.9 93.1
Malignant neoplasm of breast . . . . . . . . . . . . . . 802 6.3 *– 1.4 10.4 25.9 27.6 23.7 85.3 100.0
Malignant neoplasm of female genital organs . . . . 221 1.7 *– 2.2 *2.0 *3.7 *2.3 *16.3 57.5 100.0
Malignant neoplasm of prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benign neoplasm of breast. . . . . . . . . . . . . . . . 73 0.6 *– *0.8 *0.6 *0.9 *1.2 *2.7 *30.1 100.0
Benign neoplasm of female genital organs . . . . . . 746 5.8 *– 8.1 10.5 *4.2 *1.7 *5.0 49.6 100.0
1Includes races other than white and black and unknown family income.
*– Figure does not meet standard of reliability or precision and quantity zero.
* Figure does not meet standard of reliability or precision.
. . . Category not applicable.
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Table 39. Average annual number of selected chronic endocrine, nutritional, and metabolic diseases and immunity disorders; diseases
of the blood and blood-forming organs; and genitourinary conditions among white persons; rates per 1,000 persons by age; and percent
of conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic endocrine, nutritional, and
metabolic diseases and immunity disorders;






















Endocrine, nutritional, and metabolic
diseases and immunity disorders Rate per 1,000 persons Percent
Gout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,779 8.5 2.5 16.0 28.6 8.2 5.1 93.4
Goiter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 394 1.9 1.2 3.2 3.6 *5.3 *12.9 100.0
Other diseases of the thyroid . . . . . . . . . . . . . . . 3,020 14.5 6.7 28.0 34.6 5.7 12.7 99.4
Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,661 27.2 7.5 50.7 93.5 33.1 25.7 100.0
Diseases of the blood and
blood-forming organs
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,749 13.2 12.1 11.1 22.0 3.0 9.4 97.7
Genitourinary conditions
Kidney stones . . . . . . . . . . . . . . . . . . . . . . . . 928 4.5 2.9 8.3 6.7 *3.7 49.1 99.1
Kidney infections . . . . . . . . . . . . . . . . . . . . . . 1,125 5.4 4.5 6.6 8.4 *2.1 21.9 95.8
Other kidney trouble, not elsewhere classified . . . . 700 3.4 2.2 3.5 9.1 26.0 37.4 96.1
Bladder infections . . . . . . . . . . . . . . . . . . . . . . 1,483 7.1 6.1 7.8 11.5 *2.8 11.5 97.3
Other disorders of bladder . . . . . . . . . . . . . . . . 1,591 7.6 4.2 8.5 24.3 4.7 20.7 90.3
Diseases of prostate . . . . . . . . . . . . . . . . . . . . 1,362 6.5 1.3 11.4 26.2 4.3 27.5 96.8
Inflammatory disease of female genital organs . . . . 160 0.8 1.0 *0.2 *0.1 *2.5 *18.8 100.0
Noninflammatory disease of female
genital organs . . . . . . . . . . . . . . . . . . . . . . . 1,114 5.3 6.5 3.8 *1.7 *3.3 35.6 99.6
Menstrual disorders. . . . . . . . . . . . . . . . . . . . . 1,743 8.4 10.7 5.6 *0.3 *0.6 10.6 89.8
Other diseases of female genital organs . . . . . . . . 2,074 10.0 10.9 10.2 4.7 8.1 21.6 92.8
Female trouble, not otherwise specified . . . . . . . . 126 0.6 0.5 *1.1 *0.2 *3.2 *27.0 94.4
Malignant neoplasm of breast . . . . . . . . . . . . . . 728 3.5 0.5 5.8 15.6 23.2 86.3 100.0
Malignant neoplasm of female genital organs . . . . . 202 1.0 0.8 *1.0 2.0 *15.8 55.9 100.0
Malignant neoplasm of prostate . . . . . . . . . . . . . 288 1.4 *0.1 *0.9 8.9 21.9 70.8 100.0
Benign neoplasm of breast . . . . . . . . . . . . . . . . 62 0.3 *0.2 *0.4 *0.7 *– *35.5 100.0
Benign neoplasm of female genital organs . . . . . . 569 2.7 2.2 4.9 2.0 *5.3 47.3 100.0
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantitiy zero.
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Table 40. Average annual number of selected chronic endocrine, nutritional, and metabolic diseases and immunity disorders; diseases
of the blood and blood-forming organs; and genitourinary conditions among black persons; rates per 1,000 persons by age; and percent
of conditions causing activity limitation, hospitalization, and physician visits: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic endocrine, nutritional, and
metabolic diseases and immunity disorders;






















Endocrine, nutritional, and metabolic
diseases and immunity disorders Rate per 1,000 persons Percent
Gout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 362 11.7 *1.5 39.1 52.7 16.6 *8.8 95.6
Goiter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77 2.5 *1.3 *4.7 *9.4 *6.5 *29.9 100.0
Other diseases of the thyroid . . . . . . . . . . . . . . 186 6.0 2.5 15.8 *19.9 *21.0 *19.4 97.8
Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,119 36.2 8.8 93.3 178.7 42.3 32.4 100.0
Diseases of the blood and
blood-forming organs
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . 828 26.8 26.8 28.7 23.0 8.3 9.8 99.3
Genitourinary conditions
Kidney stones. . . . . . . . . . . . . . . . . . . . . . . . *51 *1.7 *0.8 *3.1 *6.6 *– *45.1 *100.0
Kidney infections . . . . . . . . . . . . . . . . . . . . . . 166 5.4 4.0 *8.4 *12.1 *13.9 *29.5 98.2
Other kidney trouble, not elsewhere classified . . . . 136 4.4 2.9 *4.3 *17.9 *35.3 *26.5 91.9
Bladder infections . . . . . . . . . . . . . . . . . . . . . 100 3.2 2.9 *4.1 *4.3 *– *4.0 100.0
Other disorders of bladder . . . . . . . . . . . . . . . . 210 6.8 4.0 11.3 23.4 *6.7 *14.8 86.2
Diseases of prostate. . . . . . . . . . . . . . . . . . . . 134 4.3 *0.8 *8.2 28.9 *11.9 *37.3 100.0
Inflammatory disease of female genital organs. . . . *24 *0.8 *0.6 *1.6 *– *– *41.7 *100.0
Noninflammatory disease of female
genital organs . . . . . . . . . . . . . . . . . . . . . . . 87 2.8 3.5 *1.0 *– *– *56.3 100.0
Menstrual disorders . . . . . . . . . . . . . . . . . . . . 197 6.4 7.6 *3.7 *– *1.0 *9.6 85.8
Other diseases of female genital organs . . . . . . . 242 7.8 8.9 *6.1 *1.6 *6.2 *11.2 82.6
Female trouble, not otherwise specified . . . . . . . . *18 *0.6 *0.6 *1.0 *– *16.7 *50.0 *88.9
Malignant neoplasm of breast . . . . . . . . . . . . . . 56 1.8 *0.3 *2.9 *14.0 *37.5 *73.2 100.0
Malignant neoplasm of female genital organs . . . . *12 *0.4 *0.2 *1.2 *– *33.3 *83.3 *100.0
Malignant neoplasm of prostate . . . . . . . . . . . . . *43 *1.4 *– *3.3 *10.5 *20.9 *72.1 *100.0
Benign neoplasm of breast. . . . . . . . . . . . . . . . *11 *0.4 *0.5 *– *– *18.2 *– *100.0
Benign neoplasm of female genital organs . . . . . . 164 5.3 4.5 11.9 *– *4.3 54.3 100.0
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 41. Average annual number of selected chronic endocrine, nutritional, and metabolic diseases and immunity disorders; diseases
of the blood and blood-forming organs; and genitourinary conditions; and rates per 1,000 persons, by family income: United States,
1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic endocrine, nutritional, and
metabolic diseases and immunity disorders;























Endocrine, nutritional, and metabolic
diseases and immunity disorders Number in thousands Rate per 1,000 persons
Gout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,167 288 470 407 565 8.7 11.9 12.1 7.8 6.3
Goiter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 478 64 100 75 180 1.9 2.6 2.6 1.4 2.0
Other diseases of the thyroid . . . . . . . . . . . . . . 3,303 386 601 639 1,099 13.3 15.9 15.5 12.2 12.3
Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,962 1,218 1,508 1,279 1,414 28.0 50.3 39.0 24.4 15.8
Diseases of the blood and
blood-forming organs
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,739 677 699 697 1,058 15.0 27.9 18.1 13.3 11.8
Genitourinary conditions
Kidney stones. . . . . . . . . . . . . . . . . . . . . . . . 1,009 107 166 140 411 4.1 4.4 4.3 2.7 4.6
Kidney infections . . . . . . . . . . . . . . . . . . . . . . 1,325 262 310 214 274 5.3 10.8 8.0 4.1 3.1
Other kidney trouble, not elsewhere classified . . . . 862 210 141 180 172 3.5 8.7 3.6 3.4 1.9
Bladder infections . . . . . . . . . . . . . . . . . . . . . 1,616 151 271 351 620 6.5 6.2 7.0 6.7 6.9
Other disorders of bladder . . . . . . . . . . . . . . . . 1,822 402 417 324 365 7.3 16.6 10.8 6.2 4.1
Diseases of prostate. . . . . . . . . . . . . . . . . . . . 1,513 116 266 327 559 6.1 4.8 6.9 6.2 6.2
Inflammatory disease of female genital organs. . . . 184 *25 *44 *35 68 0.7 *1.0 *1.1 *0.7 0.8
Noninflammatory disease of female
genital organs . . . . . . . . . . . . . . . . . . . . . . . 1,219 93 202 331 446 4.9 3.8 5.2 6.3 5.0
Menstrual disorders . . . . . . . . . . . . . . . . . . . . 1,984 285 320 422 735 8.0 11.8 8.3 8.0 8.2
Other diseases of female genital organs . . . . . . . 2,382 286 303 529 1,008 9.6 11.8 7.8 10.1 11.2
Female trouble, not otherwise specified . . . . . . . . 144 *15 *39 *18 *53 0.6 *0.6 *1.0 *0.3 *0.6
Malignant neoplasm of breast . . . . . . . . . . . . . . 802 110 160 158 206 3.2 4.5 4.1 3.0 2.3
Malignant neoplasm of female genital organs . . . . 221 *30 *32 *38 69 0.9 *1.2 *0.8 *0.7 0.8
Malignant neoplasm of prostate . . . . . . . . . . . . . 344 *7 100 84 89 1.4 *0.3 2.6 1.6 1.0
Benign neoplasm of breast. . . . . . . . . . . . . . . . 73 *– *– *9 *40 0.3 *– *– *0.2 *0.4
Benign neoplasm of female genital organs . . . . . . 746 57 105 172 325 3.0 2.4 2.7 3.3 3.6
1Includes unknown family income.
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 42. Average annual number of selected chronic endocrine, nutritional, and metabolic diseases and immunity disorders; diseases
of the blood and blood-forming organs; and genitourinary conditions; and rates per 1,000 persons, by geographic region: United States,
1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Chronic endocrine, nutritional, and
metabolic diseases and immunity disorders;




regions Northeast Midwest South West
All
regions Northeast Midwest South West
Endocrine, nutritional, and metabolic
diseases and immunity disorders Number in thousands Rate per 1,000 persons
Gout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,167 337 474 926 429 8.7 6.7 7.9 11.0 7.9
Goiter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 478 95 99 164 121 1.9 1.9 1.6 1.9 2.2
Other diseases of the thyroid . . . . . . . . . . . . . . 3,303 690 863 985 765 13.3 13.8 14.3 11.7 14.1
Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,962 1,470 1,643 2,673 1,176 28.0 29.4 27.2 31.7 21.7
Diseases of the blood and
blood-forming organs
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,739 821 800 1,303 815 15.0 16.4 13.3 15.5 15.1
Genitourinary conditions
Kidney stones. . . . . . . . . . . . . . . . . . . . . . . . 1,009 195 196 459 158 4.1 3.9 3.2 5.5 2.9
Kidney infections . . . . . . . . . . . . . . . . . . . . . . 1,325 125 264 703 234 5.3 2.5 4.4 8.3 4.3
Other kidney trouble, not elsewhere classified . . . . 862 146 191 331 193 3.5 2.9 3.2 3.9 3.6
Bladder infections . . . . . . . . . . . . . . . . . . . . . 1,616 313 402 489 412 6.5 6.3 6.7 5.8 7.6
Other disorders of bladder . . . . . . . . . . . . . . . . 1,822 225 487 744 365 7.3 4.5 8.1 8.8 6.7
Diseases of prostate. . . . . . . . . . . . . . . . . . . . 1,513 285 323 609 295 6.1 5.7 5.4 7.2 5.4
Inflammatory disease of female genital organs. . . . 184 *24 65 62 *33 0.7 *0.5 1.1 0.7 *0.6
Noninflammatory disease of female
genital organs . . . . . . . . . . . . . . . . . . . . . . . 1,219 240 376 374 230 4.9 4.8 6.2 4.4 4.2
Menstrual disorders . . . . . . . . . . . . . . . . . . . . 1,984 283 568 732 402 8.0 5.7 9.4 8.7 7.4
Other diseases of female genital organs . . . . . . . 2,382 403 705 769 505 9.6 8.0 11.7 9.1 9.3
Female trouble, not otherwise specified . . . . . . . . 144 *18 *48 *29 *49 0.6 *0.4 *0.8 *0.3 *0.9
Malignant neoplasm of breast . . . . . . . . . . . . . . 802 197 183 280 141 3.2 3.9 3.0 3.3 2.6
Malignant neoplasm of female genital organs . . . . 221 *32 70 91 *29 0.9 *0.6 1.2 1.1 *0.5
Malignant neoplasm of prostate . . . . . . . . . . . . . 344 56 91 127 69 1.4 1.1 1.5 1.5 1.3
Benign neoplasm of breast. . . . . . . . . . . . . . . . 73 *4 *14 *37 *17 0.3 *0.1 *0.2 *0.4 *0.3
Benign neoplasm of female genital organs . . . . . . 746 142 181 289 133 3.0 2.8 3.0 3.4 2.5
* Figure does not meet standard of reliability or precision.
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Table 43. Average annual number of days of restricted activity from selected chronic conditions and number of days per condition, by
age and sex: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Selected chronic conditions
Age Sex
































Heart disease . . . . . . . . . . . . . . . . . . . . . 399,680 19.5 167,480 14.8 232,201 25.3 183,875 19.0 215,805 20.0
Ischemic heart disease . . . . . . . . . . . . . . 177,698 23.0 82,367 25.0 95,331 21.5 94,041 20.2 83,657 27.3
Heart rhythm disorders . . . . . . . . . . . . . . 45,208 5.7 20,614 3.7 24,594 10.7 13,414 4.6 31,794 6.4
Tachycardia . . . . . . . . . . . . . . . . . . . . 15,456 8.1 *9,492 *8.2 *5,964 *8.0 *6,671 *10.5 *8,784 *6.9
Other and unspecified
heart rhythm disorders . . . . . . . . . . . 24,820 14.8 *8,300 *10.6 16,520 18.4 *5,589 *8.2 19,232 19.3
Other selected diseases of the heart
(excludes hypertension) . . . . . . . . . . . . . 169,380 40.9 60,016 31.8 109,364 48.4 70,153 38.2 99,227 42.9
Rheumatic fever with or without heart
disease. . . . . . . . . . . . . . . . . . . . . . . . . 26,456 13.0 16,225 9.9 *10,230 *26.2 *7,068 *12.3 19,387 13.3
High blood pressure (hypertension) . . . . . . . . 141,758 5.1 71,378 4.3 70,380 6.3 52,486 4.3 89,272 5.8
Cerebrovascular disease. . . . . . . . . . . . . . . 118,046 39.3 32,627 33.5 85,418 42.2 59,507 41.0 58,539 37.7
Hardening of the arteries . . . . . . . . . . . . . . 34,772 16.8 13,067 21.7 21,705 14.8 15,297 14.9 19,474 18.6
Phlebitis, thrombophlebitis . . . . . . . . . . . . . . 15,193 20.9 *5,521 *13.9 *9,672 *29.5 *5,140 *21.0 *10,053 *20.9
Varicose veins of lower extremities . . . . . . . . 19,125 2.6 13,345 2.6 *5,780 *2.6 *5,353 *3.7 13,772 2.3
Hemorrhoids . . . . . . . . . . . . . . . . . . . . . . 14,871 1.6 *10,309 *1.4 *4,562 *2.4 *5,725 *1.4 *9,146 *1.7
Poor circulation . . . . . . . . . . . . . . . . . . . . 25,336 25.9 *6,942 *16.5 18,394 32.9 *9,832 *26.5 15,504 25.5
Respiratory conditions
Chronic bronchitis . . . . . . . . . . . . . . . . . . . 51,490 4.0 29,808 2.7 21,683 11.2 18,771 3.7 32,720 4.2
Emphysema . . . . . . . . . . . . . . . . . . . . . . 88,976 47.9 36,636 50.5 52,340 46.2 60,685 52.1 28,291 40.7
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . 133,845 11.7 98,793 9.6 35,052 30.6 63,019 11.8 70,826 11.5
Hay fever or allergic rhinitis without
asthma . . . . . . . . . . . . . . . . . . . . . . . . . 28,553 1.2 23,518 1.1 *5,035 *2.2 *11,235 *1.0 17,318 1.3
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . 73,264 2.2 56,101 1.9 17,164 3.8 20,386 1.5 52,878 2.7
Malignant neoplasms of lung, bronchus,
and other respiratory sites . . . . . . . . . . . . . 20,955 96.1 *6,247 *61.9 14,708 125.7 15,401 107.0 *5,554 *75.1
Other diseases of the lung . . . . . . . . . . . . . 25,833 20.9 *8,550 *10.5 15,283 47.3 18,094 31.7 *5,739 *10.1
Digestive conditions
Gallbladder stones . . . . . . . . . . . . . . . . . . 13,264 12.4 *9,717 *13.2 *3,547 *10.7 *– *– 13,264 17.5
Liver disease including cirrhosis . . . . . . . . . . 18,453 24.1 12,489 20.2 *5,963 *40.3 12,078 29.7 *6,374 *17.7
Ulcer, gastric, duodenal, and/or peptic . . . . . . 33,937 8.1 19,115 5.9 14,822 15.7 14,420 7.3 19,517 8.7
Gastric ulcer . . . . . . . . . . . . . . . . . . . . . 22,855 7.3 13,150 5.3 *9,706 *15.8 *11,201 *7.6 *11,654 *7.1
Hernia of abdominal cavity . . . . . . . . . . . . . 41,720 8.8 30,283 10.2 *11,438 *6.4 24,184 10.3 17,536 7.2
Disease of esophagus . . . . . . . . . . . . . . . . 15,520 18.6 *8,931 *14.6 *6,588 *29.8 *11,390 *28.5 *4,129 *9.5
Gastritis and duodenitis . . . . . . . . . . . . . . . 17,686 5.9 12,635 5.4 *5,050 *7.5 *8,287 *7.2 *9,398 *5.1
Indigestion and other functional
disorders of the stomach . . . . . . . . . . . . . . 34,618 5.4 16,988 3.4 17,630 12.1 13,300 4.3 21,318 6.4
Enteritis and colitis . . . . . . . . . . . . . . . . . . 31,515 13.5 21,546 12.2 *9,969 *17.8 *10,307 *12.6 21,208 14.0
Spastic colon . . . . . . . . . . . . . . . . . . . . . . 12,978 7.7 *10,499 *7.8 *2,480 *7.4 *2,047 *6.9 *10,932 *7.9
Other stomach and intestinal disorders . . . . . . 26,977 13.1 17,830 12.0 *9,147 *16.1 *10,606 *13.0 16,371 13.2
Malignant neoplasms of stomach,
intestines, colon, and rectum . . . . . . . . . . . 19,421 60.3 *9,228 *71.5 *10,193 *53.1 12,176 83.4 *7,245 *41.4
Impairments
Blindness and other visual impairments . . . . . 32,253 3.9 18,244 3.2 14,010 5.8 14,663 2.9 17,591 5.7
Other visual impairments . . . . . . . . . . . . . 27,547 3.6 16,256 3.0 *11,291 *5.2 *11,977 *2.5 15,570 5.6
Speech impairments . . . . . . . . . . . . . . . . . 19,062 7.0 *8,526 *3.6 *10,535 *27.6 *9,268 *5.4 *9,794 *9.8
See footnotes at end of table.
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Table 43. Average annual number of days of restricted activity from selected chronic conditions and number of days per condition, by
age and sex: United States, 1990–92—Con.
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Selected chronic conditions
Age Sex
































Absence of extremities or parts
of extremities (excluding absence of
tips of fingers or toes only). . . . . . . . . . . . . 15,036 10.2 *6,536 *6.7 *8,500 *16.8 *10,265 *9.0 *4,771 *14.0
Absence of lower extremities or parts
of lower extremities . . . . . . . . . . . . . . . . 14,312 26.9 *5,812 *18.0 *8,500 *40.3 *9,542 *27.2 *4,771 *26.4
Absence of bone, joint, or muscle
of extremity . . . . . . . . . . . . . . . . . . . . . . 17,025 19.5 *10,010 *23.3 *7,015 *15.8 *5,563 *14.8 *11,462 *22.9
Paralysis of extremities, complete or partial . . . 68,005 46.5 33,298 37.8 34,707 59.5 29,196 37.2 38,809 57.2
Paralysis of extremities, complete. . . . . . . . 36,962 59.0 16,533 44.0 20,429 81.7 17,945 49.3 19,017 72.6
Paralysis of extremities, partial. . . . . . . . . . 31,043 37.0 16,765 33.2 14,278 42.9 *11,252 *26.7 19,791 47.5
Paralysis of other site, complete or partial . . . . 21,005 56.6 15,835 64.6 *5,170 *41.0 *10,039 *50.7 *10,965 *63.4
Deformities or orthopedic impairments, total . . . 599,569 17.1 444,481 15.7 155,089 23.4 271,687 16.5 327,883 17.8
Deformities or orthopedic impairments
of back . . . . . . . . . . . . . . . . . . . . . . . 276,130 15.2 218,869 14.4 57,261 19.3 134,725 17.2 141,405 13.7
Curvature or other orthopedic
impairment of back or spine . . . . . . . . . 55,440 10.9 39,996 9.5 15,445 17.6 20,994 13.6 34,447 9.8
Deformities or orthopedic impairments of
upper extremities . . . . . . . . . . . . . . . . . 86,190 22.4 70,257 23.7 15,933 18.0 35,965 16.8 50,225 29.1
Orthopedic impairment, shoulder . . . . . 69,353 23.8 59,714 25.5 *9,639 *16.8 29,517 18.7 39,836 29.7
Deformities or orthopedic impairments of
lower extremities . . . . . . . . . . . . . . . . . 217,909 17.4 144,527 14.6 73,383 27.9 89,495 14.2 128,414 20.6
Other deformities or orthopedic
impairments . . . . . . . . . . . . . . . . . . . . 19,339 42.4 *10,828 *34.3 *8,512 *60.8 *11,502 *44.8 *7,838 *39.4
Conditions of nervous system
and sense organs
Cataracts . . . . . . . . . . . . . . . . . . . . . . . . 16,600 2.6 *2,470 *1.7 14,130 2.8 *3,890 *1.8 12,709 3.0
Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . 21,912 17.6 18,072 16.2 *3,839 *30.0 14,277 23.5 *7,634 *12.0
Migraine headache . . . . . . . . . . . . . . . . . . 75,734 7.6 71,822 7.7 *3,911 *6.0 23,998 9.1 51,736 7.0
Other headache (excludes tension
headache) . . . . . . . . . . . . . . . . . . . . . . . 68,334 6.7 54,025 5.8 14,310 14.6 29,625 9.3 38,709 5.5
Conditions of musculoskeletal system
and connective tissue
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . 445,381 14.0 227,438 13.2 217,943 15.0 150,371 13.0 295,010 14.6
Sciatica (including lumbago) . . . . . . . . . . . . 25,902 12.6 16,322 10.8 *9,581 *17.7 *6,206 *8.6 19,696 14.7
Intervertebral disc disorders . . . . . . . . . . . . . 187,530 37.7 166,973 40.7 20,556 23.6 108,122 39.3 79,408 35.7
Bone spur or tendinitis, not otherwise
specified . . . . . . . . . . . . . . . . . . . . . . . . 33,511 12.7 24,359 12.0 *9,153 *15.0 12,216 11.2 21,295 13.8
Disorders of bone or cartilage . . . . . . . . . . . 45,083 28.8 27,400 29.6 17,684 27.5 *10,223 *23.2 34,860 30.9
Bursitis, not elsewhere classified. . . . . . . . . . 22,952 4.9 18,837 5.4 *4,115 *3.4 *4,226 *2.2 18,725 6.8
Condition of skin and subcutaneous tissue
Chronic ulcer of skin . . . . . . . . . . . . . . . . . 14,064 42.5 *9,110 *50.3 *4,953 *32.8 *6,273 *38.5 *7,790 *46.4
See footnotes at end of table.
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Table 43. Average annual number of days of restricted activity from selected chronic conditions and number of days per condition, by
age and sex: United States, 1990–92—Con.
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Selected chronic conditions
Age Sex































Endocrine, nutritional, and metabolic
diseases and immunity disorders
Gout . . . . . . . . . . . . . . . . . . . . . . . . . . . 25,573 11.8 12,908 10.3 12,664 13.4 12,248 8.4 13,325 18.7
Diabetes. . . . . . . . . . . . . . . . . . . . . . . . . 115,715 16.6 60,811 15.6 54,905 17.9 45,343 14.9 70,372 18.0
Diseases of the blood and
blood-forming organs
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . 22,242 6.0 16,943 5.5 *5,299 *8.0 *3,486 *5.8 18,756 6.0
Genitourinary conditions
Other kidney trouble, not elsewhere
classified. . . . . . . . . . . . . . . . . . . . . . . . 18,313 21.3 *8,018 *14.1 *10,295 *35.1 *5,843 *17.1 12,470 24.0
Other disorders of bladder. . . . . . . . . . . . . . 12,816 7.0 *8,588 *7.9 *4,229 *5.8 *5,485 *17.1 *7,331 *4.9
Diseases of prostate . . . . . . . . . . . . . . . . . 14,409 9.5 *5,807 *8.0 *8,601 *10.9 14,408 9.5 . . . . . .
Other diseases of female genital organs . . . . . 24,330 10.2 23,588 10.5 *742 *5.7 . . . . . . 24,330 10.2
Malignant neoplasms of breast . . . . . . . . . . . 15,124 18.9 *7,679 *23.1 *7,445 *15.9 . . . . . . 15,124 18.9
Malignant neoplasms of prostate . . . . . . . . . . 15,818 46.1 *5,533 *79.0 *10,285 *37.5 15,818 46.1 . . . . . .
. . . Category not applicable.
* Figure does not meet standard of reliability or precision.
*– Figure does not meet standard of reliability or precision and quantity zero.
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Table 44. Average annual number of days of bed disability from selected chronic conditions and number of days per condition, by age
and sex: United States, 1990–92
[Data are based on household interviews of the civilian noninstitutionalized population. The survey design, general qualifications, and information on the reliability of the
estimates are given in appendix I. Definitions of terms are given in appendix II]
Selected chronic conditions
Age Sex
































Heart Disease . . . . . . . . . . . . . . . . . . . . . 157,911 7.7 70,177 6.2 87,734 9.6 72,083 7.4 85,828 8.0
Ischemic heart disease . . . . . . . . . . . . . . 66,195 8.6 30,664 9.3 35,531 8.0 35,246 7.6 30,949 10.1
Heart rhythm disorders . . . . . . . . . . . . . . 17,124 2.2 *9,177 *1.6 *7,947 *3.5 *6,674 *2.3 *10,450 *2.1
Other selected diseases of the heart
(excludes hypertension) . . . . . . . . . . . . . 71,840 17.3 29,475 15.6 42,366 18.7 27,802 15.1 44,038 19.0
High blood pressure . . . . . . . . . . . . . . . . . 47,875 1.7 25,689 1.6 22,186 2.0 17,998 1.5 29,877 1.9
Cerebrovascular disease. . . . . . . . . . . . . . . 51,190 17.1 *11,293 *11.6 39,897 19.7 24,761 17.1 26,428 17.0
Poor circulation . . . . . . . . . . . . . . . . . . . . 14,202 14.5 *2,055 *4.9 12,147 21.7 *6,826 *18.4 *7,376 *12.1
Respiratory conditions
Chronic bronchitis . . . . . . . . . . . . . . . . . . . 16,413 1.3 *10,773 *1.0 *5,640 *2.9 *3,814 *0.7 12,599 1.6
Emphysema . . . . . . . . . . . . . . . . . . . . . . 33,644 18.1 12,699 17.5 20,945 18.5 24,979 21.4 *8,665 *12.4
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . 63,893 5.6 46,443 4.5 17,450 15.2 29,999 5.6 33,894 5.5
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . 22,242 0.6 17,561 0.6 *4,681 *1.0 *6,571 *0.5 15,672 0.8
Other diseases of the lung . . . . . . . . . . . . . 14,946 13.1 *6,961 *8.5 *7,984 *24.7 *11,534 *20.2 *3,412 *6.0
Digestive conditions
Hernia of abdominal cavity . . . . . . . . . . . . . 13,441 2.8 *6,442 *2.2 *6,998 *3.9 *7,635 *3.3 *5,805 *2.4
Enteritis and colitis . . . . . . . . . . . . . . . . . . 14,701 6.3 *9,757 *5.5 *4,944 *8.8 *3,700 *4.5 *11,002 *7.3
Other stomach and intestinal disorders . . . . . . 12,800 6.2 *8,918 *6.0 *3,882 *6.8 *2,996 *3.7 *9,804 *7.9
Impairments
Paralysis of extremities, complete or partial . . . 30,021 20.5 *11,221 *12.7 18,801 32.2 13,264 16.9 16,757 24.7
Paralysis of extremities, complete. . . . . . . . 18,778 30.2 *5,866 *15.6 12,912 51.6 *9,227 *25.3 *9,551 *36.5
Paralysis of other site, complete or partial . . . . 12,408 33.3 *7,238 *29.5 *5,170 *41.0 *4,587 *23.2 *7,820 *45.2
Deformities or orthopedic impairments, total . . . 160,919 4.6 115,866 4.1 45,053 6.8 63,364 3.8 97,556 5.3
Deformities or orthopedic impairments
of back . . . . . . . . . . . . . . . . . . . . . . . 93,215 5.1 74,377 4.9 18,838 6.3 41,496 5.3 51,719 5.0
Curvature of other deformity of back or
spine. . . . . . . . . . . . . . . . . . . . . . . . . 21,429 4.2 14,678 3.5 *6,751 *7.7 *6,959 *4.5 14,470 4.1
Deformities or orthopedic impairments of
lower extremities . . . . . . . . . . . . . . . . . 54,178 4.3 32,252 3.3 21,926 8.3 18,637 3.0 35,541 5.7
Conditions of nervous system
and sense organs
Migraine headache . . . . . . . . . . . . . . . . . . 34,398 3.4 32,955 3.5 *1,443 *2.2 *9,203 *3.5 25,195 3.4
Other headache (excludes tension
headache) . . . . . . . . . . . . . . . . . . . . . . . 27,256 2.7 20,934 2.3 *6,322 *6.4 *8,974 *2.8 18,282 2.6
Conditions of musculoskeletal system
and connective tissue
Arthritis . . . . . . . . . . . . . . . . . . . . . . . . . 152,141 4.8 79,484 4.6 72,656 5.0 49,544 4.3 102,596 5.1
Intervertebral disc disorders . . . . . . . . . . . . . 57,158 11.5 50,249 12.2 *6,909 *7.9 27,207 9.9 29,951 13.4
Disorders of bone or cartilage . . . . . . . . . . . 23,971 15.3 14,807 16.0 *9,165 *14.3 *5,208 *11.8 18,762 16.6
Endocrine, nutritional, and metabolic
diseases and immunity disorders
Gout . . . . . . . . . . . . . . . . . . . . . . . . . . . 12,998 6.0 *5,350 *4.3 *7,648 *8.3 *5,034 *3.5 *7,964 *11.2
Diabetes. . . . . . . . . . . . . . . . . . . . . . . . . 54,539 7.8 27,599 7.1 26,940 8.8 17,999 5.9 36,540 9.3
* Figure does not meet standard of reliability or precision.
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All persons1 . . . . . . . . . . . . . . . . . . . . . 248,754 65,553 105,498 171,050 47,416 18,289 11,999
Sex
Male . . . . . . . . . . . . . . . . . . . . . . . . . . 120,759 33,550 51,805 85,355 22,752 8,179 4,474
Female . . . . . . . . . . . . . . . . . . . . . . . . 127,995 32,002 53,693 85,696 24,664 10,110 7,525
Race
White . . . . . . . . . . . . . . . . . . . . . . . . . 208,265 . . . . . . 140,186 40,903 16,307 10,868
Black . . . . . . . . . . . . . . . . . . . . . . . . . 30,909 . . . . . . 23,467 4,879 1,609 954
Family income
Less than $10,000 . . . . . . . . . . . . . . . . . 24,231 . . . . . . . . . . . . . . . . . .
$10,000-$19,999 . . . . . . . . . . . . . . . . . . 38,712 . . . . . . . . . . . . . . . . . .
$20,000-$34,999 . . . . . . . . . . . . . . . . . . 52,492 . . . . . . . . . . . . . . . . . .
$35,000 or more . . . . . . . . . . . . . . . . . . 89,632 . . . . . . . . . . . . . . . . . .
Geographic region
Northeast . . . . . . . . . . . . . . . . . . . . . . . 50,067 . . . . . . . . . . . . . . . . . .
Midwest . . . . . . . . . . . . . . . . . . . . . . . . 60,332 . . . . . . . . . . . . . . . . . .
South . . . . . . . . . . . . . . . . . . . . . . . . . 84,217 . . . . . . . . . . . . . . . . . .
West . . . . . . . . . . . . . . . . . . . . . . . . . . 54,132 . . . . . . . . . . . . . . . . . .
1Includes races other than white and black and unknown family income.
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Technical notes on methods
Background
This report is one of a series of statistical reports pu
lished by the staff of the National Center for Health Statist
(NCHS). It is based on information collected in a continuin
nationwide sample of households included in the Natio
Health Interview Survey (NHIS). Data are obtained on t
personal, sociodemographic, and health characteristics of
family members and unrelated individuals living in the
households.
Field operations for the survey are conducted by the U
Bureau of the Census under specifications established
NCHS. The Bureau of the Census participates in the sur
planning, selects the sample, and conducts the interviews.
data are then transmitted to NCHS for preparation, process
and analysis.
Summary reports and reports on special topics for e
year’s data are prepared by the staff of the Division of Hea
Interview Statistics for publication in Series 10 publications
NCHS. Data are also tabulated for other reports published
NCHS staff and for use by other organizations and by resea
ers within and outside the Government. Since 1969, public
tapes have been prepared for each year of data collection
It should be noted that the health characteristics descri
by NHIS estimates pertain only to the resident, civilia
noninstitutionalized population of the United States living
the time of the interview. The sample does not include pers
residing in nursing homes, members of the Armed Forc
institutionalized persons, or U.S. nationals living abroad.
Statistical design of the National Health
Interview Survey
General design
Data from NHIS have been collected continuously sin
1957. The sample design of the survey has undergone cha
following each decennial census. This periodic redesign of
NHIS sample allows the incorporation of the latest populat
information and statistical methodology into the survey desi
The data presented in this report are from an NHIS sam
design first used in 1985. It is anticipated that this design w
be used until 1995.
The sample design plan of the NHIS follows a multista
probability design that permits a continuous sampling of


















States. The survey is designed in such a way that the sam
scheduled for each week is representative of the target po
lation, and the weekly samples are additive over time. Th
design permits estimates for high-frequency measures or
large population groups to be produced from a short period
data collection. Estimates for low-frequency measures or
smaller population subgroups can be obtained from a lon
period of data collection. The annual sample is designed
that tabulations can be provided for each of the four ma
geographic regions. Because interviewing is done through
the year, there is no seasonal bias for annual estimates.
The continuous data collection also has administrati
and operational advantages because fieldwork can be han
on a continuing basis with an experienced, stable staff.
Sample selection
The target population for NHIS is the civilian noninstitu
tionalized population residing in the United States. For t
first stage of the sample design, the United States is conside
to be a universe composed of approximately 1,900 geograp
cally defined primary sampling units (PSU’s). A PSU consis
of a county, a small group of contiguous counties, or
metropolitan statistical area. The PSU’s collectively cover t
50 States and the District of Columbia. The 52 largest PSU
are selected into the sample with certainty and are referred
as self-representing PSU’s. The other PSU’s in the unive
are referred to as non-self-representing PSU’s. These PS
are clustered into 73 strata, and 2 sample PSU’s are cho
from each stratum with probability proportional to populatio
size. This gives a total of 198 PSU’s selected in the first sta
Within a PSU, two types of second stage units are us
area segments and permit area segments. Area segment
defined geographically and contain an expected eight hou
holds. Permit area segments cover geographical areas con
ing housing units built after the 1980 census. The permit a
egments are defined using updated lists of building perm
issued in the PSU since 1980 and contain an expected f
households.
Within each segment, all occupied households are t
geted for interview. On occasion, a sample segment m
contain a large number of households. In this situation t
households are subsampled to provide a manageable in
viewer workload.
The sample was designed so that a typical NHIS sam






























































































icapproximately 7,500 segments containing about 59,000 assi
households. Of these households, an expected 10,000 w
vacant, demolished, or occupied by persons not in the ta
population of the survey. The expected sample of 49,
occupied households will yield a probability sample of abo
127,000 persons.
Features of the National Health Interview Survey
sample redesign
Starting in 1985, the NHIS design incorporated seve
new design features (26). The major changes include
following:
+ The use of an all-area frame—The NHIS sample is now
designed so that it can serve as a sample frame for o
NCHS population-based surveys. In previous NHIS desig
about two-thirds of the sample was obtained from lists
addresses compiled at the time of the decennial cen
that is, a list frame. Due to Bureau of the Census co
dentiality restrictions, these sample addresses could
used for only those surveys being conducted by
Bureau of the Census. The methodology used to ob
addresses in the 1985 NHIS area frame does not use
census address lists. The sample addresses thus obt
can be used as a sampling frame for other NCHS surv
+ The NHIS as four panels—Four national subdesigns, o
panels, constitute the full NHIS. Each panel contains
representative sample of the U.S. civilian noninstitution
ized population. Each of the four panels has the sa
sampling properties, and any combination of panels def
a national design. Panels were constructed to facilitate
linkage of NHIS to other surveys and also to efficien
make large reductions in the size of the sample
eliminating panels from the survey.
During 1990–92 the sample consisted of 25,253 segm
containing 182,850 assigned households. Of the 179,176 ho
holds eligible for interview, 142,638 households were actua
interviewed, resulting in a sample of 368,075 persons.
+ The oversampling of black persons—One of the goals in
designing the current NHIS was to improve the precis
of estimates for black persons. This was accomplished
the use of differential sampling rates in PSU’s wi
between about 5 and 50 percent black population. S
pling rates for selection of segments were increased
areas known to have the highest concentrations of b
persons. Segment sampling rates were decreased in
areas within the PSU to ensure that the total sample
each PSU was the same size as it would have been wit
oversampling black persons.
+ The reduction of the number of sampled PSU’s—
Interviewer travel to sample PSU’s constitutes a la
component of the total field costs for the NHIS. Th
previous NHIS design included 376 PSU’s. Resea
showed that reducing the number of sample PSU’s w
increasing the sample size within PSU’s would redu
travel costs and also maintain the reliability of hea















+ The selection of two PSU’s per non-self-representi
stratum—In the previous design, one PSU was select
from each non-self-representing stratum. This feature ne
sitated the use of less efficient variance estimation pro
dures; the selection of two PSU’s allows more efficie
variance estimation methodology (27).
Collection and processing of data
The NHIS questionnaire contains two major parts: T
first consists of topics that remain relatively the same fro
year to year. Among these topics are the incidence of ac
conditions, the prevalence of chronic conditions, perso
limited in activity due to chronic conditions, restriction i
activity due to impairment or health problems, and utilizatio
of health care services involving physician care and short-s
hospitalization. Occasionally new questions are incorpora
into the main questionnaire. Since 1985, questions that ask
household members’ city and State of birth, social secu
number, and father’s last name, have been included. In 1
questions were added that ask the location (city, county,
State) of any physician contact whether by telephone or
person; and for household members born in the United Sta
how many years they have lived in the State of residence,
for household members born in a foreign country, how ma
years they have lived in the United States. Since 1992
question was added for persons 12–21 years of age concer
whether they were either now going to school or on vacat
from school. Race was expanded into 15 detailed rac
groupings and included an ‘‘Other race’’ category. In 1992 t
Hispanic origin question was moved from section L (questio
4a and 4b) to section A (questions 4e and 4f).
The second part consists of special topics added
supplements to each year’s questionnaire. Beginning in Aug
1987, a special set of supplemental questions on the a
population’s knowledge and attitudes about acquired immu
deficiency syndrome (AIDS) was added to the National Hea
Interview Survey using Computer Assisted Personal Intervi
(CAPI).
Careful procedures are followed to ensure the quality
data collected in the interview. Most households in the sam
are contacted by mail before the interviewers arrive. Poten
respondents are informed of the importance of the survey
assured that all information obtained in the interview will b
held in strict confidence. Interviewers make repeated trips t
household when a respondent is not immediately found. T
success of these procedures is indicated by the response
for the survey, which has been between 95 and 98 percent
the years.
When contact is made, the interviewer attempts to ha
all family members of the household 19 years of age and o
present during the interview. When this is not possible, pro
responses for absent adult family members are accepted
most situations, proxy respondents are used for persons u
19 years of age. Persons 17 and 18 years of age may res
for themselves, however.
Interviewers undergo extensive training and retrainin


































































































csobservation and by reinterview. Their work is also evalua
by statistical studies of the data they obtain in their interview
A field edit is performed on all completed interviews so that
there are any problems with the information on the questi
naire, respondents may be recontacted to solve the proble
Completed questionnaires are sent from the Bureau of
Census field offices to NCHS for coding and editing. To ens
the accuracy of coding, a 5-percent sample of all questi
naires is recoded and keyed by other coders. A 100-per
verification procedure is used if certain error tolerances
exceeded. Staff of the Division of Health Interview Statisti
then edit the files to remove impossible and inconsist
codes.
The interview, fieldwork, and data processing procedu
summarized previously are described in detail in Series 1,
18 (28).
Estimation procedures
Because the design of NHIS is a complex multista
probability sample, it is necessary to reflect these comp
procedures in the derivation of estimates (26). The estim
presented in this report are based on 1990–92 sample pe
counts weighted to produce national estimates. The weight
each sample person is the product of four component weig
+ Probability of selection—The basic weight for each perso
is obtained by multiplying the reciprocals of the probabi
ties of selection at each step in the design: PSU, segm
and household.
+ Household nonresponse adjustment within segment—I
NHIS, interviews are completed in about 95 percent of
eligible households. Because of household nonrespons
weighting adjustment is required. The nonresponse adj
ment weight is a ratio with the number of households in
sample segment as the numerator and the numbe
households actually interviewed in that segment as
denominator. This adjustment reduces bias in an estim
to the extent that persons in the noninterviewed hou
holds have the same characteristics as the persons in
interviewed households in the same segment.
+ First-stage ratio adjustment—The weight for persons in
the non-self-representing PSU’s is ratio adjusted to
1980 population within four race-residence classes of
non-self-representing strata within each geographic reg
+ Poststratification by age-sex-race—Within each of 60
age-sex-race cells (table I), a weight is constructed eac
quarter to ratio adjust the first-stage population estim
based on the NHIS to an independent estimate of
population of each cell. These independent estimates
prepared by the Bureau of the Census and are upd
quarterly.
The main effect of the ratio-estimating process is to ma
the sample more closely representative of the target popula
by age, sex, race, and residence. The poststratification ad
ment helps to reduce the component of bias resulting fr
sampling frame undercoverage; furthermore, this adjustm














As noted, NHIS data were collected on a weekly basi
with each week’s sample representing the resident, civilia
noninstitutionalized population of the United States livin
during that week. The weekly samples are consolidated
produce quarterly files (each consisting of data for 13 week
Weights to adjust the data to represent the U.S. population
assigned to each of the four quarterly files. These quarte
files are later consolidated to produce the annual file, which
the basis of most tabulations of NHIS data.
NHIS uses various reference periods to reduce the amo
of bias associated with respondent memory loss. A 2-we
reference period is used in collecting data on the incidence
acute conditions, restriction in activity due to a health prob
lem, and physician contacts. Each of these measures he
events that may be forgotten soon after they occur. Examp
of such events are telephoning a physician about a min
illness, missing a day from work because of a routine hea
problem, or having a cold. Either a 12- or 6-month (dependin
on the type of statistic) reference period is used for hospita
ization data because hospitalization ordinarily involves
major event in a person’s life and is not quickly forgotten
Chronic condition prevalence estimates are based on a 12-mo
reference period.
Because most NHIS estimates based on a 2-week ref
ence period are designed to represent the number of he
events for a 12-month period, these data must be adjusted
an annual basis. Data based on a 2-week reference period
multiplied by 6.5 to produce the 13-week estimate for th
quarter. These reference period adjustments are made at
time that the quarterly files are produced. Therefore, the da
can be used to produce estimates for each quarter and are u
that way to study seasonal variation. The data from the fo
quarterly files (representing the number of events in ea
quarter) are summed to produce the annual estimate. Althou
these data are collected for only 2 weeks for each pers
included in the survey, any unusual event that may ha
occurred during a particular 2-week period does not bias t
estimate because the quarterly estimate is a sum of
estimates produced for each week’s sample during the en
quarter and the annual estimate is the sum of the four quarte
For prevalence statistics, such as the number of perso
limited in activity due to chronic conditions, the annua
estimate results from summing the weighted quarterly file
and dividing by 4. This division is necessary because, as no
above, each quarterly file has been weighted to produce
estimate of the number of persons in the U.S. population w
a given characteristic. Summing the four quarters and dividin
by 4 in effect averages these quarterly results for the ye
Thus, the type of prevalence estimate ordinarily derived fro
NHIS data is an annual average prevalence estimate. Si
larly, an estimate for 3 years is obtained by averaging 1
quarterly figures.
For data related to short-stay hospital discharges that
based on a 6-month reference period, cases identified dur
any quarter of data collection are multiplied by 2 to produce

























































































theassociated with short-stay hospital discharges. The N
average annual estimate of hospital discharges is derived
summing the four quarterly estimates and dividing by 4, ju
as the prevalence estimates are.
Reliability of the estimates
Because NHIS estimates are based on a sample, they
differ somewhat from the figures that would have been obtai
if a complete census had been taken using the same surve
processing procedures. There are two types of errors pos
in an estimate based on a sample survey: Sampling
nonsampling errors. To the extent possible, these types
errors are kept to a minimum by methods built into the surv
procedures described earlier (29). Although it is very diffic
to measure the extent of bias in NHIS, several studies h
been conducted to examine this problem. The results h
been published in several reports (30–34).
Nonsampling errors
Interviewing process
Information, such as the number of days of restrict
activity caused by the condition, can be obtained more ac
rately from household members than from any other sou
because only the persons concerned are in a position to re
this information. However, there are limitations to the acc
racy of diagnostic and other information collected in hous
hold interviews. For example, for diagnostic information, t
household respondent can usually pass on to the intervie
only the information the physician has given to the family. F
conditions not medically attended, diagnostic information
often no more than a description of symptoms. Further
respondent may not answer a question in the intended ma
because he or she has not properly understood the ques
has forgotten the event, does not know, or does not wish
divulge the answer. Regardless of the type of measure,
NHIS data are estimates of known reported morbidity, disa
ity, and so forth.
Reference period bias
NHIS estimates do not represent a complete measur
any given topic during the specified calendar period beca
data are not collected in the interview for persons who died
became institutionalized during the reference period.
many types of statistics collected in the survey, the refere
period is the 2 weeks prior to the interview week. For such
short period, the contribution by decedents to a total invent
of conditions or services should be very small. However,
contribution by decedents during a long reference period (s
as 1 year) might be significant, especially for older person
Underreporting associated with a long reference period
most germane to data on hospitalization. Analysis has sh
that there is an increase in underreporting of hospitalizati
with an increase in the time interval between the discharge
the interview. Exclusive of the hospital experience of de



























in the neighborhood of 10 percent (35). The underreporting
discharges within 6 months of the week of interview i
estimated to be about 5 percent (35). For this reason, hosp
discharge data are based on hospital discharges reported
have occurred within 6 months of the week of interview.
Because hospitalization is common in the period immed
ately preceding death or institutionalization and older perso
are much more likely to die than younger ones, the data sho
not be used to estimate the volume of hospitalization of th
elderly—although the data can be used to measure charac
istics of elderly people.
It should further be noted that, although the reporte
frequencies and rates related to hospital episodes are prese
by the year in which the data were collected, the estimates a
in most cases, based on hospitalizations that occurred dur
the year of data collection and the prior year. Overall, approx
mately one-half of the reported hospitalizations for the 12-mon
reference period occurred in the year prior to the year of da
collection.
Population estimates
Some of the published tables include population figure
for specified categories. Except for overall totals for the 6
age, sex, and race groups, which are adjusted to independ
estimates, these figures are based on the sample of househ
in NHIS. They are given primarily to provide denominator
for rate computation, and for this purpose they are mo
appropriate for use with the accompanying measures of hea
characteristics than other population data that may be ava
able. With the exception of the overall totals by age, sex, a
race mentioned previously, the population figures may diff
from figures (which are derived from different sources) pub
lished in reports of the Bureau of the Census. Official popul
tion estimates are presented in Bureau of the Census report
Series P-20, P-25, and P-60.
The population estimates for 1990, 1991, and 1992 a
inflated to national population controls by age, race, and se
The population controls are based on the 1980 census car
forward to 1990, 1991, and 1992. Therefore, the estimat
may differ from 1990 census results brought forward to th
survey date. Population controls incorporating census resu
will be used for survey estimation beginning later in th
decade.
Rounding of numbers
In published tables, the figures are rounded to the near
thousand, although they are not necessarily accurate to t
detail. Derived statistics, such as rates and percent distrib
tions, are computed after the estimates on which these
based have been rounded to the nearest thousand.
Combining data years
To reduce sampling error, data for number of years ma
be combined. However, in so doing, the questionnaire for ea
of the years should be checked, because even a small cha













































Table I. The 60 poststratification age-sex-race cells in the
National Health Interview Survey
Age
Black All other
Male Female Male Female
Under 1 year . . . . . . . . . . . . . . . . x x x x
1–4 years . . . . . . . . . . . . . . . . . . x x x x
5–9 years . . . . . . . . . . . . . . . . . . x x x x
10–14 years . . . . . . . . . . . . . . . . x x x x
15–17 years . . . . . . . . . . . . . . . . x x x x
18–19 years . . . . . . . . . . . . . . . . x x x x
20–24 years . . . . . . . . . . . . . . . . x x x x
25–29 years . . . . . . . . . . . . . . . . x x x x
30–34 years . . . . . . . . . . . . . . . . x x x x
35–44 years . . . . . . . . . . . . . . . . x x x x
45–49 years . . . . . . . . . . . . . . . . x x x x
50–54 years . . . . . . . . . . . . . . . . x x x x
55–64 years . . . . . . . . . . . . . . . . x x x x
65–74 years . . . . . . . . . . . . . . . . x x x x
75 years and over . . . . . . . . . . . . . x x x x
Table II. Estimated standard error parameters for the National




I Number of chronic conditions . . . . . . . . –0.0000218 4,700.0
II Days of restricted activity or bed days . . . 0.0001214 173,333.3
III Population estimates for demographic,
socioeconomic, and health
characteristics . . . . . . . . . . . . . . . . . –0.0000048 1,190.0
IV Age-sex-race population based on
combining the poststratification cells
of table I . . . . . . . . . . . . . . . . . . . . 0.0 0.0
NOTE: The National Health Interview Survey contained a full sample in 1990, 1991, and
1992. Therefore, 142,368 households were interviewed resulting in a sample of 368,075
persons. Standard error parameters for disability days are for the whole sample; 30%
variance cut-offs were estimated by multiplying by a factor of 6.derived estimates. This caution also applies to using NH
data on health measures where changes in other events,
as legislative changes, have occurred over time.
Sampling errors
The standard error is primarily a measure of sampl
error, that is, the variations that might occur by chan
because only a sample of the population is surveyed.
chances are about 68 in 100 that an estimate from the sam
would differ from a complete census by less than the stand
error. The chances are about 95 in 100 that the differe
would be less than twice the standard error and about 9
100 that it would be less than 2 1/2 times as large.
Individual standard errors were not computed for ea
estimate in this report. Instead, standard errors were comp
for a broad spectrum of estimates. Regression techniques
then applied to produce equations from which a standard e
for any estimate can be approximated. The regression e
tions, represented by parametersa and b, are presented in
table II. Rules explaining their use are presented in the follo
ing section.
The reader is cautioned that this procedure will give
approximate standard error of an estimate rather than
precise standard error. The reader is further cautioned
particular care should be exercised when the denominato
small.
General rules for determining standard
errors
To produce approximate standard errors for NHIS e
mates, the reader must first determine the type of character
to be estimated, that is, the parameter set intable II to be used.
The reader must then determine the type of estimate for wh
the standard error is needed. The type of estimate corresp
to one of five general rules for determining standard erro
Examples of their use are available in theCurrent Estimates
reports for 1990, 1991, and 1992 (2–4).
Rule 1. Estimated number of people or events—For the
estimated number of people or events published in this rep
there are two cases to consider. For the first case, if
estimated number is any combination of the poststratificat
age-sex-race cells intable I, then its value has been adjusted
official Bureau of the Census figures and its standard erro
assumed to be 0.0. This corresponds to parameter set I
table II. As an example, this would be the case for the num
of persons in the U.S. target population or the number of bl
persons in the 45–64 year age group. Although the race c
‘‘white’’ is not specifically adjusted to Bureau of the Censu
figures, it dominates the poststratification ‘‘all other’’ rac
class; consequently, age-sex-‘‘all other’’ race combinations
table I can be treated as age-sex-white combinations for
purpose of approximating standard errors.
For the second case, the standard errors for all o
estimates of numbers of people or events, such as the num










are approximated by using the parameters provided intable II
and formula 1 below.
If the aggregatex for a characteristic has associated
parametersa andb, then the approximate standard error forx,
SE(x), can be computed by the formula
SE~x) =√ax2 + bx (1)
Rule 2. Proportions and percents when the denominato
is not generated by the poststratification age-sex-rac
classes—If p represents an estimated percent,b is the param-
eter from table II associated with the numerator characteris
tics, andy is the number of persons in the denominator on
which p is based, then the standard error ofp may be
approximated by
SE(p) =Œ bp(100 –p)y (2)
(If p is a proportion, then the above formula can be use























Rule 3. For rates, proportions, and percents when th
denominator is generated by the poststratification age-se
race classestable I—In this case, the denominator has n
sampling error. For example, rule 2 would apply to th
estimated number of females 18–44 years of age with deafn
or other hearing problems because the denominator is
combination of the poststratification cells. Approximate sta
dard errors for such estimates can be computed usingtable II,
a andb parameters associated with the numerator characte
tics along with formula 3 below.
If the estimate of rate, proportion, or percentp is the ratio
of two estimated numbers,p = x/Y (wherep may be inflated
by 100 for percents or 1,000 for rates per 1,000 persons), w
Y having no sampling error, then the approximate standa
error forp is given by the formula
SE (p) = pŒ a + bx (3)
In this report, the value of the denominatorY is always
provided, but in a number of cases the numerator valuex is not
published. For these cases, the values ofx may be computed
by the formula









if p is a rate per 1,000 units
1,000
Rule 4.Rates when the denominator is not generated
the poststratification age-sex-race classes—If the estimated
rate p is expressed as the ratio of two estimates,p = x/y
(inflated by 100 or 1,000 when appropriate), then the es
mated standard error forp is given by the formula



















Where SE(x) and SE(y) are computed using rule 1 andx
and y are obtained from the tables. No estimates ofr, the
correlation between the numerator and denominator, are pr
sented in this report; therefore, only the first two terms ar
available. The reader must assume thatr = 0.0. Assumingr =
0.0 will yield an overestimate of the standard error ifr is
actually positive and an underestimate ifr is negative.
Rule 5. Difference between two statistics (mean, rate
total, and proportion)—If x1 andx2 are two estimates, then the
standard error of the difference (x1 – x2) can be computed as
follows:
SE~x1 – x2) =√SE (x1)2 + SE(x2)2 – 2r SE(x1) SE(x2) (5)
where SE(x1) and SE(x2) are computed using rules 1–4 as
appropriate andr is the correlation coefficient betweenx1 and
x2.
Assumingr = 0.0 will result in an accurate standard error
if the two estimates are actually uncorrelated and will result i
an overestimate of the standard error if the correlation i
positive or an underestimate if the correlation is negative.
Relative standard errors
Prior to 1985, relative standard error (RSE) curves wer
present inCurrent Estimatesfor approximating relative stan-
dard errors. For readers who wish to continue using them, th
following provides guidance. The RSE of an estimate i
obtained by dividing the standard error (SE) of the estimate b




















































Definitions of certain terms
used in this report
Terms relating to conditions
Condition—Condition is a general term that includes a
specific illness, injury, or impairment. Condition data a
derived from the survey in two ways. First, respondents
asked to identify any conditions that caused certain type
impact associated with health, such as a visit to a doctor
day spent in bed. Second, respondents are read lists of sel
chronic conditions and asked whether they or any fam
members have any of these conditions. The latter informa
is used in making the prevalence estimates in this report.
At a later point in the survey, a series of questions is as
about each of the conditions identified in either of the t
ways just described. The information obtained on each co
tion helps to clarify the nature of the condition and wheth
medical services have been involved in its diagnosis
treatment. It also aids in the coding of the condition. A
conditions except impairments are coded according to
ninth revision of theInternational Classification of Disease
(5) with certain modifications adopted to make the codes m
suitable for information derived from a household survey
special set of codes devised by NHIS is used to c
impairments (6).
Chronic condition—A condition is considered chronic i
the respondent indicates it was first noticed more tha
months before the reference date of the interview, or it i
type of condition that ordinarily has a duration of more than
months. Examples of conditions that are considered chro
regardless of their time of onset are diabetes, heart conditi
emphysema, and arthritis. A complete list of these conditi
may be obtained by contacting the Division of Health Int
view Statistics, National Center for Health Statistics.
Impairment—An impairment is a chronic or permane
defect, usually static in nature, that results from disea
injury, or congenital malformation. It represents a decreas
or loss of ability to perform various functions, particular
those of the musculoskeletal system and the sense org
Impairments are grouped according to type of functio
impairment and etiology in the special NHIS impairme
codes.
The impairment classification is shown in the NCH
Medical Coding Manual. (6). It should be noted that t
statistics on selected chronic conditions shown in this rep
are for the number of chronic conditions, not the number















more than one condition in summary categories, such as he
disease, the number of conditions exceeds the number
persons with conditions.
Chronic condition groupings—Data in this report are
presented in six sets of chronic condition groups. The
groupings with their respective ICD codes and X codes f
impairments are as follows:
1. Chronic circulatory conditions
Heart disease. . . . . 410–417,420.9,421.0,9, 422.9, 423,424
425.0–5,9,426,427.0–6,8,9,428,429.0–
8,9, 745,746,785.0–2
Ischemic heart disease. . . . . . . . . . . . . . . . .410–414,429.6
Heart rhythm disorders. . . . . . . . . . . 427.0–6,8,9,785.0–2
Tachycardia or rapid heart. . . . . . . . . . . 427.0–3,785.0
Heart murmurs. . . . . . . . . . . . . . . . . . . . . . . . . . . .785.2
Other and unspecified heart rhythm
disorders. . . . . . . . . . . . . . . . . . . . . .427.4–6,8,9, 785.1
Congenital heart disease. . . . . . . . . . . . . . . . . . . . 745,746
Other selected diseases of the heart (excludes
hypertension). . . . . . . . . . . 415–417,420.9,421.0,9,422.9
423,424,425.0–5,9, 426,428,429.0–5,8
Rheumatic fever with or without heart
disease. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .390,392–399
High blood pressure (hypertension). . . . . . . . . . . . .401–405
Cerebrovascular disease. . . . . . . . . . . . . . 430–435,436–438
Hardening of the arteries. . . . . . . . . . . . . . . . . . . . . . . . . 440
Aneurysm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .441.0–6,442
Phlebitis, thrombophlebitis. . . . . . . . . . . . . . . . . . . . . . . . 451
Varicose veins of lower extremities. . . . . . . . . . . . . . . . . 454
Hemorrhoids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 455
Poor circulation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .459,8,9
2. Chronic respiratory conditions
Chronic bronchitis. . . . . . . . . . . . . . . . . . . . . . . . . . .490,491
Emphysema. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 492
Asthma. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 493
Hayfever or allergic rhinitis without asthma. . . . . . . . . . 477
Nasal polyps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 471
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 473
Deviated nasal septum. . . . . . . . . . . . . . . . . . . . . . . . . . . 470
Chronic disease of tonsils and adenoids. . . . . . . . . . . . . 474
Chronic laryngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 476
Pleurisy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 511






s,Malignant neoplasms of lung and bronchus and other
respiratory sites. . . . . . . . . . . . . . . . 160,161,162.0,2–9,163
Other diseases of the lung. . . . . . . . . . . . . . . . . . . .515–518
3. Chronic digestive conditions
Gallbladder stones. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 574
Liver diseases including cirrhosis. . . . . . . 571,572,573.0,3–9
Ulcer, gastric, duodenal and/or peptic. . . . . . . . . . . 531–533
Gastric ulcer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 531
Duodenal ulcer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 532
Peptic ulcer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 533
Hernia of abdominal cavity. . . . . . . . . . . . . . . . . . .550–553
Disease of the esophagus. . . . . . . . . . . . . . . . . . . . . . . . . 530
Gastritis and duodenitis. . . . . . . . . . . . . . . . . . . . . . . . . . . 535
Indigestion and other functional disorders of the
stomach and digestive system. . . . . . . . . . . . . . . . . 536,787
Enteritis and colitis. . . . . . . . . . . . . . . . . . . . . . .555,556,558
Spastic colon. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .564.1
Diverticula of intestines. . . . . . . . . . . . . . . . . . . . . . . . . . 562
Constipation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .564.0
Other stomach and intestinal disorders . . . 534,537,560,
Malignant neoplasms of stomach, intestines, colon,
and rectum. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .151–154
4. Impairment and chronic condition of nervous system
and sense organs
Blindness and other visual impairments. . . . . . . . . X00–X03
Blind, both eyes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X00
Other visual impairments. . . . . . . . . . . . . . . . . . . .X01–X03
Deafness and other hearing impairments. . . . . . . . X05–X09
Deaf, both ears. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X05
Other hearing impairments. . . . . . . . . . . . . . . . . . .X06–X09
Speech impairments. . . . . . . . . . . . . . . . . . . . . . . .X10–X11
Impairment of sensation. . . . . . . . . . . . . . . . . . . . . . . . . X12
Mental retardation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X19
Absence of extremities or parts of extremities
(excluding absence of tips of fingers or toes
only) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .X20–X29
Absence of upper extremities or parts of upper
extremities . . . . . . . . . . . . . . . . . . . . . . . . . . . . .X20–X25
Absence of lower extremities or parts of lower
extremities . . . . . . . . . . . . . . . . . . . . . . . . . . . . .X26–X29
Absence of lung . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X30
Absence of kidney. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X31
Absence of breast. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X32
Absence of bone, joint, or muscle of extremity. . . . . . X34
Absence of tips of fingers, toes. . . . . . . . . . . . . . . . . . . X35
Paralysis of extremities, complete or partial. . . . . X40–X59
Paralysis of extremities, complete. . . . . . . . . . . X40–X49
Paralysis of extremities, partial. . . . . . . . . . . . . X50–X59
Cerebral palsy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . X50
Paralysis of other site, complete or partial. . . . . . X60–X64
Deformities or orthopedic impairments,
total . . . . . . . . . . . . . . . X70,X71,X73–X80, X84–X86,X89
Deformities or orthopedic impairments of
back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .X70,X71,X80729
Curvature or other deformity of back or
spine. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X70
Deformities or orthopedic impairments of upper
extremities . . . . . . . . . . . . . . . . . . . . . . . . .X73,X74,X84
Orthopedic impairment, shoulder. . . . . . . . . . . . . . . . X84
Deformities or orthopedic impairments of lower
extremities . . . . . . . . . . . . . . . . . . . . . . X75–78,X85,X86
Flat feet . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X77
Other deformities or orthopedic impairments . . X79,X8
Cleft palate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X91
Conditions of nervous system and sense organs
Glaucoma. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 365
Cataracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 366
Color blindness. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .368.5
Diseases of retina. . . . . . . . . . . . . . . . . . . . . . . .361,362.1–9
Tinnitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .388.3
Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 345
Migraine headache. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 340
Other headache (excludes tension headache). . . . . . . . 784.0
Multiple sclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 340
5. Chronic conditions of skin and subcutaneous tissue a
musculoskeletal system and connective tissue
Condition of skin and subcutaneous tissue
Sebaceous skin cyst. . . . . . . . . . . . . . . . . . . . . . . . . . . .706.2
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .706.0,1
Psoriasis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 696
Dermatitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .690–694
Dry (itching) skin, not elsewhere classified. . . . . . . . . 698.9
Chronic ulcer of skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . 707
Ingrown nails. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .703.0
Corns and calluses. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 700
Benign neoplasms of the skin. . . . . . . . . . . . . . . . . . . . . . 216
Malignant neoplasmss of the skin. . . . . . . . . . . . . . 172,173
Condition of musculoskeletal system
and connective tissue
Arthritis . . . . . . . . . . . . . 71.0,9,712.8,9,714–716,720.0,721
Rheumatism, unspecified. . . . . . . . . . . . . . . . . . . . . . .729.0
Sciatica (including lumbago). . . . . . . . . . . . . . . . . . .724.2,3
Intervertebral disc disorders. . . . . . . . . . . . . . . . . . . . . . . 722
Bone spur or tendinitis, not otherwise specified. . . . . 726.9
Disorders of bone or cartilage . . 730.0–3,9,731.0,2,732,7
Bunions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .727.1
Bursitis, not elsewhere classified. . . . . . . 726.0–8,727.0,2–9
6. Endocrine, nutritional,and metabolic disease and immuni
disorders, diseases of the blood and blood-forming organ
and chronic genitourinary conditions
Endocrine, nutritional, and metabolic
disease and immunity disorder
Gout . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 274
Goiter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .240,241,242.0–3

















































Diabetes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250
Diseases of the blood and blood-forming organs
Anemias. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .280–285
Genitourinary conditions
Kidney stones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 592
Kidney infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 590
Other kidney trouble, not elsewhere
classified . . . . . . . . . . . . . . . . . . . . . . . . . . . . .581–583,593
Bladder infections. . . . . . . . . . . . . . . . . . . . . . . .595.0–3,8,9
Other disorders of bladder. . . . . . . . . . . . . . . . . . .594.1,596
Diseases of prostate. . . . . . . . . . . . . . . .600.0–3,5–9,601,602
Inflammatory disease of female genital organs. . . . 614–616
Noninflammatory disease of female genital
organs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .620–624
Menstrual disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 626
Other diseases of female genital organs. . . . . . . . . 617–619,
625,627,628.0,2–9,629.0,1,8
Female trouble, not otherwise specified. . . . . . . . . . . . 629.9
Malignant neoplasm of breast. . . . . . . . . . . . . . . . . . . . . . 174
Malignant neoplasm of female genital organs. . . . . 179–184
Malignant neoplasm of prostate. . . . . . . . . . . . . . . . . . . . 185
Benign neoplasm of breast. . . . . . . . . . . . . . . . . . . . . . . . 217
Benign neoplasm of female genital organs. . . . . . . 218–221
Prevalence of condition—In general, prevalence of condi-
tion is the estimated number of conditions of a specified ty
existing at a specified time or the average number exist
during a specified interval of time. The prevalence of chron
conditions is defined as the number of chronic cases repor
to be present or assumed to be present at the time of
interview. Those assumed to be present at the time of int
view are cases specified by the respondent as present on
selected chronic condition list or described by the respond
in terms of one of the diseases on the list of conditions alwa
considered chronic (see definition of chronic condition abov
and reported to have been present at some time during
12-month period prior to the interview.
Onset of condition—A condition is considered to have
had its onset when it was first noticed. This could be the tim
the person first felt sick or became injured, or it could be th
time when the person or his or her family was first told by
physician that the person had a condition of which he or s
had been previously unaware.
Terms relating to disability
Disability—Disability is a general term that refers to an
long- or short-term reduction of a person’s activity as a res
of an acute or chronic condition.Limitation of activityrefers to
a long-term reduction in a person’s capacity to perform t
average kind or amount of activities associated with his or h
age group.Restriction of activityrefers to particular kinds of
behavior usually associated with a reduction in activity due
either long- or short-term conditions. Thus limitation of activ





restriction of activity ordinarily refers to a relatively short-
term reduction in a person’s activities below his or her norm
capacity.
Limitation of activity because of chronic conditions—
Persons are classified in terms of the major activity usual
associated with their particular age group. The major activitie
for the age groups are:
1. Ordinary play for children under 5 years of age
2. Attending school for those 5–17 years of age
3. Working or keeping house for persons 18–69 years of a
4. Capacity for independent living (for example, the ability
to bathe, shop, dress, eat, and so forth, without needi
the help of another person) for those 70 years of age a
over
People 18–69 years of age who are classified as keeping ho
are also classified by their ability to work at a job or busines
(In this report, the major activity of persons 65–69 years
assumed to be working or keeping house; however, questio
were also asked about the capacity for independent living
this age group, which would permit an alternative definition o
limitation.)
In regard to these activities, each person is classified in
one of four categories:
1. Unable to perform the major activity
2. Able to perform the major activity but limited in the kind
or amount of this activity
3. Not limited in the major activity but limited in the kind or
amount of other activities
4. Not limited in any way
In regard to these four categories, NHIS publications ofte
classify persons only by whether they are limited (groups 1–
or not limited (group 4). Persons are not classified as limite
in activity unless one or more chronic conditions are reporte
as the cause of the activity limitation. If more than one
condition is reported, the respondent is asked to identify th
condition that is the major cause of the limitation.
Restriction of activity—Four types of restricted activity
are measured in NHIS:bed days, work-loss daysfor currently
employed persons 18 years of age and over,school-loss days
for children 5–17 years of age, andcut-down days.
A bed dayis one during which a person stayed in bed
more than half a day because of illness or injury. All hospita
days for inpatients are considered bed days even if the pati
was not in bed more than half a day.
A work-loss dayis one on which a currently employed
person 18 years of age and over missed more than half a d
from a job or business.
A school-loss dayis one on which a student 5–17 years o
age missed more than half a day from the school in which h
or she was currently enrolled.
A cut-down dayis a day on which a person cuts down for
more than half a day on the things he or she usually does.
Work-loss, school-loss, and cut-down days refer to th
short-term effects of illness or injury. However, bed days are









































































chronically ill bedridden person and a person with a co
could both report having spent more than half a day in bed d
to an illness.
The number of restricted-activity days is the number
days a person experienced at least one of the four type
activity restriction just described. It is the most inclusiv
measure of disability days and the least descriptive; 4 day
restricted activity may mean 4 bed days associated w
serious illness or 4 days during which a person merely
down on his or her activities due to a mild illness.
A single restricted-activity day may involve both a be
day and a work-loss or school-loss day. However, a cut-do
day cannot overlap with any of these three types of disabi
days. In calculating the sum of restricted-activity days, ea
day is counted only once even if more than one type
activity restriction was involved.
Restricted-activity days may be associated with eith
persons or conditions.Person daysare the number of days
during which a person restricted his or her activity.Condition
daysare the number of days during which a condition caus
a person to restrict his or her activity. A person day
restricted activity can be caused by more than one condit
In such a case, each condition causing restriction is associ
with that day of restricted activity. Therefore, the number
condition days of restricted activity may exceed the number
person days of restricted activity. This relationship holds
each type of restricted-activity day.
When two or more conditions cause a day of restrict
activity, the conditions may be (1) both (all) acute, (2) on
(some) acute and the other (some) chronic, or (3) both (
chronic. The number of restricted-activity days associated w
acute conditions includes groups (1) and (2); the number
such days associated with chronic conditions includes gro
(2) and (3). The phrase ‘‘associated with’’ rather than ‘‘caus
by’’ is used to indicate that some days associated with acut
chronic conditions are not necessarily caused solely by t
type of condition.
Terms relating to physician contacts
Physician contact—A physician contact is defined a
consultation with a physician, in person or by telephone,
examination, diagnosis, treatment, or advice. (Physician c
tacts with hospital inpatients are not included.) The contac
considered to be a physician contact if the service is provid
directly by the physician or by a nurse or other person act
under a physician’s supervision. For the purpose of t
definition, ‘‘physician’’ includes doctors of medicine an
osteopathic physicians. The term ‘‘doctor’’ is used in th
interview rather than ‘‘physician’’ because of popular usag
However, the concept toward which all instructions are direc
is that which is described here.
Physician contacts for services provided on a mass b
are not included in the tabulations. A service received on
mass basis is defined as any service involving only a sin
test (such as a test for diabetes) or a single procedure (suc
a measles inoculation) when this single service is administe





























Hence obtaining a chest x-ray in a tuberculosis chest x-r
trailer is not included as a physician contact. However,
special chest x-ray given in a physician’s office or in a
outpatient clinic is considered a physician contact.
If a physician is called to a house to see more than o
person, the call is considered a separate physician contact
each person about whom the physician is consulted.
A physician contact is associated with the person abo
whom the advice is sought, even if that person does n
actually see or consult the physician. For example, if a moth
consults a physician about one of her children, the physici
contact is ascribed to the child.
Terms relating to hospitalization
Hospital—For this survey, a hospital is defined as an
institution either named in the listing of hospitals in the
currentAmerican Hospital Association Guide to the Health
Care Field or found on theMaster Facility Inventory List
maintained by the National Center for Health Statistics.
Hospital episode—A hospital episode is any continuous
period of stay of 1 night or more in a hospital as an inpatie
except the period of stay of a well newborn infant.
Demographic terms
Age—The age recorded for each person is the age at l
birthday. Age is recorded in single years and grouped in
variety of distributions depending on the purpose of the tab
Geographic region—For the purpose of classifying the
population by geographic area, the States are grouped i
four regions. These regions, which correspond to those us
by the Bureau of the Census, are as follows:
Region States included
Northeast Maine, Vermont, New Hampshire, Massach
setts, Connecticut, Rhode Island, New York
New Jersey, and Pennsylvania
Midwest Ohio, Illinois, Indiana, Michigan, Wisconsin,
Minnesota, Iowa, Missouri, North Dakota, South
Dakota, Kansas, and Nebraska
South Delaware, Maryland, District of Columbia, Wes
Virginia, Virginia, Kentucky, Tennessee, North
Carolina, South Carolina, Georgia, Florida, Ala
bama, Mississippi, Louisiana, Oklahoma, Arkan
sas, and Texas
West Washington, Oregon, California, Nevada, Ne
Mexico, Arizona, Idaho, Utah, Colorado, Mon-
tana, Wyoming, Alaska, and Hawaii
Race—The population is divided into three racial groups
‘‘white,’’ ‘‘black,’’ and ‘‘all other.’’ ‘‘All other’’ includes Aleut,
Eskimo or American Indian, Asian or Pacific Islander, and an
other races. Race characterization is based on the resp
dent’s description of his or her racial background.
Income of family or of unrelated individuals—Each mem-








omthe family of which he or she is a member. Within th
household, all persons related to each other by blood, m
riage, or adoption constitute a family. Unrelated individua
are classified according to their own incomes.
The income recorded is the total of all income received
members of the family (or by an unrelated individual) in thr-
12-month period preceding the week of interview. Incom
from all sources—for example, wages, salaries, rents fro



















Vital and Health Statistics
series descriptions
SERIES 1. Programs and Collection Procedures —These reports
describe the data collection programs of the National Center
for Health Statistics. They include descriptions of the methods
used to collect and process the data, definitions, and other
material necessary for understanding the data.
SERIES 2. Data Evaluation and Methods Research —These reports
are studies of new statistical methods and include analytical
techniques, objective evaluations of reliability of collected
data, and contributions to statistical theory. These studies also
include experimental tests of new survey methods and
comparisons of U.S. methodology with those of other
countries.
SERIES 3. Analytical and Epidemiological Studies —These reports
present analytical or interpretive studies based on vital and
health statistics. These reports carry the analyses further than
the expository types of reports in the other series.
SERIES 4. Documents and Committee Reports —These are final
reports of major committees concerned with vital and health
statistics and documents such as recommended model vital
registration laws and revised birth and death certificates.
SERIES 5. International Vital and Health Statistics Reports —These
reports are analytical or descriptive reports that compare U.S.
vital and health statistics with those of other countries or
present other international data of relevance to the health
statistics system of the United States.
SERIES 6. Cognition and Survey Measurement —These reports are
from the National Laboratory for Collaborative Research in
Cognition and Survey Measurement. They use methods of
cognitive science to design, evaluate, and test survey
instruments.
SERIES 10. Data From the National Health Interview Survey —These
reports contain statistics on illness; unintentional injuries;
disability; use of hospital, medical, and other health services;
and a wide range of special current health topics covering
many aspects of health behaviors, health status, and health
care utilization. They are based on data collected in a
continuing national household interview survey.
SERIES 11. Data From the National Health Examination Survey, the
National Health and Nutrition Examination Surveys, and
the Hispanic Health and Nutrition Examination Survey —
Data from direct examination, testing, and measurement on
representative samples of the civilian noninstitutionalized
population provide the basis for (1) medically defined total
prevalence of specific diseases or conditions in the United
States and the distributions of the population with respect to
physical, physiological, and psychological characteristics, and
(2) analyses of trends and relationships among various
measurements and between survey periods.
SERIES 12. Data From the Institutionalized Population Surveys —
Discontinued in 1975. Reports from these surveys are
included in Series 13.
SERIES 13. Data From the National Health Care Survey —These
reports contain statistics on health resources and the public’s
use of health care resources including ambulatory, hospital,
and long-term care services based on data collected directly
from health care providers and provider records.
SERIES 14. Data on Health Resources: Manpower and Facilities —
Discontinued in 1990. Reports on the numbers, geographic
distribution, and characteristics of health resources are now
included in Series 13.
SERIES 15. Data From Special Surveys —These reports contain
statistics on health and health-related topics collected in
special surveys that are not part of the continuing data
systems of the National Center for Health Statistics.
SERIES 16. Compilations of Advance Data From Vital and Health
Statistics —Advance Data Reports provide early release of
information from the National Center for Health Statistics’
health and demographic surveys. They are compiled in the
order in which they are published. Some of these releases
may be followed by detailed reports in Series 10–13.
SERIES 20. Data on Mortality —These reports contain statistics on
mortality that are not included in regular, annual, or monthly
reports. Special analyses by cause of death, age, other
demographic variables, and geographic and trend analyses
are included.
SERIES 21. Data on Natality, Marriage, and Divorce —These reports
contain statistics on natality, marriage, and divorce that are
not included in regular, annual, or monthly reports. Special
analyses by health and demographic variables and
geographic and trend analyses are included.
SERIES 22. Data From the National Mortality and Natality Surveys —
Discontinued in 1975. Reports from these sample surveys,
based on vital records, are now published in Series 20 or 21.
SERIES 23. Data From the National Survey of Family Growth —
These reports contain statistics on factors that affect birth
rates, including contraception, infertility, cohabitation,
marriage, divorce, and remarriage; adoption; use of medical
care for family planning and infertility; and related maternal
and infant health topics. These statistics are based on
national surveys of women of childbearing age.
SERIES 24. Compilations of Data on Natality, Mortality, Marriage,
Divorce, and Induced Terminations of Pregnancy —
These include advance reports of births, deaths, marriages,
and divorces based on final data from the National Vital
Statistics System that were published as supplements to the
Monthly Vital Statistics Report (MVSR). These reports provide
highlights and summaries of detailed data subsequently
published in Vital Statistics of the United States. Other
supplements to the MVSR published here provide selected
findings based on final data from the National Vital Statistics
System and may be followed by detailed reports in Series 20
or 21.
For answers to questions about this report or for a list of reports published
in these series, contact:
Data Dissemination Branch
National Center for Health Statistics
Centers for Disease Control and Prevention
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